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The objective of this dissertation was to investigate the manipulation and 
regulation of post-weaning growth in the pig. Specific objectives, as reflected in the 
individual chapters of this thesis, were to investigate the basis for differences in post-
weaning growth rate and the modification of growth achieved through the use of two feed 
additives: tylosin phosphate (TP) and ractopamine hydrochloride (RAC). In the first 
experiment, 18 cannulated barrows (initial BW = 32.6 ± 1.2 kg) were utilized to evaluate 
the impact of TP on energy and nutrient digestibility in growing pigs fed corn-soybean 
meal or corn-soybean meal-distillers dried grains with solubles (DDGS) based diets. 
Results of this study indicated that the ileal digestibility of all indispensible AA, except 
leucine, and the apparent total tract digestibility of energy and fiber was lower (P < 0.05) 
in corn-soybean meal-DDGS-based diets than in corn-soybean meal-based diets. Tylosin 
phosphate did not affect digestibility of AA or digestibility and gastrointestinal tract flow 
of energy (P > 0.10). A second experiment was conducted to determine if a higher fiber 
diet alters the response of finishing pigs to TP and RAC in terms of N and water 
utilization and energy digestibility using 72 gilts (initial BW = 107.4 ± 4.2 kg) housed in 
individual metabolism pens. Ractopamine HCl improved ADG (P < 0.0001), feed 
efficiency (P < 0.0001), and N retention (P < 0.001) and tended to increase daily water 
intake (P < 0.10), and the response to RAC was similar in both corn-soybean meal based 
and corn-soybean meal-DDGS based diets. Tylosin phosphate tended to increase ADG in 
pigs fed corn-soybean meal based diets (P < 0.10), but not in diets containing 30% 
DDGS (P > 0.10), but this response was not accompanied by changes in N balance or 
energy digestibility. A third experiment was conducted to develop a better understanding 
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of the metabolic basis for poor post-weaning growth in pigs using RNA-Seq 
transcriptional profiling of skeletal muscle and adipose tissue. A total of 1,054 pigs were 
reared in commercial conditions and weighed at birth, weaning, and 3 weeks post-
weaning. Transition average daily gain (tADG) was calculated as the average daily gain 
for the 3-wk period post-weaning. Nine pigs from each of the lowest 10th percentile (low 
tADG) and the 60th-70th percentile (high tADG) for transition ADG were harvested at 3 
weeks post-weaning. Differential expression analysis was conducted in longissimus dorsi 
muscle (LM) and subcutaneous adipose tissue. In LM, 768 transcripts were differentially 
expressed (DE), and no DE transcripts were identified in adipose tissue. The group of DE 
genes with lower expression in LM of low tADG pigs was enriched in genes with 
functions related to muscle contraction, glucose metabolism, cytoskeleton organization, 
muscle development, and response to hormone stimulus (enrichment score > 1.3). The 
list of DE genes with higher expression in low tADG LM was enriched in genes with 
functions related to protein catabolism (enrichment score > 1.3). Analysis of known gene-
gene interactions identified forkhead box O1 (FOXO1), growth hormone (GH1), and the 
glucocorticoid receptor (NR3C1) as possible regulators of these differences in gene 
expression. Differences in transcript abundance between poor transitioning pigs and their 
contemporaries indicate a possible shift to decreased protein synthesis, increased protein 
degradation, and reduced glucose metabolism in the LM of low tADG pigs. Post-weaning 
growth is a complex biological process that is influenced by nutritional, genetic, and 
environmental factors. These experiments provide findings that enhance the 
understanding of the manipulation and regulation of post-weaning growth in the pig. 
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CHAPTER 1. LITERATURE REVIEW 
Introduction 
Brody (1945) classically defined growth as “the constructive or assimilatory 
synthesis of one substance at the expense of another which undergoes dissimilation”. 
Growth in pigs results from the conversion of dietary nutrients, mainly plant-based 
materials, into body proteins and other nitrogenous compounds, structural and depot 
lipids, minerals and, to a very small extent, carbohydrates Differences in the rate of 
deposition for each component result in changes in body composition during pig growth. 
It is generally accepted that the growth of pigs in terms of weight per unit of time from 
conception through senescence occurs in a sigmoidal pattern (Whittemore and Kyriazakis, 
2006). This pattern consists of a period of slow growth at conception, which is followed 
by rapid growth through puberty until a period of terminal deceleration occurs as animals 
approach mature size. Even though a number of genetic, environmental, management, 
and nutritional factors can affect the rate of growth, this fundamental pattern of growth 
remains the same (Elsley, 1976).  
An understanding of growth and development is key to determining the impact of 
nutrition and management strategies on pig performance. The objective of this 
dissertation was to investigate the manipulation and regulation of post-weaning growth in 
the pig. Specific objectives, as reflected in the individual chapters of this thesis, were to 
investigate the basis for differences in post-weaning growth rate and the modification of 
growth achieved through the use of two feed additives: tylosin phosphate (Tylan®, 
Elanco Animal Health, Greenfield, IN) and ractopamine hydrochloride (RAC; Paylean®, 
Elanco Animal Health, Greenfield, IN; Engain™, Zoetis, Florham Park, NJ). This 
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dissertation is comprised of a literature review, three manuscripts published in or 
accepted by the Journal of Animal Science and one general conclusions section. 
The objectives of this review are to summarize the published literature on the 
stimulation of growth by two common feed additives, ractopamine hydrochloride (RAC) 
and tylosin phosphate (TP) and to summarize the literature pertaining to poor post-
weaning growth in pigs. 
 
Tylosin Phosphate 
Tylosin is a 16-member ring macrolide antibiotic (Figure 1) that was originally 
isolated from a strain of Streptomycetes fradiae found in soil from Thailand (Jordan et al., 
1960). The phosphate form of tylosin, tylosin phosphate, is approved in the U.S. for 
inclusion in diets for various species including swine, beef cattle, and broiler chickens. In 
swine feeds, TP is currently approved in the U.S. for the following: 1) for increased rate 
of weight gain and improved feed efficiency, 2) for control of porcine proliferative 
enteropathies (ileitis) associated with Lawsonia intracellularis, 3) for control of swine 
dysentery associated with Brachyspira hyodysenteriaeor and 4) for maintaining weight 
gains and feed efficiency in the presence of atrophic rhinitis. 
 
Bactericidal Effects of Tylosin 
Tylosin inhibits bacterial protein synthesis by binding to the 23S rRNA in the 50S 
subunit of the bacterial ribosome (Corcoran et al., 1977). Tylosin is effective against 
Gram-positive bacteria; however, it also has activity against some Gram-negative 
bacteria, mycoplasmas, vibrios and spirochetes (Giguere et al., 2007). Tylosin has been 
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shown to be effective for the prevention and treatment of several swine diseases 
including porcine proliferative enteropathies (PPE, ileitis) caused by Lawsonia 
intracellularuis (McOrist et al., 1997), swine dysentery associated with Brachyspira 
hyodysenteriae (Curtis, 1962) and enzootic pneumonia caused by Mycoplasma 
hyopneumoniae (Vicca et al., 2005). 
 
Figure 1. Chemical structure of tylosin. Figure adapted from Petropoulos et al. (2008). 
 
Mode of Action of Tylosin Phosphate and other Antibiotic Growth Promoters  
Although the precise growth promoting mechanism of orally ingested antibiotic 
growth promoters (AGP) is unknown, it is presumed that their effects are mediated by 
the reduction of the overall numbers and/or the numbers of species of gut bacteria 
(Collier et al., 2003; Dibner and Richards, 2005; Gaskins et al., 2002; Visek, 1978). This 
is supported by early studies showing that oral antibiotics did not have growth-promoting 
effects when given to germ-free animals (Coates et al., 1963).  
Several mechanisms of action for the growth promoting actions of antibiotics 
have been suggested including: 1) reduction in opportunistic pathogens and subclinical 
infection, 2) reduction in microbial metabolites that depress growth, 3) suppressed 
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microbial degradation of nutrients prior to absorption, and 4) enhanced uptake and use of 
nutrients through the thinner intestinal wall associated with antibiotic-fed animals 
(Gaskins et al., 2002; Visek, 1978). The reduction in gut wall thickness has been used to 
explain the enhanced nutrient digestibility observed with AGP. These mechanisms point 
towards reduced immunological stress in AGP fed animals. Injection of bacterial 
metabolites such as lipopolysaccharides or immune mediators such as interleukin-1 can 
mimic the reduced efficiency of an animal with a conventional microflora and no 
antimicrobial in the diet (Roura et al., 1992), which illustrates the importance of the host 
response to the microflora as a major factor limiting growth efficiency. The host response 
to the gut microflora is quite costly. Experiments have demonstrated that AGP can 
increase the net energy available for growth by approximately 2.5% (Vervaeke et al., 
1979). This is, in part, due to improvements in nitrogen utilization (Roth and 
Kirchgessner, 1993; Roth et al., 1994), reduced gut epithelial cell turnover (Visek, 1978) 
and reduced mucus secretion (Gaskins et al., 2002) in AGP fed animals. 
Tylosin phosphate has been shown to decrease total bacterial populations in the 
small intestine of growing pigs (Collier et al., 2003; Gedek et al., 1992). Collier et al. 
(2003) utilized 4-wk-old barrows that were ileally cannulated and placed on an antibiotic-
free diet, a diet with TP, or a weekly rotation of antibiotics. Relative to the no antibiotic 
controls, antibiotic treatments reduced species diversity and total number of bacteria. 
Concentration of Lactobacillus, a genus of commensal bacteria known to competitively 
exclude potentially pathogenic species from colonizing the intestine, was increased in TP 
fed pigs. Kim et al. (2012) also reported higher relative concentrations of Lactobacillus 




Growth Promoting Effects of Tylosin Phosphate 
The use of TP as an antibiotic feed additive to enhance production performance 
has been widely demonstrated in growing swine. In a summary of antibiotic effects, Hays 
(1979) reported that TP improved ADG by 14.8, 10.9, and 4.6% in the nursery, grower, 
and finisher phases, respectively, when summarized across 21 to 27 experiments for each 
phase. The same summary also reported improvements in feed efficiency of 6.0, 4.2, and 
1.5% in the nursery, grower, and finisher phases, respectively. More recent studies have 
shown that TP-induced improvement in carcass muscling (Van Lunen, 2003) and carcass 
gain to feed ratio (Puls et al., 2009) in pigs, indicating TP may indirectly improve 
partitioning of dietary nutrients to carcass lean. 
Several studies have demonstrated that TP improves digestibility and utilization 
of N and energy in growing pigs (Kirchgessner et al., 1995; Roth and Kirchgessner, 1993; 
Roth et al., 1994). There is evidence that virginiamycin, another AGP commonly used in 
swine diets, increases the apparent ileal digestibility of AA (Stewart et al., 2010); 
however,  there is no published information on the impact of tylosin phosphate on 
standardized ileal digestibility (SID) of AA. 
 
Ractopamine Hydrochloride 
Ractopamine hydrochloride is an orally active β-adrenergic receptor (βAR) 
agonist. It is approved by the Food and Drug Administration in the U.S. for inclusion in 
finishing swine diets at 5 to 10 mg/kg for the last 20.4 to 40.8 kg of body weight gain. 
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The RAC compound is also approved in the U.S. for inclusion in diets of finishing cattle 
and turkeys. 
 
Figure 1. Chemical structure of ractopamine hydrochloride. 
 
Ractopamine Hydrochloride Mode of Action 
Ractopamine administration elicits responses via βAR. Three isoforms of βAR 
have been identified in swine, β1, β2, and β3 (Mills et al., 2003). The βAR are present on 
the cell membrane of most mammalian cells, but their distribution and proportion varies 
among tissues and species (Mersmann, 1998). Ractopamine HCl activates both the β1 and 
β2 isoforms (Spurlock et al., 1993). The βAR are stimulated physiologically by the 
catecholamines, norepinephrine and epinephrine. 
The βAR are cell membrane receptors that belong to the G-protein-coupled 
receptor (GPCR) family. The GPCR are 7-transmembrane domain proteins defined by 
their selective coupling to heterotrimeric G-protein (Gαβγ). Binding of the β-agonist to 
the βAR promotes the interaction between intracellular domains of the βAR and the G-
protein. This interaction catalyzes the exchange of guanosine triphosphate for guanosine 
diphosphate in the Gα subunit and leads to the dissociation of the Gα from Gβγ. The 
activated Gα activates adenylyl cyclase, catalyzing the synthesis of cAMP from ATP. 
The cAMP in turn activates protein kinase A (PKA) leading to subsequent 
phosphorylation of a number of intracellular proteins (Mersmann, 1998). 
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Some of these proteins are enzymes that are activated when phosphorylated, 
including hormone sensitive lipase, the rate-limiting enzyme for triglyceride degradation. 
The effect of RAC on stimulating lipolysis in porcine adipose tissue has been demonstrated 
in vitro (Mills et al., 2003); however, decreases in carcass adiposity have not always occurred 
in vivo in response to RAC (Dunshea et al., 1993). The responsiveness of adipose tissue to 
RAC is short-lived due to rapid desensitization or down regulation of the adipose βARs 
(Spurlock et al., 1994). 
The primary effect of βAR agonists is to cause skeletal muscle fiber hypertrophy. 
Evidence of an increase in protein synthesis and/or a decrease in protein degradation has been 
reported for pigs fed RAC (Bergen et al., 1989; Sainz et al., 1993). Adeola et al. (1992) 
demonstrated that RAC-fed pigs had increased protein concentration in longissimus dorsi and 
biceps femoris muscles and that this was due to an increase in the fractional synthesis rates of 
myofibrillar, but not sarcoplasmic proteins. The mode of action of RAC in skeletal muscle is 
thought to be via direct activation of βAR, resulting in a shift from slow-twitch (type IIA and 
IIX) to fast-twitch (type IIB) muscle fibers in pigs (Depreux et al., 2002; Gunawan et al., 
2007); however, the exact mechanisms of this response in skeletal muscle are not fully 
understood. 
 
Impact of Ractopamine Hydrochloride on Pig Growth 
The growth performance and carcass responses to RAC have been well 
documented. When fed to pigs, RAC improves average daily gain, feed efficiency, 
carcass leanness, and carcass cutting yield (Adeola et al., 1990; Bohrer et al., 2013; 
Patience et al., 2009; Peterson et al., 2015). Feeding RAC also decreases N excretion and 
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increases N retention in finishing pigs (Ross et al., 2011). In a meta-analysis of the RAC 
response in finishing pigs, Apple et al. (2007) reported that 5 mg RAC/kg improved ADG 
by 12% and G:F by 10% with no change in ADFI (23 studies). Schinckel et al. (2003) 
developed a model to predict the RAC response (Figure 2). The response to 5 vs. 0 mg/kg 
RAC is predicted to be 12% greater ADG (1.15 vs. 1.03 kg/d) and gain:feed (0.401 vs. 
0.360 kg/kg) for a 78 to 110 kg BW feeding period.  
 
 
Figure 2.Effect of ractopamine on predicted ADG (kg/d) and gain:feed (kg/kg) as modeled 
by Schinckel et al. (2003). 
 
The RAC-induced response in growth and feed efficiency declines over time (See 
et al., 2004; Williams et al., 1994). This is thought to be due to down regulation or 
desensitization of the β-adrenergic receptors in the membranes of adipose and muscle 
tissue (Sainz et al., 1993; Spurlock et al., 1994). Because of the declining growth 
response to RAC, the dietary AA requirements of RAC-fed pigs also decline over the 
RAC feeding period (Schinckel et al., 2003; Schinckel et al., 2006). Increasing RAC 
concentration in the diet during the RAC feeding period (i.e., step-up program) has been 
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shown to extend the period in which RAC is most effective (Rikard-Bell et al., 2009; See 
et al., 2004). It is well established that the RAC-induced response in growth performance 
tends to decline over time; however, many swine producers currently feed only one diet 
during the RAC-feeding period (i.e., constant RAC level and SID AA concentrations). 
This likely results in underfeeding of AA early in the RAC feeding period and 
overfeeding of AA later in the RAC feeding period (Schinckel et al., 2006). There is 
currently a lack of data demonstrating RAC-induced changes in N utilization over time. 
More information is needed to quantify changes in nutrient utilization during this period 
to understand if changes to current RAC feeding recommendations are warranted. 
 
Impact of Ractopamine Hydrochloride on Water Utilization 
Ractopamine supplementation increases carcass lean and water content (Dunshea 
et al., 1993; Ross et al., 2011); therefore, it can be assumed that RAC-fed pigs would 
require more water to sustain the RAC-induced increase in protein and water deposition. 
Recent results by Ross et al. (2011), reported that pigs fed 5 and 10 mg RAC/kg actually 
consumed 0.4 and 1.0 L less water per day and had lower urinary water excretion than 
controls. These somewhat surprising results warrant further investigation on the impact of 
RAC on water utilization. 
 
Interactive Effects of Tylosin Phosphate, Ractopamine Hydrochloride, and Dietary 
Fiber 
Increased inclusion of corn co-products has increased the concentration of dietary 
fiber in typical US swine diets, raising concerns about energy and nutrient digestibility, 
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and pig performance. In general, distillers dried grains with solubles (DDGS) have 
greater concentrations of protein, lipids, vitamins, minerals, and fiber than its parent grain 
because of the removal of most of the starch during the fermentation portion of the 
ethanol production process. However, the SID of AA, especially Lys, and the apparent 
total tract digestibility (ATTD) of energy are generally lower and more variable than in 
the parent grain (Stein and Shurson, 2009; Widyaratne and Zijlstra, 2007). This reduction 
in energy and nutrient digestibility may be due, in part, to the greater levels of dietary 
fiber (Gutierrez et al., 2014). Dietary fiber is less digestible than starch and can increase 
specific endogenous losses of nutrients and alter passage rate (Souffrant, 2001). There are 
several reports of the digestibility of nutrients within DDGS (Almeida et al., 2011; 
Fastinger and Mahan, 2006; Gutierrez et al., 2014; Urriola and Stein, 2010); however, 
there is very little information on the effect of the addition of DDGS to complete diets on 
digestibility of nutrients and energy within those diets. 
There is also very limited information on the impact of ractopamine HCl (RAC) 
and tylosin phosphate (TP) when used in combination. The benefits of RAC and TP may 
be at least partially additive as their modes of action greatly differ. Both additives are 
commonly used in the North American pig industry, but recent increases in the fiber 
content of practical diets raises questions about the response of pigs under this changing 
nutritional regime.  
 
Post-weaning Growth Rate 
The period immediately post-weaning involves a myriad of stressors and is 
associated with poor feed intake, reduced growth performance, and impaired gastro-
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intestinal function in pigs (Moeser et al., 2007; Wijtten et al., 2011). While most pigs 
recover quickly from the stress of weaning, others do not. Previous research indicates that 
poor performance during the weaning transition period is associated with poor overall 
wean-to-finish performance and increased mortality. Tokach et al. (1992) reported that 
pigs that lost weight during the first wk post-weaning were 8.0 kg lighter at 156 d post-
weaning and required over 10 more d to achieve market weight than pigs that gained 
greater than 227 g/d during the first wk post-weaning. Jones (2012) reported that pigs in 
the bottom 10th percentile for ADG during the first 3 wk post-weaning were 7.7 kg lighter 
at 22 wk post-weaning and had over 3 times as many mortalities during the wean-to-
finish period than their contemporaries in the 60th-70th percentile for ADG during the first 
3 wk post-weaning. 
 
Characterizations of Pigs with Poor Post-weaning Growth Rates 
In recent years, two main characterizations have emerged for pigs that perform 
poorly during the post-weaning transition period. Jones (2012) defined fallback pigs as 
“those that fail to achieve performance equal to that of their contemporaries.” This definition 
is quite broad and encompasses pigs that are light birth weight pigs, which have a diminished 
capacity for postnatal growth due to intrauterine growth retardation, and pigs with a normal 
or heavy birth weight that fail to achieve performance equal to their contemporaries due to a 
number of compromising factors, including poor nutrition, environmental conditions, or 
disease. Huang et al. (2011) clinically characterized PFTS as “the progressive debilitation 
of weanling (nursery) pigs in the absence of discernible and detrimental infections, 
nutritional, managemental, or environmental factors that can explain the clinical 
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syndrome. At weaning, affected pigs are of average to above average body weight, and 
neither affected pigs nor their cohorts show evidence of residual illnesses from the 
suckling phase. Within 7 days of weaning, pigs are anorexic and lethargic. They 
deteriorate and within 2 to 3 weeks of weaning demonstrate marked muscle weakness 
and loss of body condition. Some affected pigs in all affected farms show repetitive oral 
behavior such as licking, chewing, or chomping. In affected farms, morbidity and 
mortality by batch varies by time, but case fatality is high”. The incidence of PTFS has 
been reported in North America and Europe (Huang et al., 2011; Segales et al., 
2012),with a mean flow prevalence estimated at 4.3% in the U.S. and Canada (O'Sullivan 
et al., 2014). While these definitions differ slightly, they often encompass many of the 
same individuals within a population of pigs. 
It was originally hypothesized that both fallback PFTS were associated with or 
caused by infections agents. Jones et al. (2014) reported no differences between fallback 
pigs and their contemporaries for the incidence of Haemophilus parasuis, porcine 
circovirus type 2 (PCV2), rotavirus, Streptococcus suis, or Salmonella spp B infection or 
for immune marker concentrations (i.e. IgA, IL-1β, IL-8, and total glutathione) in serum 
or ileal mucosa at 3 wk post-weaning. Likewise, Huang et al. (2012) found a lack of 
evidence that PFTS is caused by common swine pathogens including porcine 
reproductive and respiratory syndrome virus, PCV2, influenza A virus, alphacoronavirus 
1 (transmissible gastroenteritis virus), rotavirus A, betacoronavirus 1, Clostridium. 
perfringens, pathogenic Escherichia coli, Brachyspira hyodysenteriae, Brachyspira 
pilosicoli, Bordetella spp., Streptococcus spp., Haemophilus parasuis, Pasteurella 
multocida, and coccidia. Huang and Harding (2014) were unable to experimentally 
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replicate the symptoms of PFTS by attempting to infect normal pigs with tissue 
homogenates of PFTS pigs. These authors concluded that PFTS may not have an 
infections etiology. 
Moeser et al. (2012) presented compelling evidence that PFTS is associated with 
profound alterations in intestinal barrier function and alterations in mucosal and epithelial 
morphology. Pigs exhibiting PFTS had lower transepithelieal electrical resistance and 
higher fluorescein isothiocyanate-dextran flux compared to both control and fasted pigs 
at 4 d post-weaning. Ileum from PFTS pigs exhibited greater villus atrophy and crypt 
hyperplasia than ileum from control pigs at 4 and 11 d post-weaning and fasted pigs at 4 
d post-weaning. Huang et al. (2012) also noted significant villus atrophy in the small 
intestine of PFTS pigs. 
While much of the research on fallback pigs and PFTS has focused on 
pathological and immunological measures, little is known about post-absorptive 
metabolism in these poor-performing phenotypes. Poor weaning transition in pigs is often 
associated with low feed intake (Huang et al., 2011; Jones et al., 2012) and decreased 
protein and lipid deposition rates (Jones et al., 2012; Jones and Patience, 2014); however, 
more research is needed to better understand the biological mechanisms that are involved 
in variable post-weaning outcomes. This may enable us to identify molecular pathways 
that could be targeted to increase productive efficiency by optimizing genetics, 
management and nutrition at the farm level. Skeletal muscle is a key component of 
growth and is capable of physiological adaptations to a variety of conditions including 
disease, stress, and reduced nutrient availability. The remainder of this review will focus 




Skeletal Muscle Growth 
Skeletal muscle growth is highly regulated and occurs as a result of both 
hyperplasia, an increase in cell number, and hypertrophy, an increase in cell size. 
Hyperplasia occurs during myogenesis, the formation of muscle fibers from 
mononucleated cells, during fetal development. The main steps of myogenesis include: 1) 
determination of myogenic precursor cells into myoblasts, 2) myoblast proliferation, 3) 
myoblast differentiation and fusion into myotubes, and 4) maturation of muscle fibers 
(Rehfeldt et al., 2000; Stockdale and Miller, 1987). These events determine the number 
of muscle fibers that are formed prenatally. 
Skeletal muscle fibers develop from mesodermal progenitor cells in the somites. 
Commitment of precursor cells to muscle cell lineages occurs upon activation of 
myogenic regulatory factors. Once myogenic precursors have been specified, skeletal 
muscle development requires differentiation and fusion of the precursors to form 
multinucleated myotubes and myofibers. Muscle fibers are formed in the fetus as two 
distinct waves. The first wave occurs during the early stages of embryogenesis and results 
in the formation of primary myotubes. These primary fibers serve as the scaffolding on 
which a second population of myoblasts forms secondary fibers (Ashmore et al., 1973). 
In pigs, primary muscle fiber formation occurs from d 35 to d 55 of gestation; whereas, 
secondary muscle fiber formation occurs from d 55 to d 90 of gestation (Foxcroft et al., 
2006). A third population of myoblasts, the satellite cells, remains quiescent. Satellite 
cells proliferate to increase the myonuclear population of myofibers and contribute nuclei 
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to myofibers during hypertrophic growth postnatally (Campion et al., 1981; Rehfeldt et 
al., 2000). 
In pigs and most mammals, the total number of myofibers is determined prior to 
birth (Stickland and Goldspink, 1973); therefore, postnatal growth of skeletal muscle is 
driven by hypertrophy of the existing fibers. This requires both the accretion of muscle-
specific proteins and an increase in the number of myonuclei. The quantity of cytoplasm 
regulated by a single myonucleus is tightly regulated (Allen et al., 1999), so additional 
myonuclei are required as the myofiber grows in mass. Nuclei within myofibers are post-
mitotic; therefore, satellite cells are responsible for an increase in muscle fiber DNA that 
occurs postnatally. 
 
Skeletal Muscle Protein Synthesis. 
Skeletal muscle hypertrophy occurs as a result of two dynamic and opposing 
processes: protein synthesis and protein degradation. Skeletal muscle growth occurs 
when the rate of protein synthesis exceeds that of degradation. The major intercellular 
pathway regulating muscle protein synthesis is the mechanistic target of rapamycin 
(mTOR) pathway. The mTOR pathway is highly conserved and has been studied 
extensively in a number of species, including pigs (Davis et al., 2008; Suryawan et al., 
2011). 
The mTOR pathway enhances global protein synthesis by increasing translation 
initiation via phosphorylation of both S6 kinase 1 (S6K1) and a repressor protein, 
eukaryotic initiation factor 4E (eIF4E) - binding protein 1 (4E-BP1). The mTOR pathway 
is regulated by a wide variety of cellular signals, including growth factors, nutrients, 
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cellular energy levels, and stress conditions. Anabolic signaling vial insulin and insulin-
like growth factors(IGFs) stimulate mTOR signaling via a signal transduction cascade 
involving phosphorylation of phosphatidylinositol 3-kinase (PI3K) and Akt.  Akt 
suppresses the activity of the tumor suppression complex (TSC1/TSC2). When activated, 
TSC1/TSC2 inhibits Ras homologue enriched in brain (Rheb), an essential activator of 
the protein kinase mTOR. The AMP-activated protein kinase (AMPK), which is a sensor 
for the cellular ratio of AMP/ATP, also regulates mTOR signaling. When cellular energy 
levels are low, AMPK activates TSC1/TSC2 (Wolff et al., 2011). 
When anabolic signaling is low, the 4E-BP1 protein represses translation 
initiation by binding to eIF4E, blocking eIF4E-eIF4G complex formation. When 4E-BP1 
is phosphorylated, eIF4E is released, which can then bind to eIF4G forming a complex 
that up-regulate mRNA binding to the 40S ribosomal subunit, thereby increasing 
translation initiation (Davis et al., 2008). When anabolic signaling via mTOR is high, 4E-
BP1 is phosphorylated, eIF4E is released, which can then bind to eIF4G forming a 
complex that up-regulates mRNA binding to the 40S ribosomal subunit, thereby 
increasing translation initiation (Davis et al., 2008).  
The mTOR pathway cannot be activated long-term by growth factors in the 
absence of amino acids .Several experiments using the neonatal pig as a model have 
shown that leucine is a key nutritional signal of amino acid availability via mTOR  
(Davis et al., 2002; Davis et al., 2000; Davis et al., 2008; Suryawan et al., 2011); 
however, prolonged stimulation of protein synthesis by leucine is also dependent on 




Skeletal Muscle Protein Degradation. 
There are three main intracellular proteolytic systems in muscle that contribute to 
skeletal muscle protein degradation: 1) the ubiquitin–proteasome system, 2) the calpain 
system, and 3) the autophagy-lysosome system. The autophagy-lysosome system plays a 
critical role in the turnover of damaged or unused proteins. There is a low level of 
lysosomal proteolytic activity in skeletal muscle and its overall contribution to catabolism 
in this tissue is small, except in the case of tissue injury (Farges et al., 2002). 
The calpains are cysteine proteases that require cytosolic calcium for activation. 
Calpains and calpastatin have been extensively studied in muscle of livestock species, 
because of their involvement in postmortem proteolysis and meat quality (Huff-Lonergan 
and Lonergan, 2005; Melody et al., 2004; Zhang et al., 2006). The calpain system plays a 
significant role in several cellular processes including cell motility, apoptosis, and protein 
turnover (Campbell and Davies, 2012; Cruzen et al., 2013). However, calpains do not 
fully degrade proteins; rather, they carry out limited cleavage of specific target proteins. 
Peptide chains cleaved via calpain enzymes are degraded to amino acids through the 
ubiquitin-proteasome system (Smith and Dodd, 2007).  
The ubiquitin-proteasome system is widely distributed among tissues and 
involves ubiquitin tagging of substrates and degradation by the proteasome. The initial 
step in the ubiquitin pathway is ATP-dependent and involves the linkage of ubiquitin to 
an ubiquitin-activating enzyme (E1). Ubiquitin is then transferred to an ubiquitin-
conjugating enzyme (E2). Ubiquitin-protein ligase (E3) binds to E2 and the protein 
substrate, inducing the transfer of ubiquitin from E2 to the substrate. Once the substrate is 
polyubiquitinated, it is presented to the 26S proteasome where proteolysis occurs. The 
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20S subunit is the catalytic core of the 26S proteasome with two 19S regulatory caps. The 
20S core is where proteins are degraded and the 19S regulatory caps have multiple 
ATPase active sites and ubiquitin binding sites to recognize polyubiquinated proteins to 
be transferred to the catalytic core. Two muscle specific E3 ligases, atrogin 1 and MuRF1 
have been identified as key markers of muscle atrophy in mammalian species and have 
been shown to be induced in multiple models of skeletal muscle atrophy resulting from a 
variety of conditions including muscle inactivity, multiple disease states, and starvation 
(Schiaffino et al., 2013). 
 
Link between Skeletal Muscle Protein Synthesis and Degradation. 
Muscle protein synthesis and protein degradation are independently regulated; 
however, they are closely linked by insulin-induced activation of Akt via the forkhead-
box O (FoxO) transcription factors In the presence of insulin or IGF-I, the 
phosphorylation via Akt pathway signaling sequesters FOXO transcription factors in the 
cytoplasm (Stitt et al., 2004). In the absence of insulin or IGF-I, Akt is inactive, and 
FOXO proteins are translocated to the nucleus and induce the transcription of target 
genes that encode the E3 ubiquitin ligases atrogen 1 and MuRF1, which regulate 
ubiquitin-proteasomal degradation (Kamei et al., 2004). Thus, in times of low feed intake 
(i.e., when insulin levels are low) muscle mass can be reduced by increasing protein 
degradation; whereas, high nutritional supply leads to the blockade of protein degradation 





Post-Weaning Growth Summary 
The transition at weaning is one of the most stressful events in the pig’s life and is 
associated with poor feed intake, reduced growth performance, and impaired gastro-
intestinal function. Improvements in technology related to nutrition, health, and 
management have been utilized to minimize the adverse effects of weaning stress; 
however, there is still a tremendous amount of within-population variation in growth 
performance during the post-weaning transition period. Previous research indicates that 
poor performance during the period immediately post-weaning is associated with poor 
overall wean-to-finish performance and increased mortality (Jones, 2012; Jones et al., 
2014), which ultimately reduces profitability for pig producers . While numerous 
contributing factors have been identified, many of the underlying biological and 
molecular mechanisms involved in post-weaning differences in growth performance are 
not well defined. 
Skeletal muscle is a key component of growth and is capable of physiological 
adaptations to a variety of conditions including disease, stress, and reduced nutrient 
availability. High-throughput sequencing techniques, such as RNA-Seq, are used to 
measure the expression of the transcriptome of a tissue and may help to identify complex 
biological mechanisms that are involved in variable post-weaning outcomes. Analyzing 
RNA profiles at critical points post-weaning may enable us to identify molecular 
pathways that could be targeted to increase productive efficiency by optimizing genetics, 
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CHAPTER 2. IMPACT OF TYLOSIN PHOSPHATE AND DISTILLERS DRIED 
GRAINS WITH SOLUBLES ON ENERGY AND NUTRIENT DIGESTIBILITY 
AND FLOW THROUGH THE GASTROINTESTINAL TRACT IN GROWING 
PIGS 
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Abstract 
The objective of this study was to evaluate the impact of tylosin phosphate (TP) 
on energy and nutrient digestibility and flow through the gastrointestinal tract in growing 
pigs fed corn-soybean meal or corn-soybean meal-distillers dried grains with solubles 
(DDGS) based diets. Eighteen barrows (initial BW = 32.6 ± 1.2 kg) were surgically fitted 
with a T-cannula in the distal ileum and allotted to a Youden square design with 6 diets 
and 3 replicate periods. Treatments were arranged in a 2 × 2 factorial: TP (0 vs. 44 mg/kg) 
and DDGS (0 vs. 25%). Two N-free dietary treatments (0 vs. 44 mg/kg TP) were also 
included for determining basal ileal endogenous AA losses (IAAend) and the effect of TP 
on basal IAAend. Replicate periods included 4 d of adaptation to treatments and 2 
sampling periods. Fecal collection occurred on d 5 and 6 and ileal digesta collection 
occurred on d 7 and 8 for sampling period 1, whereas sampling period 2 included fecal 
collection on d 11 and 12 and ileal digesta collection on d 13 and 14. Apparent ileal  
______________________ 
*Department of Animal Science, Iowa State University, Ames 50011 
 †Elanco Animal Health, Greenfield, IN 46140 
29 
 
digestibility (AID) and apparent total tract digestibility (ATTD) were calculated for 
DM,energy, and NDF. The AID and standardized ileal digestibility (SID) of AA were 
calculated. Inclusion of DDGS reduced AID (68.0 vs. 72.8%; P < 0.001) and ATTD 
(79.9 vs. 85.0%; P < 0.001) of energy. There were no effects of TP on energy 
digestibility. Inclusion of DDGS increased the amount of GE (1.47 vs. 1.18 Mcal/kg DMI; 
P < 0.001) and NDF (94 vs. 60 g/kg DMI; P <0.001) remaining at the terminal ileum; 
however, hindgut disappearance of energy (0.55 vs. 0.53 Mcal/kg DMI) and NDF (13 vs. 
15 g/kg DMI) was similar between the corn-soybean meal-DDGS and corn-soybean meal 
based diets. There were no effects of TP on basal IAAend; therefore, SID AA values were 
calculated using means of the 2 N-free diets. The SID of Lys (79.6 vs. 84.1%; P < 0.001) 
and all other indispensible AA, except Leu, was lower in the DDGS diets. Inclusion of 
TP did not influence SID of AA. In conclusion, under the conditions of this experiment, 
TP did not affect digestibility of AA or the digestibility and gastrointestinal tract flow of 
energy and the inclusion of DDGS did not affect the response to TP. 
 
Key words: tylosin phosphate, distillers dried grains with solubles, swine 
 
Introduction 
Tylosin phosphate (TP) is a macrolide antibiotic used in swine diets to prevent 
and control certain diseases, such as ileitis (McOrist et al., 1997) and swine dysentery 
(Curtis, 1962), and to improve growth performance and feed efficiency (Jordan et al., 
1960). Tylosin phosphate may also enhance N utilization (Roth and Kirchgessner, 1993), 
apparent total tract digestibility (ATTD) of N, AA, and energy (Kirchgessner et al., 1995; 
30 
 
Roth et al., 1994), and apparent ileal digestibility (AID) of some indispensable AA 
(Smiricky et al., 2002). To our knowledge, there are no published data on the effects of 
TP on standardized ileal digestibility (SID) of AA in swine diets or data designed to 
determine if higher fiber diets influence the response to TP. 
In general, distillers dried grains with solubles (DDGS) have greater 
concentrations of protein, lipids, vitamins, minerals, and fiber than its parent grain 
because of the removal of most of the cereal starch during the fermentation portion of the 
ethanol production process. However, the SID of AA, especially Lys, and the ATTD of 
energy are generally lower and more variable than in the parent grain (Stein and Shurson, 
2009; Widyaratne and Zijlstra, 2007). This reduction in energy and nutrient digestibility 
may be due, in part, to the greater levels of dietary fiber. Dietary fiber is less digestible 
than starch and can increase specific endogenous losses of nutrients and passage rate 
(Souffrant, 2001). There are several reports of the digestibility of nutrients within the 
ingredient DDGS; however, there is very little information on the effect of the addition of 
DDGS to complete diets on digestibility of nutrients and energy within those diets, and 
there is no information on the impact of antibiotic feed additives on digestibility of diets 
containing DDGS, or vice versa. It was our hypothesis that TP would improve the energy 
and AA digestibility of both corn-soybean meal and corn-soybean meal-DDGS based 
diets and reduce the digestibility of dietary fiber. The objective of this study was to 
evaluate the impact of TP on the AID and SID of AA and the AID, ATTD, and digestive 
tract flow of DM, energy, and NDF in growing pigs fed corn-soybean meal or corn-




Materials and Methods 
All experimental procedures adhered to the ethical and humane use of animals for 
research, and were approved by the Iowa State University Institutional Animal Care and 
Use Committee (#2-10-6900-S). 
 
Animals, Housing, and Experimental Design  
The experiment was conducted in an environmentally controlled room at the Iowa 
State University Swine Nutrition Farm (Ames, IA). Eighteen crossbred barrows (PIC 337 
sires × C22 or C29 dams, Pig Improvement Company, Hendersonville, TN) with an 
initial BW of 32.6 ± 1.2 kg were surgically fitted with a T-cannula in the distal ileum 
(Stein et al., 1998). After surgery, pigs were housed individually in 1.8 × 1.9 m pens. 
Each pen had a partially slatted concrete floor, a stainless steel feeder, and a nipple 
drinker. Water was available continuously throughout the experiment. Following a 7-d 
recovery period after surgery, pigs were randomly allotted to treatments in a Youden 
design with 6 diets and 3 periods. 
 
Diets and Feeding 
Dietary treatments were arranged as a 2 × 2 factorial (0 vs. 44 mg/kg TP and 0 vs. 
25% DDGS). A basal corn-soybean meal diet and a basal corn-soybean meal-25% DDGS 
diet were formulated to be isocaloric (ME-basis) and to contain similar concentrations of 
SID Lys and similar SID Lys:SID indispensable AA ratios (Tables 1 and 2). Tylosin 
premix (Tylan 40, Elanco Animal Health, Greenfield, IN) was added to each basal diet at 
a rate of 0.05% at the expense of corn. At this inclusion rate, the diets were supplemented 
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with 44 mg tylosin as TP per kilogram of feed.  Two N-free diets were also fed to 
estimate basal ileal endogenous AA losses (IAAend) and to determine the impact of 44 
mg/kg TP on basal IAAend. Minerals and vitamins were supplied at levels formulated to 
meet or exceed the requirements of 30- to 60-kg growing pigs (NRC, 1998). All diets 
contained 0.5% chromic oxide as an indigestible marker. Allotment to treatment diets 
was structured so that each pig was fed each diet type (i.e., corn-soybean meal based, 
corn-soybean meal-DDGS based, or N-free) for 1 of the 3 replicates. 
An attempt was made to feed pigs as close to ad libitum as possible to achieve 
intake similar to how these diets would be fed in commercial practice.  During the 7-d 
surgical recovery period, pigs were fed a typical corn-soybean meal diet at a level 3.5 
times the estimated energy required for maintenance (i.e., 3.50 × 106 kcal of ME per 
BW0.75; NRC, 1998). The daily allotment of feed was divided into 2 equal meals that 
were provided as a mash at 0700 and 1600 h. Not all pigs were able to achieve this level 
of intake; therefore, pigs were blocked by feed intake level (3.50 vs. 3.25 vs. 3.00 × 106 
kcal of ME per BW0.75 based on the average BW at the start of each 14-d replicate period 
using an estimated diet ME of 3.40 Mcal/kg diet). Individual pigs remained within the 
same feed intake block throughout the experiment. 
 
Sample Collection 
Pigs were weighed at the beginning and at the end of each period and the amount 
of feed provided at each meal was recorded. A representative feed sample was obtained 
from each replicate and then pooled for each of the 6 diets. For all pigs except those 
receiving the N-free diets, each replicate period included 4 d of adaptation to treatment 
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diets and 2 sampling periods. Feces were collected twice daily via grab sampling on d 5 
to 6 and 11 to 12 of dietary treatment for sampling periods 1 and 2, respectively. Ileal 
digesta was collected from 0730 to 1600 h on d 7 to 8 and 13 to 14 for sampling periods 1 
and 2, respectively, by attaching a 207-mL plastic bag (Whirl-Pak, Nasco, Fort Atkinson, 
WI) to the opened cannula with a cable tie. Bags were removed whenever they were 
filled with digesta or at least every 30 min. During each replicate period, pigs assigned to 
the 0 or 44 mg/kg TP N-free diets were fed the 0 or 44 mg/kg TP corn-soybean meal-
based diets, respectively, for 7 d followed by a 5-d acclimation to N-free diet and ileal 
digesta collection on d 13 to 14. All fecal and digesta samples were immediately stored at 
-20°C for later processing and assay. 
 
Analytical Methods and Calculations 
At the conclusion of each sampling period, ileal and fecal samples were thawed at 
room temperature and mixed thoroughly within animal and sampling period. A sub-
sample was collected, stored at -20°C, and then lyophilized (Model 10-100, Virtis Co. 
Ltd., Gardiner, NY) to a constant weight. Feed, fecal, and digesta samples were finely 
ground through a 1-mm screen in a grinder (Model ZM1, Retsch Inc., Newtown, PA) 
prior to chemical analysis. 
Feed, fecal, and digesta samples were analyzed in duplicate at the Iowa State 
University Monogastric Nutrition Laboratory (Ames, IA), unless otherwise noted. DM 
was determined by drying samples in an oven at 105°C to a constant weight. Gross 
energy was determined using a bomb calorimeter (Model 6200, Parr Instrument Co., 
Moline, IL) with benzoic acid used as a standard. Benzoic acid (6,318 kcal GE/kg; Parr 
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Instruments, Moline, IL) was used as the standard for calibration and was determined to 
contain 6,322 ± 10.4 kcal GE/kg. The NDF was determined by analyzing samples in 
triplicate using a fiber analyzer (Model 2000, ANKOM Technology Method 9; ANKOM 
Technology, Macedon, NY). Chromic oxide was determined using the method of Fenton 
and Fenton (1979) and absorption was measured at 440 nm using a spectrophotometer 
(Synergy 4; BioTek, Winooski, VT). Chromic oxide standard samples were assayed to 
confirm the accuracy of the analytical procedure, and a recovery of 100.7 ± 1.9% was 
attained. Digesta samples from sampling period 2 and feed samples were analyzed for N 
by Kjeldahl (Method 984.13; AOAC, 2005). Calibration was conducted with a Gly 
standard (N content 18.7%; Fisher Scientific, Fair Lawn, NJ), and was determined to 
contain 18.7 ± 0.2% N. Crude protein was expressed as N × 6.25. Digesta samples from 
sampling period 2 and feed samples were analyzed for AA [University of Missouri 
Agriculture Experiment Station Chemical Laboratories, Columbia, MO; Method 982.30 
E (a, b, c); AOAC, 2005]. 
 
Calculations 
The AID (%) and ATTD (%) of dietary components were calculated using the 
following equation (Oresanya et al., 2007): 
AID or ATTD = 100 – [100 × (concentration of Cr2O3 in diet × concentration of 
component in feces or digesta/concentration of Cr2O3 in feces or digesta × concentration 
of component in diet)]. 
The basal ileal endogenous losses (IAAend) of an AA or CP (g/kg of DMI) were 
calculated by the equation (Stein et al., 2007): 
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IAAend = [AA or CP in digesta × (Cr2O3 in diet/ Cr2O3 in digesta)]. 
Standardized ileal digestibility values for each AA were then calculated by 
correcting the AID for basal ileal endogenous losses by the equation (Stein et al., 2007): 
SID = [AID + (IAAend/AA in diet)]. 
The amount of DM (g/kg DMI), GE (Mcal/kg DMI), and NDF (g/kg DMI) 
remaining at the terminal ileum and excreted in feces were calculated using the following 
equations: 
Amount remaining at terminal ileum (g or Mcal/kg DMI) = [Concentration of component 
in digesta × (Cr2O3 in diet / Cr2O3 in digesta)] 
Amount excreted in feces (g or Mcal/kg DMI) = [Concentration of component in feces × 
(Cr2O3 in diet / Cr2O3 in feces)] 
Disappearance of DM (g/kg DMI), GE (Mcal/kg DMI), and NDF (g/kg DMI) 
prior to the terminal ileum and in the hindgut was calculated using the following 
equations: 
Disappearance prior to the terminal ileum = (intake – amount remaining at terminal ileum) 
Hindgut disappearance = (amount remaining at terminal ileum – amount excreted in feces) 
 
Statistical Analysis  
The PROC UNIVARIATE procedure (SAS Inst., Cary, NC) was used to verify 
normality and homogeneity of variances of the variables, and all data were analyzed 
using the PROC MIXED procedure of SAS. The individual pig served as the 
experimental unit for all analyses. The model for basal IAAend included the fixed effect of 
treatment and the random effect of replicate period. The model for AID and SID of CP 
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and AA included the fixed effects of TP, DDGS, feed intake level, and all possible 
interactions, and the random effects of replicate period and pig. The model for AID and 
ATTD of DM, energy, and NDF included the fixed effects of TP, DDGS, sampling 
period, feed intake level, and all possible interactions, and the random effects of replicate 
period and pig. The REPEATED statement was used to model the effect of sampling 
period on the AID and ATTD of DM, GE, and NDF using the individual pig as the 
subject from which repeated observations were recorded (Littell et al., 1998). Interactions 
with P > 0.20 were removed from the final model. Differences between least squares 
means were separated using the PDIFF option of SAS with results considered significant 
if P < 0.05 and trends if P > 0.05 and < 0.10. 
 
Results 
Pigs remained healthy during the experiment, and all pigs consumed their daily 
feed allowance throughout the experiment. The analyzed nutrient concentration in the 
diets is presented in Table 2. The 0% DDGS diets contained less GE (3.88 and 3.84 vs. 
4.13 and 4.12 Mcal/kg), CP (14.7 and 14.6 vs. 17.7 and 17.7%), and NDF (7.0 and 6.9 vs. 
11.4 and 11.4%, for diets without or with TP, respectively) than the diets containing 25% 
DDGS. The BW of pigs at the start of periods 1, 2, and 3 was 34.9 ± 1.0, 40.9 ± 1.9, and 
48.8 ± 2.7 kg, respectively, and the final BW at the end of period 3 was 58.2 ± 3.8 kg. 
 
Digestibility of Amino Acids, Dry Matter, Gross Energy, and Neutral Detergent Fiber 
The AID for all indispensable AA, except Leu and Trp, were less (P < 0.05) in the 
25% DDGS diets than in the 0% DDGS diets (Table 3). There was no effect of TP on 
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basal IAAend (Table 4); therefore, SID values were calculated using mean basal IAAend 
values from the 2 N-free diets. Inclusion of 25% DDGS lowered (P < 0.05) the SID for 
CP and all AA, except Leu, Ala, and Pro (Table 5). There was no effect of TP on AID or 
SID of any indispensable or dispensable AA and there were no TP × DDGS interactions 
for AA digestibility. 
The AID and ATTD of DM, GE, and NDF were not affected by inclusion of 44 
mg/kg TP in the diet, and there were no TP × DDGS interactions (Table 6). The AID and 
ATTD of DM, and GE were lower in the 25% DDGS diets than in the 0% DDGS diets (P 
< 0.001).  
The AID of NDF was greater in the 25% DDGS diet than in the 0% DDGS diets 
(P < 0.05); however, the ATTD of NDF was lower in the 25% DDGS diets (P < 0.01). 
The ATTD of NDF was greater during sampling period 2 than sampling period 1 (P = 
0.01); however, the AID of DM, GE, and NDF and the ATTD of DM and GE were not 
affected by sampling period. 
 
Flow of Dry Matter, Gross Energy, and Neutral Detergent Fiber 
There was no effect of TP on the flow or disappearance of DM or GE (Table 7). 
There was a TP × DDGS interaction for NDF excreted in the feces (P = 0.04). Tylosin 
phosphate inclusion did not influence NDF excretion in the 0% DDGS diets (46 vs. 45 
g/kg of DMI), but increased fecal excretion of NDF in the 25% DDGS diets (78 vs. 83 
g/kg of DMI).  
Pigs fed the 25% DDGS diets had greater amounts of DM remaining at the 
terminal ileum (P < 0.001) and excreted in the feces (P < 0.001) and tended to have 
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greater hindgut disappearance of DM (P = 0.07) than the 0% DDGS fed pigs. Pigs fed 0% 
DDGS diets had greater disappearance of DM prior to the terminal ileum (P < 0.001). For 
GE, intake, flow remaining at the terminal ileum (P < 0.001), and fecal excretion (P < 
0.001) were greater for pigs fed 25% DDGS diets than for pigs fed the 0% DDGS diets.  
Pigs fed 0% DDGS diets had greater disappearance of GE prior to the terminal ileum (P 
< 0.001), whereas, hindgut disappearance of GE was similar. The NDF intake, flow 
remaining at the terminal ileum (P < 0.001), and disappearance prior to the terminal 
ileum (P < 0.001) were greater for pigs fed 25% DDGS diets than for pigs fed the 0% 
DDGS diets.  However, hindgut disappearance of NDF was similar.  
There was no effect of sampling period on the flow or disappearance of DM or 
GE. Sampling period did not impact flow of NDF remaining at the terminal ileum, but 
flow of NDF excreted in the feces was lower during sampling period 2 than in sampling 
period 1 (P = 0.01). 
 
Discussion 
Tylosin is a 16-member ring macrolide antibiotic that inhibits bacterial protein 
synthesis by binding to the bacterial ribosome (Corcoran et al., 1977). The use of TP as 
an antibiotic feed additive to enhance production performance has been widely 
demonstrated in growing swine. In a summary of antibiotic effects, Hays (1979) reported 
that TP improved ADG by 14.8, 10.9, and 4.6% in the nursery, grower, and finisher 
phases, respectively, when summarized across 21 to 27 experiments for each phase. The 
same summary also reported improvements in feed efficiency of 6.0, 4.2, and 1.5% in the 
nursery, grower, and finisher phases, respectively, for pigs fed TP supplemented diets. 
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The mode of action for these whole-animal responses has been explained by 
several possibilities: 1) inhibition of subclinical infections, 2) reduction of growth-
depressing microbial metabolites, 3) suppressed microbial degradation of nutrients before 
absorption, and 4) enhanced uptake and use of nutrients through the thinner intestinal 
wall associated with antibiotic-fed animals (Gaskins et al., 2002). These modes of action 
may be due to shifts in microflora in the gastrointestinal tract that occur during dietary TP 
supplementation (Collier et al., 2003; Kim et al., 2012). 
Tylosin phosphate inclusion reduced the hindgut disappearance of NDF in the 25% 
DDGS diets, but not in the 0% DDGS diets. Tylosin phosphate has been shown to 
decrease total bacteria (Collier et al., 2003), which may have reduced microbial 
fermentation of fiber. However, this difference in NDF disappearance was small (5 g 
NDF/kg DMI), and did not translate into differences in energy digestibility and, therefore, 
may be of little importance to the overall energy balance of the pig.  
The general lack of response in this experiment to TP could be due to pig health 
and the environment in which the research was conducted. Pigs utilized in this study had 
a high health status and were housed in individual pens, which were cleaned frequently to 
facilitate fresh fecal sample collections. This likely resulted in a low incidence of 
pathogen exposure. Several authors have reported a lack of a growth promotion response 
to sub-therapeutic levels of antibiotics, including TP, in high health status pigs (Van 
Lunen, 2003; Weber and Kerr, 2008). Tylosin phosphate has been shown to enhance 
ATTD of N, AA, and energy (Kirchgessner et al., 1995; Roth et al., 1994), N utilization 
(Roth and Kirchgessner, 1993), and AID of Lys, Thr, Ile, and Val (Smiricky et al., 2002); 
however, sanitation conditions and health status of pigs were not clearly indicated in 
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these publications. Future nutrient utilization research involving antimicrobial agents may 
need to be conducted under environmental and health conditions similar to those 
experienced in commercial practice. Unfortunately, it is not possible to undertake this 
type of study in a group housing situation because of the risk of injury or damage to the 
ileal cannulae. 
Another possible explanation for the general lack of response to TP could be due 
to inadequate acclimation time. Collier et al. (2003) reported that TP reduced total 
bacteria in the ileum of growing pigs at d 14 of TP supplementation but not at d 7. In our 
experiment, fecal samples were collected at d 5 to 6 and 11 to 12 and ileal digesta 
samples were collected at d 7 to 8 and 13 to 14, which may not have allowed enough time 
for major microbial population changes. 
The SID of Lys was 4.5% units lower in the 25% DDGS diets than the 0% DDGS 
diets. Adding 25% DDGS reduced the amount of corn content of the diet from 73.0 to 
51.4% and the soybean meal content from 21.5 to 18.5%. Therefore, more of the Lys and 
other AA are derived from soybean meal and corn in the 0% DDGS diets. The SID of 
Lys is considerably greater in soybean meal and corn than in DDGS (NRC, 2012). Lysine 
is sometimes destroyed or converted to compounds that cannot be utilized by the pig 
because of Maillard reactions that may occur during the DDGS drying process (Pahm et 
al., 2009). Mallard reactions may result in reduction of total Lys and the SID of Lys in 
DDGS (Fastinger and Mahan, 2006; Pahm et al., 2009). Dietary fiber may reduce 
digestibility of AA (Lenis et al., 1996). The 25% DDGS diets contained more NDF than 
the 0% DDGS diets (11.4 vs. 7.0%). 
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The GE of the 25% DDGS was greater than the GE of the 0% DDGS diets (4.60 
vs. 4.35 Mcal/kg of DM); however, because of the digestibility of GE being lower in the 
DDGS diets, the DE content of the diets was similar. A greater portion of the GE in the 0% 
DDGS diets disappeared prior to the terminal ileum compared to the 25% DDGS diets 
(3.16 vs. 3.13 Mcal GE/kg DMI). A much greater amount of GE from the 25% DDGS 
diets entered the lower gut (1.47 vs. 1.18 Mcal/kg DMI); however, hindgut disappearance 
of GE was similar between treatments. The DDGS diets contained more dietary fiber 
(11.4 vs. 7.0% NDF), and much of the fiber in DDGS is insoluble (Urriola et al., 2010). 
Insoluble fiber is poorly digested by the pig in either the upper or lower gut and 
negatively contributes to the ATTD of energy in the DDGS diets. 
In conclusion, the results of this study indicate that the ileal digestibility of most 
AA are lower in corn-soybean meal-DDGS-based diets than in corn-soybean meal-based 
diets. The ATTD energy and fiber was also lower in the DDGS-based diets. Tylosin 
phosphate did not affect digestibility of AA or digestibility and gastrointestinal tract flow 
of energy; however, this lack of response may be due to low incidence of pathogen 
exposure experienced under these experimental conditions. 
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Table 1. Ingredient composition of the experimental diets (as-fed basis)1 
 DDGS, %  
Ingredient, %      0   25 N-free 
Cornstarch - - 78.85 
Ground corn 73.04 51.40 - 
DDGS2 - 25.00 - 
Soybean meal (46.5% CP) 21.50 18.50 - 
Dextrose - - 10.00 
Solka floc2 - - 4.00 
Soybean oil 2.00 2.00 3.00 
Monocalcium phosphate 1.10 0.50 1.35 
Limestone 0.90 1.15 1.00 
Salt 0.50 0.50 0.50 
Chromic oxide 0.50 0.50 0.50 
Potassium carbonate - - 0.40 
Lys HCl 0.15 0.15 - 
L-Thr 0.01 - - 
Vitamin premix3 0.15 0.15 0.15 
Mineral premix4 0.15 0.15 0.15 
Magnesium oxide - - 0.10 
1 DDGS = distillers dried grains with solubles. Tylosin phosphate 
treatment diets (44 mg/kg of tylosin as tylosin phosphate) were created 
by adding 0.05% of Tylan 40 premix (Elanco Animal Health, Greenfield, 
IN) to diets at the expense of ground corn or cornstarch. 
2International Fiber Corporation (North Tonawanda, NY). 
3Provided per kilogram of complete diet: vitamin A, 6,614 IU; vitamin 
D, 827 IU; vitamin E, 26 IU; vitamin K, 2.6 mg; niacin, 29.8 mg; 
pantothenic acid, 16.5 mg; riboflavin, 5.0 mg; and vitamin B12, 0.023 
mg. 
4Provided per kilogram of diet: Zn, 165 mg as zinc sulfate; Fe, 165 mg as 
iron sulfate; Mn, 39 mg as manganese sulfate; Cu, 17 mg as copper 






Table 2. Analyzed nutrient composition of experimental diets (as-fed basis)1 
 0% DDGS  25% DDGS  N-free 
Item 0 mg/kg TP 44 mg/kg TP  0 mg/kg TP 44 mg/kg TP  0 mg/kg TP 44 mg/kg TP 
DM, % 88.6 89.1  89.8 89.5  94.1 94.0 
GE, Mcal/kg 3.88 3.84  4.13 4.12  3.69 3.70 
CP, % 14.7 14.6  17.7 17.7  0.3 0.3 
NDF, % 7.0 6.9  11.4 11.4  - - 
Indispensable AA, % 
Arg 0.97 0.92  1.02 1.02  0.01 0.01 
His 0.39 0.38  0.48 0.48  0.01 0.01 
Ile 0.64 0.62  0.75 0.75  0.02 0.02 
Leu 1.33 1.31  1.74 1.74  0.04 0.04 
Lys 0.94 0.90  0.97 0.97  0.01 0.01 
Met 0.21 0.20  0.27 0.27  0.01 0.01 
Met + Cys 0.44 0.41  0.55 0.56  0.02 0.02 
Phe 0.74 0.72  0.86 0.87  0.02 0.02 
Thr 0.55 0.54  0.66 0.67  0.01 0.01 
Trp 0.15 0.15  0.17 0.18  0.00 0.00 
Val 0.75 0.71  0.90 0.89  0.02 0.02 
Dispensable AA, % 
Ala 0.78 0.76  1.06 1.06  0.02 0.02 
Asp 1.48 1.40  1.54 1.57  0.02 0.02 
Cys 0.23 0.22  0.28 0.29  0.01 0.01 
Glu 2.63 2.49  2.89 2.92  0.07 0.07 
Gly 0.63 0.60  0.74 0.74  0.01 0.01 
Pro 0.91 0.90  1.22 1.20  0.03 0.04 
Ser 0.63 0.62  0.72 0.76  0.01 0.01 
Tyr 0.49 0.47  0.59 0.60  0.01 0.01 




Table 3.  Effects of tylosin phosphate (TP) and distillers dried grains with solubles 
(DDGS) on apparent ileal digestibility (AID) of CP and AA by growing pigs1 
 TP, mg/kg  DDGS  P-value2 
Item 0 44  0% 25% SEM TP DDGS 
CP, % 69.4 70.6  70.8 69.3 1.3 0.30 0.15 
Indispensable AA, %         
Arg 81.7 81.3  82.8 80.2 1.2 0.48 <0.001 
His 79.5 79.1  80.8 77.8 1.1 0.41 <0.001 
Ile 78.1 78.1  79.3 76.9 0.9 0.91 <0.001 
Leu 81.5 81.5  81.4 81.5 0.8 0.93 0.69 
Lys 75.3 75.0  77.3 73.1 1.0 0.51 <0.001 
Met 81.8 81.1  82.0 80.9 0.9 0.22 0.02 
Met + Cys 74.6 73.9  75.4 73.1 1.3 0.22 <0.001 
Phe 79.7 79.7  80.5 78.9 1.0 0.94 <0.001 
Thr 68.8 68.8  70.3 67.3 1.3 0.94 <0.001 
Trp 78.2 77.9  78.4 77.7 1.5 0.78 0.36 
Val 73.5 72.8  73.9 72.5 1.1 0.18 0.01 
Dispensable AA, %         
Ala 73.8 74.0  73.0 74.8 1.2 0.83 0.01 
Asp 75.5 75.3  78.0 72.8 1.0 0.85 <0.001 
Cys 67.8 67.3  69.4 65.7 1.6 0.42 <0.001 
Glu 81.2 80.9  82.4 79.7 1.0 0.53 <0.001 
Gly 47.3 48.7  47.5 48.5 3.3 0.37 0.49 
Pro 36.5 41.3  31.7 46.1 9.3 0.38 0.01 
Ser 76.0 76.4  77.3 75.2 0.7 0.49 <0.001 
Tyr 79.4 79.3  79.6 79.2 1.0 0.72 0.29 
1AID (%) = 100 - [100 × (CP or AA in digesta/CP or AA in diet) × (Cr2O3 in diet/Cr2O3 in 
digesta)] (Oresanya et al., 2007). 





Table 4. Effects of tylosin phosphate (TP) on basal ileal endogenous losses 
of CP and AA (g/kg of DMI)1 
 TP   
Item 0 mg/kg 44 mg/kg SEM P-value 
CP, 22.52 21.14 1.41 0.42 
Indispensable AA     
Arg 1.01 1.00 0.09 0.93 
His 0.21 0.19 0.01 0.19 
Ile 0.37 0.33 0.02 0.18 
Leu 0.60 0.54 0.04 0.20 
Lys 0.75 0.66 0.07 0.34 
Met 0.10 0.08 0.01 0.20 
Met + Cys 0.31 0.27 0.02 0.13 
Phe 0.37 0.33 0.02 0.18 
Thr 0.58 0.54 0.03 0.34 
Trp 0.12 0.12 0.01 0.65 
Val 0.62 0.58 0.04 0.45 
Dispensable AA     
Ala 0.85 0.80 0.05 0.51 
Asp 0.93 0.85 0.05 0.26 
Cys 0.21 0.19 0.01 0.10 
Glu 1.23 1.11 0.08 0.29 
Gly 2.29 2.12 0.17 0.47 
Pro 9.15 8.99 0.87 0.89 
Ser 0.56 0.52 0.03 0.37 
Tyr 0.30 0.27 0.02 0.22 
1Basal ileal endogenous losses = AA or CP in digesta × (Cr2O3 in 




Table 5.  Effects of tylosin phosphate (TP) and distillers dried grains with solubles 
(DDGS) on standardized ileal digestibility (SID) of CP and AA by growing pigs1 
 TP, mg/kg  DDGS  P-value2 
Item 0 44  0% 25% SEM TP DDGS 
CP, % 81.5 82.8  84.0 80.4 1.3 0.28 0.002 
Indispensable AA,%         
Arg 90.8 90.7  92.3 89.1 1.2 0.83 <0.001 
His 83.7 83.4  85.5 81.7 1.1 0.54 <0.001 
Ile 82.6 82.7  84.2 81.1 0.9 0.77 <0.001 
Leu 84.8 84.9  85.2 84.5 0.8 0.88 0.05 
Lys 81.9 81.8  84.1 79.6 1.0 0.80 <0.001 
Met 85.2 84.7  86.0 83.9 0.9 0.35 <0.001 
Met + Cys 80.0 79.4  81.5 77.9 1.3 0.37 <0.001 
Phe 83.7 83.8  84.9 82.6 1.0 0.81 <0.001 
Thr 77.1 77.2  79.5 74.9 1.3 0.97 0.04 
Trp 84.9 84.7  85.6 84.0 1.5 0.83 <0.001 
Val 80.0 79.6  81.2 78.5 1.0 0.39 <0.001 
Dispensable AA, %         
Ala 82.0 82.3  82.5 81.8 1.2 0.67 0.23 
Asp 80.7 80.7  83.5 77.9 1.0 0.99 <0.001 
Cys 75.0 74.6  77.4 72.1 1.4 0.56 <0.001 
Glu 85.0 84.8  86.5 83.4 1.0 0.67 <0.001 
Gly 76.2 78.6  79.5 75.3 3.3 0.15 0.009 
Pro 114.2 120.0  120.7 113.4 9.4 0.29 0.13 
Ser 83.2 83.5  84.9 81.7 0.7 0.60 <0.001 
Tyr 84.2 84.1  84.9 83.5 1.0 0.83 0.002 
1SID (%) = apparent ileal digestibility of diet + (basal ileal losses of CP or AA/ CP or AA 
in diet) (Stein et al., 2007).  Basal endogenous losses (g/kg of DMI) of CP and AA were 
as follows: CP, 21.83; Arg, 1.01; His, 0.20; Ile, 0.35; Leu, 0.57; Lys, 0.71; Met, 0.09; 
Met + Cys, 0.29; Phe, 0.35; Thr, 0.56; Trp, 0.12; Val, 0.60; Ala, 0.82; Asp, 0.89; Cys, 
0.20; Glu, 1.17; Gly, 2.20; Pro, 9.07; Ser, 0.54; and Tyr, 0.29. 









Table 6.  Effects of tylosin phosphate (TP) and distillers dried grains with solubles (DDGS) on apparent ileal digestibility (AID) 
and apparent total tract digestibility (ATTD) of nutrients and energy by growing pigs1,2 
       P-value4 
 TP, mg/kg  DDGS  Sampling period3    Sampling 
Item 0 44  0% 25%  1 2 SEM TP DDGS period 
AID, %             
  DM 68.3 68.9  71.9 65.3  68.3 68.9 0.6 0.13 <0.001 0.16 
  GE 70.2 70.6  72.8 68.0  70.1 70.7 0.7 0.34 <0.001 0.14 
  NDF 24.6 24.6  22.8 26.4  24.2 25.0 2.5 0.99 0.03 0.56 
ATTD, %             
  DM 82.6 82.6  85.5 79.7  82.4 82.8 0.6 0.98 <0.001 0.14 
  GE 82.4 82.4  85.0 79.9  82.3 82.6 0.6 0.82 <0.001 0.26 
  NDF 39.6 38.9  42.0 36.5  37.4 41.1 2.6 0.71 0.002 0.01 
Energy, Mcal/kg DM             
  GE 4.48 4.46  4.35 4.60  4.47 4.47 - - - - 
  DE5 3.69 3.68  3.69 3.68  3.68 3.69 0.03 0.27 0.44 0.54 
  ME6 3.58 3.56  3.59 3.56  3.57 3.57 0.03 0.24 0.005 0.53 
1AID (%) = 100 - [100 × (component in digesta/component in diet) × (Cr2O3 in diet/Cr2O3 in digesta)] (Oresanya et al., 2007). 
2ATTD (%) = 100 - [100 × (component in digesta/component or AA in diet) × (Cr2O3 in diet/Cr2O3 in digesta)] (Oresanya et 
al., 2007). 
3Feces was collected on d 5 to 6 and d 11 to 12 of dietary treatment for sampling periods 1 and 2, respectively. Ileal digesta 
was collected on d 7 to 8 and 13 to 14 of dietary treatment for sampling periods 1 and 2, respectively. 
4There were no interactions (P > 0.05) among treatments; therefore, only main effects are reported. 
5Determined DE content 







Table 7.  Effects of tylosin phosphate (TP), distillers dried grains with solubles (DDGS), and sampling period on intake, disappearance, and excretion of DM, 
energy, and NDF by growing pigs1,2,3,4 
       P-value 
 TP  DDGS  Sampling period5 Pooled   Sampling 
Item 0 mg/kg 44 mg/kg  0% 25%  1 2 SEM TP DDGS period 
Intake             
DM, g/d 1.46 1.47  1.46 1.48  1.47 1.47 - - - - 
GE, Mcal/d 6.57 6.57  6.32 6.81  6.59 6.56 - - - - 
NDF, g/d 154 150  114 188  152 152 - - - - 
DM, g/kg DMI             
Disappearance prior to TI 684 689  719 653  683 689 6 0.16 <0.001 0.16 
Remaining at terminal ileum 316 311  281 347  317 310 7 0.15 <0.001 0.14 
Hindgut disappearance 143 138  136 145  142 139 9 0.37 0.07 0.46 
Excreted in feces 173 173  145 202  174 172 7 0.89 <0.001 0.28 
GE, Mcal/kg DMI             
Intake 4.49 4.46  4.34 4.60  4.48 4.47 - - - - 
Disappearance prior to TI 3.15 3.15  3.16 3.13  3.13 3.16 0.03 0.98 <0.001 0.15 
Remaining at terminal ileum 1.34 1.32  1.18 1.47  1.34 1.31 0.03 0.27 <0.001 0.15 
Hindgut disappearance 0.55 0.54  0.53 0.55  0.55 0.53 0.04 0.67 0.34 0.34 
Excreted in feces 0.79 0.78  0.65 0.92  0.79 0.78 0.03 0.57 <0.001 0.51 
NDF, g/kg DMI             
Intake 105 102  78 127  103 103 - - - - 
Disappearance prior to TI 26 26  18 34  25 26 3 0.86 <0.001 0.48 
Remaining at terminal ileum 77 77  60 94  77 76 3 0.95 <0.001 0.49 
Hindgut disappearance 15 13  15 13  13 15 3 0.49 0.54 0.15 
Excreted in feces6 62 64  45 81  65 61 3 0.10 <0.001 0.01 
0% DDGS 46a 45 a  - -  - - - - - - 
25% DDGS 78 b 83 c  - -  - - - - - - 
a-cWithin NDF excreted in feces, means with different superscripts differ, P < 0.05.     
1Disappearance prior to the terminal ileum (TI) = [intake – amount remaining at terminal ileum] 
2Amount remaining at terminal ileum = component in digesta × (Cr2O3 in diet/Cr2O3 in digesta) 
3Hindgut disappearance = amount remaining at terminal ileum – amount excreted in feces 
4Amount excreted in feces = component in feces × (Cr2O3 in diet/Cr2O3 in feces) 
5Feces was collected on d 5 to 6 and 11 to 12 of dietary treatment for sampling periods 1 and 2, respectively. Ileal digesta was collected on d 7 to 8 and 13 to 
14 of dietary treatment for sampling periods 1 and 2, respectively. 




CHAPTER 3. THE INTERACTION OF FIBER, SUPPLIED BY DISTILLERS 
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Abstract 
The objective of this study was to determine if a higher fiber diet alters the 
response of finishing pigs to an antimicrobial (tylosin phosphate; TP) and a nutrient 
partitioning agent (ractopamine HCl; RAC) in terms of N and water utilization and 
energy digestibility. Seventy-two gilts (initial BW = 107.4 ± 4.2 kg) were blocked by 
weight and allotted to 1 of 8 dietary treatments. Treatments were arranged as a 2 × 2 × 2 
factorial: DDGS (0 vs. 30%), RAC (0 mg of RAC/kg and 0.70% SID Lys vs. 5 mg of 
RAC/kg and 0.95% SID Lys) and TP (0 vs. 44 mg of TP/kg). Pig was the experimental 
unit, with 9 replications per treatment. Pigs were housed in individual metabolism crates 
and fed treatment diets for 17 d. Feed was provided twice daily, as much as the pigs 
could consume within 1 h per meal and water was provided to the pigs between feeding 
periods, ad libitum. Fecal and urine collection occurred on d 7 and 8 and on d 15 and 16, 
for sampling periods 1 and 2, respectively. Pigs fed the DDGS diets had reduced ADG (P  
______________________ 
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< 0.001) and ADFI (P < 0.0001). The ATTD of N and GE were lower for the 30% DDGS 
diets that the 0% DDGS diets (P < 0.0001). Ractopamine improved ADG (P < 0.0001), 
G:F (P < 0.0001), and N retention (P < 0.001) and tended to increase daily water intake 
(P < 0.10). Pigs fed RAC had higher N intake and urinary excretion and lower N 
retention in Period 2 than in Period 1 (P < 0.05), indicating a decline in the response to 
RAC over time. TP did not affect ADFI, or G:F (P > 0.10), but did improve apparent 
total tract digestibility (ATTD) of N (P < 0.05). There was a tendency for a TP × DDGS 
interaction (P < 0.10) for ADG, where TP tended to increase ADG in pigs fed 0% DDGS 
diets (P < 0.10), but not in pigs fed 30% DDGS diets (P > 0.10). Pigs fed DDGS diets 
had higher N intake (P < 0.01) and higher fecal (P < 0.0001) and urinary (P < 0.01) N 
excretion with no difference in N retention (g/d). Overall, RAC increased N retention by 
33% (P < 0.0001) and the response to RAC was similar in both corn-soybean meal based 
and corn-soybean meal-DDGS based diets. Tylosin phosphate tended to improve growth 
performance in pigs fed corn-soybean meal based diets but not in diets containing 30% 
DDGS; however, this response was not explained by changes in N balance or in energy 
digestibility. 
 




There is very limited information on the impact of ractopamine HCl (RAC) and 




when used in diets with higher dietary fiber content. Both additives are commonly used 
in the North American pig industry, but recent increases in the fiber content of practical 
diets raises questions about the response of pigs under this changing nutritional regime. 
Furthermore, while there have been numerous studies on the impact of DDGS on growth 
performance (Stein and Shurson, 2009), there is much less data on their impact on energy 
and water utilization. 
Ractopamine HCl is a β-adrenergic agonist that repartitions nutrients away from 
adipose tissue and towards muscle, resulting in increased muscle mass (Mersmann, 1998) 
and slightly reduced lipid accretion (Webster et al., 2007). Inclusion of RAC in finishing 
swine diets improves growth performance (Patience et al., 2009) and may improve water 
utilization (Ross et al., 2011). Tylosin phosphate is a macrolide antibiotic that inhibits 
bacterial protein synthesis by binding to the bacterial ribosome (Corcoran et al., 1977). It 
is used in swine diets to control diseases, such as ileitis (McOrist et al., 1997) and swine 
dysentery (Curtis, 1962), and to improve growth performance (Jordan et al., 1960). 
Energy and N utilization may be enhanced by TP (Roth and Kirchgessner, 1993). The 
benefits of RAC and TP may be at least partially additive as their modes of action greatly 
differ. 
The primary objective of this study was to evaluate the impact of DDGS on the 
pig’s response to RAC and TP alone or in combination on N balance, water utilization 
and energy digestibility. It is well established that the RAC-induced response in growth 
performance tends to decline over time (Schinckel et al., 2003). Therefore, a secondary 
objective of this study was to determine if the affects of dietary treatment on N, water and 





Materials and Methods 
All experimental procedures adhered to guidelines for the ethical and humane use 
of animals for research, and were approved by the Iowa State University Institutional 
Animal Care and Use Committee (#7-10-6989-S). 
 
Dietary Treatments 
Dietary treatments were arranged as a 2 × 2 × 2 factorial, with DDGS (0 and 30%; 
Dakota Gold BPX, Poet Biorefining, Hanlontown, IA), RAC (0 and 5 mg of RAC/kg; 
Paylean, Elanco Animal Health, Greenfield, IN) and TP (0 and 44 mg of TP/kg; Tylan, 
Elanco Animal Health, Greenfield, IN) as the main factors. The DDGS utilized in this 
experiment contained 25.4% crude protein, 10.0% crude fat, and 24.6% NDF. Four basal 
diets (Table 1) were formulated to be isocaloric (ME-basis) and were formulated to meet 
or exceed the nutrient requirements of finishing pigs (NRC, 1998). The RAC diets were 
formulated to include an additional 0.25% SID Lys (0.95% vs. 0.70% SID Lys) to 
support elevated RAC-induced protein accretion (Patience et al., 2009). When Lys was 
increased, minimum ratios of AA to Lys were maintained so that as Lys increased, other 
limiting AA increased proportionately. Tylosin premix (Tylan 40, Elanco Animal Health, 
Greenfield, IN) was added to each basal diet at a rate of 0.05% at the expense of corn. At 
this inclusion rate, the diets were supplemented with 44 mg tylosin as tylosin phosphate 
per kg of feed. Concentrations of TP and RAC were confirmed by a commercial 
laboratory (Covance Laboratory, Greenfield, IN). All diets contained 0.4% titanium 





Animals, Housing, and Experimental Design  
The experiment was conducted in an environmentally controlled room at the Iowa 
State University Swine Nutrition Farm. Twenty-four crossbred gilts (PIC 337 sires × C22 
or C29 dams, Pig Improvement Company, Hendersonville, TN) were selected for each of 
3 replicates; the 8 gilts with the smallest range in BW were selected for each of the 3 
blocks within replicate. Within each block, pigs were randomly assigned to 1 of the 8 
dietary treatments. In total, this experiment was replicated 3 times, providing 9 pigs per 
treatment or 72 gilts in total. 
Pigs were housed in individual metabolism crates (0.8 × 2.1 m). Each crate had a 
fully slatted stainless steel floor and stainless steel feeder. Pigs were provided feed twice 
daily, as much as they could consume within two 1-h meals at 0700 and 1500. Feed was 
weighed before and after meals to determine ADFI. Water was presented to the pigs in 
the feeder between the feeding periods. Thus, pigs had ad libitum access to water for 22 h 
per day. Trays were placed beneath feeders to collect any spilled water. Before the next 
feeding, the remaining water was removed from the feeders and the spillage trays and 
weighed to calculate daily water intake.  
Gilts remained in the crates for a period of 21 d, including a 5 d acclimation 
period prior to experimental treatment. Pigs assigned to the TP treatments received 66 
mg/L tylosin (Tylan Soluble, Elanco Animal Health, Greenfield, IN) in the drinking 
water for the final three days of acclimation, to adhere to TP label directions. The pigs 
were placed on their assigned experimental diet (d 0; initial BW = 107.4 ± 4.18 kg) for a 






A representative feed sample was obtained from each replicate and then pooled 
for each of the 8 diets.  Each replicate period included 6 d of adaptation to treatment diets 
and 2 sampling periods. Fecal samples were collected twice daily on d 7 to 8 and d 15 to 
16 of dietary treatment for sampling periods 1 and 2, respectively. Although great care 
was taken to collect all feces, digestibility of nutrients was based on the marker method 
(Oresanya et al., 2007). Urine was collected quantitatively during each 48 h sampling 
period (d 7 to 8 and d 15 to 16) into 4-L bottles containing a sufficient amount of 6 N 
HCl to ensure the pH was maintained below 2 to minimize volatilization of nitrogen 
compounds.  For each collection, total urine output was weighed and aliquots were taken, 
pooled per pig and collection period in a sealable container. All collected samples were 
immediately stored at -20°C. 
 
Analytical Methods and Calculations 
At the conclusion of each sampling period, frozen urine and fecal samples were 
thawed for 12 h at room temperature in sealed containers and mixed thoroughly within 
animal and sampling period. A sub-sample was collected and stored at -20°C. Fecal 
samples were oven dried at 75°C to a constant weight. Feed and fecal samples were finely 
ground through a 1-mm screen in a Wiley mill (model number 3379-K35, Thomas 
Scientific; Swedesboro, NJ) prior to chemical analysis. 
Feed, fecal, and urine samples were analyzed in duplicate at the Iowa State 




samples was determined by drying samples in an oven at 105°C to a constant weight. 
Nitrogen in feed, fecal, and urine samples were measured by combustion (Method 990.03, 
AOAC, 2005) using a Leco TruMac N determinator (Leco Corp., St. Joseph, MI). 
Calibration was conducted with an EDTA standard (N content 9.56 ± 0.03%; Leco Corp., 
St. Joseph, MI). On analysis, the N content of the EDTA standard was 9.55 ± 0.05%. 
Gross energy was determined using a bomb calorimeter (Model 6200, Parr Instrument 
Co., Moline, IL). Benzoic acid (6318 kcal/kg; Parr Instruments, Moline, IL) was used as 
the standard for calibration and was determined to be 6,321 ± 9 kcal/kg. Titanium dioxide 
content of feed and fecal samples was determined using the method of Leone (1973) and 
absorption was measured at 410 nm using a spectrophotometer (Synergy 4, BioTek, 
Winooski, VT).  
The apparent total tract digestibility (ATTD) of dietary components was 
calculated using the following equation (Oresanya et al., 2007): 
ATTD, % = 100 – [100 × (concentration of TiO2 in diet × concentration of component in 
feces /concentration of TiO2 in feces × concentration of component in diet)]. 
 
Statistical Analysis  
The PROC UNIVARIATE procedure (SAS Inst., Cary, NC) was used to verify 
normality and homogeneity of variances of the variables, and all data were analyzed 
using the PROC MIXED procedure of SAS. Outliers were identified by box-plot and by 
the predicted vs. residual plot procedure. The individual pig served as the experimental 
unit for all analyses. The model included the fixed effects of RAC, TP, DDGS, and all 




utilization, and digestibility data, sampling period was included as a fixed effect and the 
REPEATED statement was used to model the effect of sampling period using the 
individual pig as the subject from which repeated observations were recorded (Littell et 
al., 1998). Differences among least squares means were separated using the PDIFF option 




Two pigs were removed from the experiment due to leg injuries (0 mg of RAC/kg, 
0 mg of TP/kg, and 30% DDGS treatment and 5 mg of RAC/kg, 0 mg of TP/kg, and 0% 
DDGS treatment) and one pig was removed from the experiment due to a prolapsed 
rectum (0 mg of RAC/kg, 44 mg of TP/kg, and 0% DDGS treatment). There were no 
apparent relationships between these removals and dietary treatment. No other health 
issues or feed refusals were observed. 
 
Growth Performance and Water Utilization 
Ractopamine HCl increased ADG (P < 0.0001; Table 2) and G:F (P < 0.0001) but 
did not alter ADFI. There were no main effects of TP on ADG, ADFI, or G:F. Pigs fed 
diets containing 30% DDGS had reduced ADG (P < 0.001) and ADFI (P < 0.0001) with 
similar G:F as pigs fed 0% DDGS diets. There was a tendency for a TP × DDGS 
interaction (P < 0.10) for ADG, where TP tended to increase ADG in pigs fed 0% DDGS 
diets  (1.34 vs. 1.24 kg/d, P < 0.10), but did not affect ADG in pigs fed 30% DDGS (1.14 




Pigs fed RAC diets had higher water:feed ratios (P < 0.05) and tended to have 
higher average daily water intake (P < 0.10) for the 16-d experimental period than pigs 
fed diets without RAC. However, there was no effect of RAC on water intake during the 
collection periods (P > 0.10; Table 3). There were no main effect of TP on water intake, 
water:feed, or water:gain (P > 0.10). Pigs fed 30% DDGS diets had higher water:feed (P 
< 0.01) and water:gain (P < 0.05) ratios, and fecal water excretion (P < 0.01) than pigs 
fed 0% DDGS diets. There was a TP × DDGS interaction for overall average daily water 
intake (P < 0.05), where TP decreased water intake in pigs fed 30% DDGS diets (P < 
0.05), but pigs fed 0% DDGS diets.  
Water intake was similar between Period 1 and 2 (P > 0.10; Table 4); however, 
fecal (P < 0.05) and urinary (P < 0.001) water output were higher in Period 2 than in 
Period 1. There was a TP × DDGS × sampling period interaction for water intake during 
the water balance collection periods (P < 0.05); water intake increased from Period 1 to 
Period 2 for pigs fed 0 mg/kg TP and corn-soy diets (7.9 to 8.7 L/d), but did not change 
for any other TP × DDGS treatment combination. 
 
Nitrogen Balance 
Pigs fed RAC diets had increased N intake (P < 0.0001; Table 5), N digestibility 
(P < 0.0001), and N retention (g/d; P <0.0001 and % of intake; P < 0.001). On the other 
hand, TP inclusion improved ATTD of N (P < 0.05), but did not affect N intake, 
excretion, or retention (P > 0.10). Pigs fed DDGS diets had decreased ATTD of N (P < 
0.0001) and increased N intake (P < 0.01), fecal N excretion (P < 0.0001), urinary N 




not affect N retention when expressed as grams per d. Nitrogen intake (P < 0.001; Table 
6), urinary N excretion (P < 0.0001), and ATTD of N (P < 0.01) increased from Period 1 
to Period 2, while N retention decreased (P = 0.01 and P < 0.0001 for g/d and % of intake, 
respectively). 
A RAC × TP interaction was observed for N retention (g/d; Figure 1) for Period 1 
(P < 0.05) and for the combined data set (P < 0.05). From d 7 to 8, TP increased N 
retained (41.6 vs. 37.8 g/d; P < 0.05) in the 5 mg of RAC/kg diets but not in the 0 mg of 
RAC/kg diets (28.9 vs. 30.1 g/d; P > 0.10). In the combined data set, TP tended to 
increase N retained (39.6 vs. 37.3 g/d; P < 0.10) in the 5 mg of RAC/kg diets but 
numerically decreased N retained in the 0 mg of RAC/kg diets (28.0 vs. 29.8 g/d; P > 
0.10). 
There were RAC × sampling period interactions for urinary N excretion (P < 0.01; 
Table 6) and for N retention (% of intake; P < 0.05). Urinary N excretion increased from 
Period 1 to Period 2 in pigs fed diets with RAC or without RAC, but the magnitude of the 
increase was greater in RAC treated pigs. A RAC × period interaction was also observed. 
Nitrogen retention decreased from Period 1 to Period 2 in pigs fed diets with RAC or 
without RAC, but the magnitude of the decrease was greater in RAC treated pigs. 
 
Dry Matter and Energy Digestibility 
There were no effects of RAC on ATTD of DM or GE (P > 0.10; Table 7), but the 
RAC diets were higher in determined DE (P < 0.0001) due to the higher dietary GE 
content. Tylosin phosphate did not affect ATTD of DM or GE (P > 0.10); however, the 




had lower ATTD of DM and GE (P < 0.0001), but were similar in determined DE content 
(P > 0.10). The ATTD of GE and the determined diet DE content was higher for Period 2 
than Period 1 (P < 0.001; Table 8). There was a RAC × TP interaction for ATTD of DM 
(P < 0.05), where TP lowered DM digestibility in diets without RAC (84.9 vs. 84.2%; P 
= 0.15) and increased DM digestibility in diets containing RAC (84.3 vs. 85.0%; P = 
0.16). 
Similar RAC × TP × DDGS interactions were observed for ATTD of DM and GE 
(P < 0.01; Figure 2). For ATTD of DM, there were no differences among RAC and TP 
treatments within 0% DDGS diets (P > 0.10); however, TP inclusion increased ATTD of 
DM in RAC diets but decreased ATTD of DM in diets without RAC within the 30% 
DDGS diets (P < 0.05). For ATTD of GE, there were no affects of TP in the 0% DDGS 
diets (P > 0.10); however, in the 30% DDGS diets, TP inclusion increased ATTD of GE 
in RAC diets but decreased ATTD of GE in diets without RAC (P < 0.05). 
 
Discussion 
Distillers Dried Grains with Solubles 
Somewhat surprisingly, pigs fed 30% DDGS diets had lower ADFI (12%) and 
ADG (12%) than pigs fed 0% DDGS diets. In a summary of 25 grow-finish experiments, 
Stein and Shurson (2009) showed that most studies found no change in ADG (72% of 
experiments) or ADFI (65% of experiments) with up to 30% DDGS inclusion. In the 
current experiment, the G:F ratio and the determined DE content of the 30% DDGS diets 
were similar to the 0% DDGS diets, so the reduction in performance was not likely due to 




pigs were allowed to eat for 1 h periods twice per day, was chosen to ensure accurate 
collection of water intake data between feeding periods (Ross et al., 2011). It is possible 
that the pigs fed the 30% DDGS were unable to achieve consumption equal to that of the 
0% DDGS fed pigs during this limited amount of time as a consequence of the greater 
bulk and fiber in these diets. Whittemore et al. (2002) reported that pigs fed high-bulk 
diets did not maintain intake and performance when feeder access was reduced from 24 h 
to 6 h per d. This may be important to note when high-bulk ingredients are fed in 
commercial production settings where the feed intake capacity of the pigs may be limited 
by health or environmental factors (e.g. health challenge, heat stress, limited feeder space 
access). 
As expected, N utilization and energy digestibility were lower in DDGS diets. 
The lower digestibility of nutrients and energy within the DDGS compared to corn and 
soybean meal is well is documented (NRC, 2012) and diets were formulated to account 
for these differences. However, traditional digestibility measurements may overestimate 
the feeding value of DDGS. During the DDGS drying process, lysine is sometimes 
destroyed or converted to compounds that cannot be utilized by the pig due to Maillard 
reactions (Pahm et al., 2009). Maillard reaction end-products may be either excreted in 
feces or absorbed and excreted in urine (Faist and Erbersdobler, 2001). Also, higher 
concentrations of dietary fiber may reduce utilization of AA by increasing specific 
endogenous losses (Lenis et al., 1996) which contribute to higher fecal N losses. Thus, 
the SID concentration reported for corn DDGS may overstate their nutritive value, 






Ractopamine increased growth rate and feed efficiency without altering feed 
intake. Numerous studies have reported similar responses in pigs fed the 5 mg/kg dosage 
of RAC (Apple et al., 2007; Patience et al., 2009). In the present study, RAC increased N 
retained by 33%, which is similar to the RAC-induced protein accretion improvement of 
34% modeled by Schinckel et al. (2003) for the first 2 wk of RAC supplementation. 
There was a RAC × sampling period interaction for N retention (% of intake; P < 
0.05), where N retention decreased from Period 1 to Period 2 in pigs fed diets with RAC 
or without RAC, but the magnitude of the decrease was more pronounced in RAC fed 
pigs. This response was largely driven by changes in urinary N excretion (RAC × 
sampling period interaction; P < 0.01). It is well established that the RAC-induced 
response in growth and feed efficiency declines over time (See et al., 2004; Williams et 
al., 1994). This is thought to be due to down regulation or desensitization of the β-
adrenergic receptors in the membranes of adipose and muscle tissue (Sainz et al., 1993; 
Spurlock et al., 1994). Thus, our results reported herein confirm previous findings, and 
reaffirm the need to adopt specific practices to acknowledge this decline in N retention 
over time when using RAC in the field. Possible strategies would be to increase RAC 
concentration (i.e. step-up program) to extend the period in which RAC is most effective 
(Rikard-Bell et al., 2009; See et al., 2004), or implement a phase feeding program 
reducing dietary AA later in the RAC feeding period to more closely meet the AA needs 
of the pigs. 
Pigs fed RAC diets tended to have higher daily water intake than controls for the 




lean and water content (Dunshea et al., 1993; Ross et al., 2011); therefore, it can be 
assumed that RAC-fed pigs would require more water to sustain the RAC-induced 
increase in protein and water deposition. Our results disagree with Ross et al. (2011), 
who reported that pigs fed 5 and 10 mg of RAC/kg actually consumed 0.4 and 1.0 L less 
water per day than controls. 
 
Tylosin Phosphate 
Tylosin phosphate tended to increase ADG in pigs fed 0% DDGS diets (P < 0.10), 
but did not affect ADG in pigs fed 30% DDGS diets (P > 0.10). The use of TP as an 
antibiotic feed additive to enhance production performance has been widely demonstrated 
in growing swine; however, much of the research on TP was conducted feeding corn-
soybean meal based diets. Hays (1979) summarized over 20 experiments and reported 
that TP improved ADG by 10.9 and 4.6% and feed efficiency by 4.2 and 1.5% in the 
grower and finisher phases, respectively. These whole-animal responses may be 
explained by several possible modes of action: 1) inhibition of sub-clinical infections, 2) 
reduction of growth-depressing microbial metabolites, 3) suppressed microbial 
degradation of nutrients prior to absorption, and 4) enhanced uptake and use of nutrients 
through the thinner intestinal wall associated with antibiotic-fed animals (Gaskins et al., 
2002). These possible modes are supported by beneficial shifts in the microflora in the 
gastrointestinal tract that occur during dietary TP supplementation (Collier et al., 2003; 
Kim et al., 2012).  
A TP × RAC interaction was observed for N retention (g/d; P < 0.05) for Period 1, 




Due to the quite different modes of actions of TP and RAC, we hypothesized that the 
effects of TP and RAC may be additive. However, this response was not present in 
Period 2 (P > 0.10), so it is unclear if this response is of biological significance.  
The general lack of TP main effects in this experiment could be due to pig health 
and the environment in which the research was conducted. Pigs utilized in this study had 
a high health status and were housed individually in metabolism cages which were 
cleaned frequently to facilitate fresh fecal sample collections. This likely resulted in a low 
incidence of pathogen exposure. Several authors have reported a lack of a response to 
sub-therapeutic levels of antibiotics, including TP, in high health status pigs (Van Lunen, 
2003; Weber and Kerr, 2008). Future nutrient utilization research involving TP and other 
antimicrobial agents may need to be conducted under environmental and health 
conditions similar to those experienced in commercial practice. This will be difficult to 
achieve, because collection of urine and feces separately requires use of metabolism 
crates, which by design typically offer little social or disease stress. 
 
Conclusions 
Ractopamine HCl improved growth performance and N retention and tended to 
increase water intake. The N retention response to RAC declined over time. Tylosin 
phosphate tended to increase ADG in pigs fed corn-soybean meal based diets, but not in 
diets containing 30% DDGS, but this response was not accompanied by changes in N 
balance or energy digestibility. Diets containing 30% DDGS result in lower N and energy 
digestibility, even when formulated to equivalency. Under the conditions of this 




general, RAC improved performance and N utilization similarly in both corn-soybean 
meal based and corn-soybean meal-DDGS based diets. 
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Table 1. Ingredient composition (as-fed basis) of the experimental diets1,2 
 Corn-soy  DDGS 
Item 0 mg/kg RAC 5 mg/kg RAC  0 mg/kg RAC 5 mg/kg RAC 
Ingredient, %      
  Ground corn 83.63 75.685  60.94 53.065 
  DDGS - -  30.00 30.00 
  Soybean meal (46.5% CP) 12.26 19.99  5.79 13.51 
  Soybean oil 0.77 0.81  0.40 0.47 
  Monocalcium phosphate 0.94 0.90  0.06 0.02 
  Limestone 0.85 0.80  1.28 1.23 
  Salt 0.50 0.50  0.50 0.5 
  Titanium dioxide 0.40 0.40  0.40 0.4 
  Lysine HCl 0.26 0.34  0.31 0.39 
  L-threonine 0.08 0.15  0.03 0.09 
  Dl-methionine 0.02 0.11  - 0.01 
  Vitamin premix3 0.14 0.14  0.14 0.14 
  Mineral premix4 0.15 0.15  0.15 0.15 
  Ractopamine HCl premix5 - 0.025  - 0.025 
Calculated content      
  ME, Mcal/kg 3.36 3.36  3.36 3.36 
  Total Lys, % 0.79 1.06  0.86 1.13 
  SID6 Lys, % 0.70 0.95  0.70 0.95 
  SID Thr, % 0.47 0.64  0.47 0.64 
  SID Met, % 0.22 0.34  0.25 0.29 
  SID TSAA, % 0.43 0.59  0.54 0.61 
  Ca, % 0.55 0.55  0.55 0.55 
  Total P, % 0.51 0.54  0.49 0.51 
  Available P, % 0.25 0.25  0.25 0.25 
  NDF, % 9.3 9.3  13.8 13.9 
Analyzed content      
  Gross energy, Mcal/kg 3.82 3.87  4.08 4.13 
  Crude protein, % 11.4 14.6  14.4 17.6 
1Tylosin phosphate treatment diets (44 mg/kg tylosin as tylosin phosphate) were created by adding 
0.05% of Tylan 40 premix (Elanco Animal Health, Greenfield, IN) to diets at the expense of ground 
corn. 
2Corn-soy = corn-soybean meal, DDGS = distillers dried grains with solubles, RAC = ractopamine HCl 
3DSM Nutritional Products (Ames, IA). Provided per kilogram of complete diet: vitamin A, 4,288 IU; 
vitamin D, 490 IU; vitamin E, 35 IU; vitamin K, 2.1 mg; niacin, 39.2 mg; pantothenic acid, 18.9 mg; 
riboflavin, 7.7 mg; vitamin B12, 0.035 mg. 
4Provided per kilogram of diet: Zn, 165 mg as zinc sulfate; Fe, 165 mg as iron sulfate; Mn, 39 mg as 
manganese sulfate; Cu, 17 mg as copper sulfate; I, 0.3 mg as calcium iodate; and Se, 0.3 mg as sodium 
selenite. 
5Paylean 9 premix (Elanco Animal Health, Greenfield, IN). 






Table 2. Least squares means for the main effects of ractopamine HCl (RAC), tylosin phosphate (TP), and distillers dried grains with 






DDGS, % Pooled P-value 




0 30 SEM RAC TP DDGS 




107.2 107.4 1.01 0.51 0.62 0.88 




129.1 127.1 2.42 <0.0001 0.94 0.01 




1.29 1.15 0.057 <0.0001 0.50 0.0006 




3.19 2.80 0.122 0.34 0.96 <0.0001 




0.41 0.41 0.013 <0.0001 0.46 0.55 




7.6 7.8 0.41 0.051 0.38 0.68 




- - 0.49 - - - 




- - - - - - 




2.40 2.79 0.115 0.01 0.30 0.003 




6.1 6.8 0.41 0.34 0.29 0.048 
ab Means within a row with different superscripts differ, P < 0.05 
1Ractopamine HCl (Elanco Animal Health, Greenfield, IN), tylosin phosphate (Elanco Animal Health, Greenfield, IN). 
2Calculated based on 16-d experimental period. 






Table 3.  Least square means for the main effects of ractopamine HCl (RAC), tylosin phosphate (TP), and distillers dried grains 






DDGS, % Pooled P-value 




0 30 SEM RAC TP DDGS 




8.6 8.5 0.60 0.28 0.31 0.91 
Water excretion, L/d 




0.80 1.00 0.039 0.96 0.80 <0.0001 




5.1 5.2 0.43 0.39 0.36 0.77 
Apparent water retention4, L/d 2.3 2.4 2.4 2.3 2.5 2.2 0.16 0.30 0.44 0.01 
1Ractopamine HCl (Elanco Animal Health, Greenfield, IN), tylosin phosphate (Elanco Animal Health, Greenfield, IN). 
2Measured at d 7 to 8 and d 15 to 16 of dietary treatment. 
3Water intake included drinking water consumption and diet moisture. 




Table 4.  Least square means for the main effect of sampling period on 
water utilization in finishing gilts1 
 Sampling Period   
 d 7 to 8 d 15 to 16 SEM P-value 
Water intake2, L/d 8.4 8.5 0.54 0.20 
Water excretion, L/d     
  Feces water output 0.88 0.92 0.034 0.048 
  Urine water output 4.9 5.4 0.38 0.0001 
Apparent water 
retention3, L/d 
2.6 2.2 0.17 0.0001 
1DDGS = distillers dried grains with solubles, TP = tylosin phosphate 
(Elanco Animal Health, Greenfield, IN). 
2TP × DDGS × Period interaction, P = 0.04.  Water intake increased 
from d 7-8 to d 15-16 for pigs fed 0 mg/kg TP and 0% DDGS diets (7.9 
to 8.7 L/d), but did not significantly change for any other TP × DDGS 
treatment combination. 
3Apparent water retention = water intake – urinary water output – fecal 







Table 5.  Least square means for the main effects of ractopamine HCl (RAC), tylosin phosphate (TP), and distillers dried 






DDGS, % Pooled P-value 




0 30 SEM RAC TP DDGS 
N balance, g/d 




68.2 73.8 3.37 <0.0001 0.93 0.002 




11.3 13.8 0.72 0.66 0.15 <0.0001 




56.9 60.0 2.66 <0.0001 0.75 0.04 




23.0 26.4 1.67 0.01 0.85 0.01 




33.8 33.6 1.35 <0.0001 0.79 0.79 
N balance, % of intake   




16.7 18.8 0.28 <0.0001 0.046 <0.0001 




83.3 81.2 0.28 <0.0001 0.046 <0.0001 




33.5 35.7 1.08 0.12 0.66 0.09 




49.7 45.5 1.10 0.0003 0.92 0.002 
1Ractopamine HCl (Elanco Animal Health, Greenfield, IN), tylosin phosphate (Elanco Animal Health, Greenfield, IN). 
2Measured at d 7 to 8 and d 15 to 16 of dietary treatment 
3Absorbed N, % of intake = apparent total tract digestibility of N = 100 - [100 × (N in feces / N in diet) × (TiO2 in diet / TiO2 
in feces)] (Oresanya et al., 2007). 




Table 6.  Least square means for the main effect of sampling period on nitrogen balance  in finishing 
gilts1 
 Sampling Period  P-value 
 d 7 to 8 d 15 to 16 SEM Period 
Period × 
RAC 
Period × RAC × 
TP × DDGS 
N balance, g/d       
  Intake 69.2 72.8 3.29 0.0003 0.22 0.43 
  Excreted in feces 12.5 12.7 0.70 0.39 0.19 0.45 
  Absorbed 56.7 60.1 2.59 <0.0001 0.27 0.47 
  Excreted in urine 22.1 27.3 1.61 <0.0001 0.003 0.004 
      0 mg/kg RAC 21.3c 25.0b 1.75 - - - 
      5 mg/kg RAC 22.9bc 29.7a - - - - 
  Retained 34.6 32.8 1.30 0.01 0.34 0.18 
N balance, % of intake         
  Excreted in feces 18.1 17.4 0.24 0.003 0.27 0.79 
  Absorbed 81.9 82.6 0.24 0.003 0.27 0.79 
  Excreted in urine 31.9 37.3 0.90 <0.0001 0.11 0.01 
  Retained 50.0 45.2 0.93 <0.0001 0.046 0.01 
      0 mg/kg RAC 46.9b 43.4c 1.18 - - - 
      5 mg/kg RAC 53.0a 47.1b - - - - 
1RAC = ractopamine HCl (Elanco Animal Health, Greenfield, IN), TP = tylosin phosphate (Elanco 








Table 7.  Least square means for the main effects of ractopamine HCl (RAC), tylosin phosphate (TP), and distillers dried 
















SEM RAC TP DDGS 
ATTD3, % 




86.8 82.3 0.27 0.69 0.96 <0.0001 




85.6 81.4 0.28 0.10 0.60 <0.0001 
Energy, Mcal/kg DM 




4.29 4.51 - - - - 




3.68 3.67 0.013 <0.0001 0.08 0.79 




10.8 9.7 0.47 0.34 0.93 <0.0001 
1Ractopamine HCl (Elanco Animal Health, Greenfield, IN), tylosin phosphate (Elanco Animal Health, Greenfield, IN). 
2Measured at d 7 to 8 and d 15 to 16 of dietary treatment. 
3ATTD, % = 100 - [100 × (DM or GE in feces / N in diet) × (TiO2 in diet / TiO2 in feces)] (Oresanya et al., 2007). 
4Determined digestible energy content. 
5RAC × TP interaction, P = 0.04 




Table 8.  Least square means for the main effect of sampling period on the 
apparent total tract digestibility (ATTD) of dry matter (DM), and gross 
energy (GE) in finishing gilts 
 Sampling Period   
 d 7 to 8 d 15 to 16 SEM P-value 
ATTD1, %     
  DM 84.5 84.7 0.23 0.10 
  GE 83.3 83.7 0.25 0.0004 
Energy, Mcal/kg DM     
  GE 4.40 4.40 - - 
  DE2 3.66 3.69 0.011 0.0004 
DE intake, Mcal/d 9.9 10.6 0.46 <0.0001 
1ATTD, % = 100 - [100 × (DM or GE in feces / N in diet) × (TiO2 in diet / 
TiO2 in feces)] (Oresanya et al., 2007). 





Figure 1.  Interaction between ractopamine HCl (RAC) and tylosin phosphate (TP) on N 
retention (g/d) at d 7 to 8 (P = 0.02), d 15 to 16 (P = 0.25), and for the combined data set 
(P = 0.045).  Error bars represent the SEM.  ab Means within period with different 
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Figure 2.  Interactions between ractopamine HCl (RAC), tylosin phosphate (TP), and distillers dried grains with solubles (DDGS) on 
apparent total tract digestibility (ATTD) gross energy (GE) (P = 0.009) and measured diet digestible energy (DE) content (P < 0.001).  
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CHAPTER 4. TRANSCRIPT PROFILES IN LONGISSIMUS DORSI MUSCLE 
AND SUBCUTANEOUS ADIPOSE TISSUE: A COMPARISON OF PIGS WITH 
DIFFERENT POST-WEANING GROWTH RATES 
 
A paper accepted for publication in the Journal of Animal Science 
C. M. Pilcher*, C. K. Jones*, M. Schroyen*, A. J. Severin†, J. F. Patience*, C. K. 
Tuggle*, and J. E. Koltes* 
 
Abstract 
Although most pigs recover rapidly from stresses associated with the transition of 
weaning, a portion of the population lags behind their contemporaries in growth 
performance. The underlying biological and molecular mechanisms involved in post-
weaning differences in growth performance are poorly understood. The objective of this 
experiment was to use transcriptional profiling of skeletal muscle and adipose tissue to 
develop a better understanding of the metabolic basis for poor weaned-pig transition. A 
total of 1,054 pigs were reared in commercial conditions and weighed at birth, weaning, 
and 3 weeks post-weaning. Transition average daily gain (tADG) was calculated as the 
average daily gain for the 3-wk period post-weaning. Nine pigs from each of the lowest 
10th percentile (low tADG) and the 60th-70th percentile (high tADG) were harvested at 3 
weeks post-weaning. Differential expression analysis was conducted in longissimus dorsi  
______________________ 
*Department of Animal Science, Iowa State University, Ames 50011 




muscle (LM) and subcutaneous adipose tissue using RNA-Seq methodology. In LM, 768 
transcripts were differentially expressed (DE), 327 with higher expression in low tADG 
and 441 with higher expression in high tADG pigs (q < 0.10). Expression patterns 
measured in LM by RNA-Seq were verified in 30 of 32 transcripts using qPCR. No DE 
transcripts were identified in adipose tissue. To identify biological functions potentially 
underlying the effects of tADG on skeletal muscle metabolism and physiology, functional 
annotation analysis of the DE transcripts was conducted using DAVID and Pathway 
Studio analytic tools. The group of DE genes with lower expression in LM of low tADG 
pigs was enriched in genes with functions related to muscle contraction, glucose 
metabolism, cytoskeleton organization, muscle development, and response to hormone 
stimulus (enrichment score > 1.3). The list of DE genes with higher expression in low 
tADG LM was enriched in genes with functions related to protein catabolism (enrichment 
score > 1.3). Analysis of known gene-gene interactions identified possible regulators of 
these differences in gene expression in LM of high and low tADG pigs; these include 
forkhead box O1 (FOXO1), growth hormone (GH1), and the glucocorticoid receptor 
(NR3C1). Differences in gene expression between poor transitioning pigs and their 
contemporaries indicate a shift to decreased protein synthesis, increased protein 
degradation, and reduced glucose metabolism in the LM of low tADG. 
Key Words: post-weaning growth, transcriptional profiling, pig 
 
Introduction 
The transition at weaning is one of the most stressful events in the pig’s life and is 




intestinal function (Moeser et al., 2007; Wijtten et al., 2011). Improvements in 
technology related to nutrition, health, and management have been utilized to minimize 
the adverse effects of weaning stress; however, there is still a tremendous amount of 
within-population variation in growth performance during the post-weaning transition 
period. Previous research indicates that poor performance during the period immediately 
post-weaning is associated with poor overall wean-to-finish performance and increased 
mortality (Jones, 2012; Jones et al., 2014). Poor energy intake and decreased protein and 
lipid deposition rates have been identified as key factors associated with low ADG during 
the post-weaning transition period (Jones et al., 2012; Jones and Patience, 2014). While 
numerous contributing factors have been identified, many of the underlying biological 
and molecular mechanisms involved in post-weaning differences in growth performance 
are poorly understood. 
Skeletal muscle and adipose tissue are key components of growth and are capable 
of physiological adaptations to a variety of conditions including disease, stress, and 
reduced nutrient availability. High-throughput sequencing techniques, such as RNA-Seq, 
are used to measure the expression of the transcriptome of a tissue and may help to 
identify complex biological mechanisms that are involved in variable post-weaning 
outcomes. Analyzing RNA profiles at critical points post-weaning, may enable us to 
identify molecular pathways that could be targeted to increase productive efficiency by 
optimizing genetics, management and nutrition at the farm level. The objective of this 
study was to investigate the molecular basis for poor weaning transition in pigs reared in 






Materials and Methods 
All experimental procedures adhered to the ethical and humane use of animals for 
research, and were approved by the Iowa State University Institutional Animal Care and 
Use Committee (#2-11-7095-S). 
 
Animals and Housing 
Over a 3.5 d period 1,500 pigs (Danbred 600 × Newsham NC32) were farrowed at 
a commercial farm. Prior to suckling, pigs were weighed individually to obtain birth 
weights and tagged with a unique identification number. All procedures from birth until 
weaning were carried out according to normal procedures at the source farm, including 
cross-fostering among litters to standardize litter size among sows. At 16 or 17 days of 
age, a total of 1,054 pigs were randomly selected from this farrowing group, weaned, and 
transported to a commercial wean-to-finish barn. Pigs were sorted by sex and randomly 
allotted to 40 pens with 26-27 pigs per pen. 
Pigs were weighed individually at 0 and 3 wks post-weaning. Transition ADG 
(tADG) was calculated as the average daily gain between wk 0 and 3 post-weaning. All 
pigs were fed the same diets in the phase-feeding program utilized by the commercial 
producer. Pigs originated from a sow herd that was negative for Porcine Reproductive 
and Respiratory Syndrome virus (PRRSv). However, a PRRSv and an Influenza A virus 






Tissue Collection and Sample Preparation 
Nine pigs from both the lowest 10th percentile (low tADG) and the 60th-70th 
percentile (high tADG) for tADG were used to create nine pairs of pigs, with pairs 
derived from litters of the same size and from sows of the same parity. These nine pairs 
(18 total pigs) were transported approximately 45 min to the Iowa State University 
Diagnostic Laboratory where they were euthanized via captive-bolt stunning followed by 
exsanguination. Samples of subcutaneous backfat between the 8th and last ribs and 
longissimus dorsi muscle (LM) and were rapidly collected, frozen in liquid nitrogen, and 
stored at -80°C for later isolation of RNA. The remainder of each whole carcass, 
including blood, was stored at -20°C. Carcasses were later ground, homogenized, and 
sub-sampled. Sub-samples were freeze dried and ground through a 1-mm screen and 
analyzed for DM, ash, crude fat and nitrogen content. Dry matter of feed and fecal 
samples was determined by drying samples in an oven at 105°C to a constant weight. Ash 
was determined by method 942.05 (AOAC, 2005). Crude fat was determined by ether 
extraction according to method 920.39 (AOAC, 2005). Nitrogen content was determined 
by Kjeldahl according to method 981.13 (AOAC, 2005). Calibration of the N assay was 
conducted with a glycine standard (N content 18.7%). Upon analysis, N content of the 
glycine standard was determined to be 18.7 ± 0.07%. Crude protein was expressed as 
nitrogen content × 6.25. All chemical analyses were carried out in duplicate and repeated 
when the intra-duplicate coefficient of variation exceeded 1%. Based on the sub-sample 
chemical composition, total body composition was calculated for water, protein, lipid, 




Total RNA was isolated and purified from LM and adipose tissues using Ambion 
MagMAX total RNA isolation kits (Life Technologies, Carlsbad, CA) per manufacturer’s 
instructions. Quality and quantity of RNA were determined by using a Nanodrop ND-
1000 (Thermo Scientific, Wilmington, DE) and an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Inc., Santa Clara, CA). Mean RNA integrity numbers were 8.7 ± 0.60 for 
LM RNA samples and 7.4 ± 0.61 for adipose tissue RNA samples. 
RNA sequencing libraries were prepared using TruSeq RNA Sample Prep Kits 
(Illumina Inc., San Diego, CA) and samples sequenced by 2 × 100 bps paired-end 
sequencing on an Illumina HiSeq 2000 instrument at the Iowa State DNA facility. All 
RNA samples were indexed, and 10 samples were loaded per flow cell lane. High and 
low tADG samples for each tissue were distributed randomly with roughly equal numbers 
of each tissue, and high and low groups were distributed within a flow cell so that tissue 
and group were not confounded in a flow cell lane. 
 
RNA-Seq Analysis 
Raw sequence data were transferred to the Iowa State University Genome 
Informatics Facility. The raw read sequences were aligned to the Sus scrofa genome build 
10.2 (Ensembl release 70) using the Genomic Short-read Nucleotide Alignment Program 
(GSNAP; Version 2012-07-20) (Wu and Nacu, 2010). Reads that mapped uniquely to the 
genome were utilized for downstream analysis and differential expression. For each gene, 
raw read counts were then determined using HTSeq and the Ensembl gene set GTF 




publically available at the National Center for Biotechnology Information’s Gene 
Expression Omnibus (GEO) under GEO data set ID GSE65983. 
 
Statistical Analyses 
Growth and Body Composition 
Data were analyzed using the PROC MIXED procedure of SAS (SAS Inst. Inc., 
Cary, NC) with the variables tADG (high vs. low) and parity (1 vs. 2+) as fixed effects. 
Differences between least squares means were separated using the PDIFF option of SAS 
with results considered significant if P < 0.05 and trends if P > 0.05 and < 0.10. 
 
Gene Expression 
Statistical analysis of RNA-Seq read counts were performed using the QuasiSeq 
package in R (Lund et al., 2012). The raw read counts were normalized using upper 
quartile normalization. Normalized read counts were fit as the dependent variable in a 
generalized linear model, assuming a negative binomial distribution, including the 
variables tADG (high vs. low), parity (1 vs. 2+) and birth weight (in kg) as fixed effects. 
This model was compared to a reduced model, including all fixed effects except tADG to 
test for differences in gene expression as a function of tADG. The QuasiSeq software 
allows users to account for over-dispersion in count data by modeling the estimated over-
dispersion by the total number of read counts in a gene. A spline correction was used to 
account for some of the effects of over-dispersion. The q-value method was used to 
correct for multiple testing as a means to control the false discovery rate (FDR) (Storey 




0.10. There were no DE genes (q < 0.10) identified in adipose tissue samples; therefore, 
additional analyses were conducted on only LM sample genes. 
 
Pathway Analysis with Gene Ontology and Kyoto Encyclopedia Genes and Genomes 
Genes in LM that were differentially expressed were divided into two gene lists: 1) 
higher expression in high tADG pigs and 2) higher expression in low tADG pigs. Using 
the Database for Annotation, Visualization and Integrated Discovery (DAVID) version 
6.7, an open-access Web-based functional annotation and clustering program (Huang et 
al., 2009a, b), the DE gene lists were analyzed for overrepresented biological process and 
metabolic function categories based on Gene Ontology (GO) or Kyoto Encyclopedia 
Genes and Genomes (KEGG) pathway categories. The P-values for over-representation 
of GO terms and KEGG pathways were computed by a modified Fisher’s exact test, 
using the LM transcriptome as background. The Benjamini-Hochberg method was used 
to correct for multiple testing as a means to control the FDR. The individual GO terms 
and KEGG pathways were considered significant if FDR < 0.10.The GO biological 
process terms were clustered using the functional annotation clustering tool, where the 
enrichment score for each cluster was computed as the negative log of the geometric 
mean of P-values in the cluster. The resulting statistically significant clusters (enrichment 
score > 1.3) were further curated to keep only GO terms with P-values < 0.05. 
 
Pathway Studio Analysis 
Genes in LM that were DE were analyzed with Pathway Studio version 9.0 




cell processes, and diseases as recorded in the PubMed database (Ariadne Genomics, 
Rockville, MD). The datasets were studied using sub-network enrichment analysis to find 
statistically significant entities connecting DE genes with higher expression in high or 
low tADG pigs. Common gene hubs were obtained based on reported (PubMed) 
interactions, which were defined as regulation, direct regulation, promoter binding, 
and/or expression. 
 
Quantitative Reverse Transcriptase PCR for Verification of DE Genes 
Quantitative Reverse Transcriptase PCR (qRT-PCR) was used to verify DE of 32 
genes in LM. The 32 genes were selected to represent key pathways and biological 
functions identified by DAVID and Pathway Studio analytical tools. Total RNA was 
isolated from LM of all 18 pigs using Norgen Animal Tissue RNA purification kits 
(Norgen Biotek Corp, Thorold, Ontario, Canada) and reverse transcribed to cDNA using 
SuperScript VILO cDNA synthesis kits (Life Technologies). For the qRT-PCR, 
DELTAgene Assays (Fluidigm, San Francisco, CA) were used (Supplementary Table 1) 
and specific sequences were obtained after 12 cycles of denaturation at 95°C for 15 
seconds and annealing and elongation at 60°C for 4 minutes using 2x TaqMan PreAmp 
Master Mix (Life Technologies). The pre-amplified products were 10-fold diluted and 
further amplified with the 2x SsoFast EvaGreen Supermix with Low ROX (Biorad; 
Hercules, CA) in a 48.48 Dynamic Array on a Biomark system (Fluidigm). The relative 
expression value of each gene was calculated relative to the housekeeping gene 
topoisomerase II beta (TOP2B) (Erkens et al., 2006) using the 2-ΔΔCt method (Livak and 




the same model as the RNA-Seq data as described above. Differences between least 
squares means were estimated using the PDIFF option of SAS. To control for multiple 
testing, FDR (Benjamini and Hochberg, 1995) was estimated. Results were considered 
significant if FDR < 0.10. 
 
Results  
Growth and Body Composition 
High tADG pigs gained 130% more body weight than low tADG pigs (220 vs. 96 
g/d, P < 0.0001; Table 1) during the 3-wk post-weaning transition period. The mean 
tADG from the population of 1,054 pigs from which pigs for the experiment were 
selected was 197 g/d (Jones et al., 2014). Birth weight, weaning weight, and ADG from 
birth to weaning were similar (P > 0.10) between high and low tADG pigs. Low tADG 
pigs were higher in whole body water (P < 0.05), tended to have greater ash percentage 
(P = 0.06) and were lower in body lipid content (P < 0.01). 
 
Read Alignment Statistics 
For LM, an average of 15.3 million paired-end reads was generated per sample 
(Supplementary Table 2). For adipose tissue, an average of 16.4 million paired-end reads 
was generated per sample. In total, 82% of LM and 83% of adipose tissue reads were 
uniquely mapped back to the reference genome after alignment. There were 15,569 and 
17,802 expressed genes in LM and adipose tissue, respectively that mapped to the Sus 
scrofa genome. Additional details on read mapping and counting statistics are available 





Detection of DE Genes 
RNA-Seq analyses revealed a total of 768 DE (q < 0.10) in LM. A total of 327 
DE genes had higher expression in low tADG pigs and 441 DE genes had lower 
expression in low tADG pigs (i.e. higher expression in high tADG pigs). No DE genes (q 
< 0.10) were identified in adipose tissue samples. 
 
RNA-Seq Data Validation by qPCR 
To verify expression patterns measured by RNA-Seq in LM, we used qPCR to 
assay mRNA levels for 32 genes, which were predicted to be DE between high and low 
tADG pigs (q < 0.10). For all genes tested for validation by qPCR, differences in 
expression between the high and low tADG pigs were consistent in direction with the 
RNA-Seq results (Supplementary Table 3). Statistical significance (FDR < 0.10) was 
confirmed by qPCR in 90% of the tested genes in LM. 
 
Gene Ontology Enrichment Analysis in LM 
To identify biological pathways potentially underlying the effects of tADG on 
skeletal muscle metabolism and physiology, we performed a functional enrichment 
analysis of genes DE between high and low tADG pigs using DAVID (Supplementary 
Tables 4 and 5). Over-representation of GO Biological Process terms was determined for 
the list of DE genes, and 113 processes were identified; 79 by genes with lower 




Terms with significant similarity were further clustered into eight significant 
annotation clusters (enrichment scores > 1.3; Table 2) for DE genes with lower 
expression in low tADG. These clusters showed the following enriched functions: muscle 
contraction, glucose metabolic process, cytoskeleton organization, actin filament-based 
movement, angiogenesis, muscle development, glycogen metabolism, and response to 
hormone stimulus. Differentially expressed genes with higher expression in low tADG 
LM produced one cluster with over-representation of GO terms related to protein 
catabolic process (enrichment scores < 1.3; Table 3). 
Analysis of KEGG Pathways using DAVID revealed over-representation of 
glycolysis/gluconeogenesis (FDR < 0.001) in DE genes with lower expression in low 
tADG pigs and over-representation of the proteasome (FDR < 0.01) in DE genes with 
higher expression in low tADG pigs (Supplementary Table 6). 
 
Pathway Studio Analysis of DE Genes 
 To understand and identify possible regulators of the pathways identified by DE 
gene analysis, DE gene lists were analyzed for their connections to common transcription 
factors, nuclear receptor regulators, and other genes by using Pathway Studio (Nikitin et 
al., 2003). Connections were identified based on literature evidence of at least one of four 
interaction categories provided by Pathway Studio, which were promoter binding, direct 
regulation, regulation, and expression (Table 4; Supplementary Table 7). Candidate hub 
genes identified by Pathway Studio were declared significant if the list of genes 




The most connected gene hub for DE genes with higher expression in low tADG 
pigs was the nuclear receptor subfamily 3, group C, member 1 (NR3C1; 11 connected DE 
genes). The NR3C1 gene encodes the glucocorticoid receptor, which is the exclusive 
mediator of physiological effects of glucocorticoids in skeletal muscle (Reyer et al., 
2013). Prolactin (PRL), cyclic adenosine monophosphate responsive element binding 
protein 1 (CREB1), and janus kinase 2 (JAK2) were also identified as highly connected 
with DE genes with higher expression in low tADG LM. 
The most connected gene hub for DE genes with lower expression in LM of low 
tADG pigs was growth hormone (GH1; 13 connected DE genes). Thyroid stimulating 
hormone (TSH), forkhead box O1 (FOXO1), androgen receptor (AR), forkhead box M1 
(FOXM1), myeloblastosis transcription factor (MYB), and peroxisome proliferator-
activated receptor delta (PPARD) were also identified as highly connected to those DE 
genes with lower expression in LM of low tADG pigs. 
Figure 1 provides a summary of the connections between GO enrichment and 
Pathway Studio analyses in LM. 
 
Discussion 
Changes in gene expression and metabolic pathways in LM were observed among 
pigs in the 10th versus the 60th to 70th percentile of post-weaning ADG. There was a 
greater than 2-fold difference in ADG during the 3-wk period following weaning. 
Although alterations in RNA expression do not always correspond with alterations in 




that have over-represented GO terms, KEGG pathways, or Pathway Studio categories 
indicate potential functional changes in the respective pathways or biological processes. 
We understand that differences in gene expression between high and low tADG 
pigs may be the result of up-regulation or down-regulation in one phenotype or both. For 
the sake of clarity, and to focus specifically on the objective of this study (i.e. to 
investigate the molecular basis of poor post weaning growth performance), the discussion 
focuses on changes in gene expression and pathways in the low tADG pigs. 
It is important to note that a PRRSv outbreak that occurred wk 2 post-weaning 
likely influenced the results of this experiment. All pigs in both high and low tADG 
groups were PCR positive for the North American genotype of PRRS in lung tissue at 3 
wk post weaning (Jones et al., 2014). The PRRS virus is highly associated with 
secondary infections (Done and Paton, 1995; Zimmerman et al., 1997); however, there 
were no differences between tADG categories for the incidence of Haemophilus parasuis, 
porcine circovirus type 2, rotavirus, Streptococcus suis, or Salmonella spp B infection or 
for immune marker concentrations (i.e. IgA, IL-1β, IL-8, and total glutathione) in serum 
or ileal mucosa at 3 wk post-weaning for the population from which pigs in this 
experiment were selected (Jones et al., 2014). 
 
No Differentially Expressed Genes were Identified in Adipose Tissue 
Previous research indicated that poor transitioning pigs had reduced whole body 
lipid accretion rates (Jones et al., 2012). In the current experiment, the low tADG pigs 
had less whole body lipid content than the high tADG pigs. However, we were unable to 




groups. Exploring transcript changes at different time points after weaning or different 
adipose tissue depots may identify differentially expressed genes. 
 
Expression Differences in Genes Involved in Energy Utilization in Muscle 
Poor weaning transition in pigs is often associated with low feed intake (Huang et 
al., 2011; Jones et al., 2012). Undernourished animals are capable of altering metabolism 
to prioritize glucose for the brain and other obligate users of glucose. One possible way 
that glucose utilization in muscle may be reduced is through decreased transcription of 
genes encoding glycolytic enzymes. We observed reductions in the mRNA levels for 
several key glycolytic genes in the LM of low tADG pigs including glucose-6-phosphate 
isomerase (GPI), phosphoglycerate kinase (PGK1), phosphoglyceratemutase (PGAM2) 
and pyruvate kinase (PKM) (q < 0.10). We also observed lower expression of genes 
involved in glycogen metabolism in LM of low tADG pigs including glycogen synthase 
(GYS1),glycogen phosphorylase (PYGM), phosphorylase kinase (PHKA1) and the 
glycogen debranching enzyme amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase 
(AGL). These results indicate that glucose utilization and turnover are likely reduced in 
skeletal muscle of the low tADG pigs. 
The AMP-activated protein kinase (AMPK) system plays an important role in 
regulation of cellular energy balance and in whole body energy metabolism. Activation 
of AMPK in skeletal muscle leads to increased fatty acid oxidation and glucose uptake. 
The AMPK protein is heterotrimeric, consisting of a catalytic (α) and two regulatory (β 




(PRKAB2) the main catalytic and regulatory isoforms in skeletal muscle, respectively, 
had lower expression in LM of low tADG pigs.  
Hormone-sensitive lipase (HSL), the major enzyme mediator of the lipolytic 
pathway, had higher mRNA expression in LM of low tADG. Although hormone sensitive 
lipase activity is controlled post-translationally through phosphorylation (Yeaman, 1990), 
there is evidence that prolonged feed deprivation results in an increase in HSL mRNA in 
skeletal muscle tissue in the pig (Spurlock et al., 2001). Fatty acids liberated by HSL may 
be utilized as an energy source within the muscle via beta oxidation. 
 
GO Term Clusters Indicate Possible Changes in Protein Turnover in Muscle 
The low tADG pigs had lower expression of genes related to skeletal muscle 
structure and function including actin, alpha 1 (ACTA1), myomesin 2 (MYOM2), 
tropomyosin 1, alpha (TPM1), myosin light chain 1 (MYL1) and six myosin heavy chain 
isoforms including IIA, IIB, and IIX (q < 0.10). Previous research indicated that poor 
transitioning pigs have lower rates of protein accretion than their contemporaries (Jones 
et al., 2012), and gene expression data from the current study indicate that the reduced 
rate of protein accretion may be driven by lower gene expression related to both synthesis 
and degradation of skeletal muscle protein. 
The ubiquitin-proteasomal system is a major contributor to protein degradation in 
skeletal muscle. Several genes involved in ubiquitin-dependent catabolism, including 
genes that encode ubiquitin specific peptidases, ATPase and non-ATPase components of 
the 26S proteasome subunit, and the F-box only protein 32 (FBXO32) had higher 




atrogin 1, is the substrate recognition component of a muscle-specific E3 ubiquitin ligase. 
Atrogin 1 binds to target proteins to induce ubiquitin binding and degradation through the 
proteasome. Atrogin 1 is a key marker of the atrophy process and has been shown to be 
induced in multiple models of skeletal muscle atrophy resulting from a variety of 
conditions including muscle inactivity, multiple disease states, and starvation (Schiaffino 
et al., 2013).  
The major pathway regulating muscle protein synthesis is the mechanistic target 
of rapamycin (mTOR) pathway. Genes that encode two negative regulators of mTOR 
signaling, the eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) 
and DNA-damage-inducible transcript 4-like (DDIT4L), had higher expression in low 
tADG pigs (q < 0.10). When anabolic signaling is low, the EIF4E-BP1 protein represses 
translation initiation by binding to eIF4E, blocking eIF4E-eIF4G complex formation. 
When anabolic signaling via mTOR is high, 4E-BP1 is phosphorylated, eIF4E is 
released, which can then bind to eIF4G forming a complex that up-regulates mRNA 
binding to the 40S ribosomal subunit, thereby increasing translation initiation (Davis et 
al., 2008). Transcriptional control of 4EBP has not been extensively evaluated; however, 
due to its function as a negative regulator of translational initiation, higher expression 
may lead to reduced protein synthesis. The protein encoded by the DDIT4L gene, 
REDD2, suppresses anabolic signaling upstream of mTOR, and has been shown to inhibit 
mTOR signaling due to a variety of stress-related responses, including DNA damage, 
hypoxia, and glucocorticoid treatment (Corradetti et al., 2005; Miyazaki and Esser, 2009). 
These alterations in gene expression related to muscle protein turnover indicate a 




synthesis is energetically costly, and can be slowed as a survival mechanism during 
periods of low feed intake. Amino acids resulting from the breakdown of skeletal muscle 
tissue can be mobilized and redistributed for maintenance of more critical tissues in a 
period of low feed intake. The amino acids can also be oxidized and utilized as an energy 
source for the liver and other key tissues in the body during times of energy shortage. 
 
FOXO1 – Key Link between Protein Synthesis and Degradation and Energy 
Metabolism 
The forkhead-box O transcription factor FOXO1 had higher expression in the low 
tADG pigs (q < 0.10). Muscle protein synthesis (via Akt - mTOR signaling) is linked to 
muscle ubiquitin-dependent protein degradation and muscle atrophy via FOXOs. In the 
presence of insulin or IGF-I, the phosphorylation via Akt pathway signaling sequesters 
FOXO transcription factors in the cytoplasm (Stitt et al., 2004). In the absence of insulin 
or IGF-I, Akt is inactive, and FoxO proteins are translocated to the nucleus and induce 
the transcription of target genes that regulate protein degradation (Kamei et al., 2004). 
FBXO32 is a key transcriptional target of FOXO1. Over-expression of FOXO1 in 
transgenic mice showed markedly reduced muscle mass (Kamei et al., 2004). FOXO 
knockdown blocks the upregulation of FBXO32 (atrogin 1), preventing muscle loss 
during atrophy (Sandri et al., 2004). Interestingly, FOXO1 was identified by our Pathway 
Studio analysis due to its negative association with several genes with higher expression 
in high tADG pigs. The FOXO genes also mediate glucocorticoid induced muscle protein 
catabolism (Schakman et al., 2008). The glucocorticoid receptor, NR3C1, was identified 




transcription changes in the FOXO1 regulator and glucocorticoid pathway that may play 
a role in muscle protein catabolism. Gene and pathway enrichment results in this study 
indicate that changes in muscle protein growth and breakdown maybe mediated through 
FOXO1, NR3C1 and mTOR signaling. 
 
Conclusions 
This study identified differences in transcript abundance in the LM but not in 
adipose tissue related to the reduced growth in low tADG pigs. Changes in transcript 
abundance in the LM indicate a possible shift in low tADG pigs to decreased protein 
synthesis, increased protein degradation, and reduced glucose metabolism. These 
responses are consistent with gene expression differences in insulin and GH signaling and 
increased glucocorticoid signaling in the LM of low tADG pigs. We identified 
transcriptional changes in the FOXO1 and the NR3C1 glucocorticoid receptor pathways 
that are consistent with this concept. Many of the gene expression differences between 
poor transitioning pigs and their contemporaries may be related to limited availability of 
energy and amino acids due to low feed intake. Interestingly, we did not detect any 
differences in gene expression in subcutaneous back fat tissue, which may suggest that 
transcript changes in muscle are more relevant to understanding variation in tADG. 
However, further studies are needed to determine if genetics, management, and 
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Figure 1. Pathway enrichment analysis of differentially expressed (DE) genes in 
longissimus dorsi muscle (LM) indicates that forkhead box O1 (FOXO1) and the 
glucocorticoid receptor (NR3C1) may play a role in differences in low and high 
transistion ADG (tADG) pigs. These results are consistent with the known roles of 
FOXO1 and glucocorticoid signaling through mechanistic target of rapamycin (mTOR), a 
major regulator of protein synthesis. It is known that NR3C1 and FOXO1 interact and 
that FOXO1 influences glucocorticoid signaling via atrogin 1 to result in protein 
degradation and muscle atrophy. Solid lines represent interactions based on Pathway 
Studio (NR3C1 and FOXO1) and the literature (FOXO1 and atrogin 1). Dashed lines 
represent inferred relationships and biological outcomes predicted based on previous 
studies. Both FOXO1 and atrogin 1 were DE (q < 0.10) and expressed higher in the low 
vs. high tADG pigs. The NR3C1 gene was not DE, but its targets were DE and were 
identified as enriched by Pathway Studio.  References are denoted by superscripts: 
1Corradetti et al. (2005); 2Miyazaki and Esser (2009); 3Schakman et al. (2008); 4Stitt et al. 
(2004); 5Kamei et al. (2004); 6Conn and Qian (2011); 7Wang and Proud (2006); 





Table 1. Body weight, average daily gain, and body composition of low and high 
transition average daily gain (tADG) pigs. 
 Low tADG High tADG SEM P-value 
n = 9 9 - - 
Body weight, kg     
    Birth 1.26 1.44 0.103 0.2362 
    Weaning 4.51 5.23 0.350 0.1641 
    3 wk post-weaning 6.23 9.19 0.383 <0.0001 
ADG, g/d     
    Birth to weaning 197 230 17.3 0.1972 
    0-3 wk post-weaning 96 220 5.0 <0.0001 
Body composition1, %     
    Water 68.5 66.2 0.51 0.0055 
    Protein 15.9 15.9 0.14 0.9900 
    Lipid 12.6 15.5 0.52 0.0012 
    Ash 3.0 2.4 0.19 0.0571 







Table 2. Functional annotation clusters and corresponding Gene Ontology biological process terms for 
genes with lower expression (q < 0.10) in longissimus dorsi tissue of low transition average daily gain 
pigs1 
Cluster 





 Cluster 1   
6.29 GO:0006936~muscle contraction 18 < 0.0001 
 GO:0003012~muscle system process 18 < 0.0001 
 GO:0006941~striated muscle contraction 9 < 0.0001 
 Cluster 2   
3.42 GO:0006006~glucose metabolic process 18 < 0.0001 
 GO:0019318~hexose metabolic process 18 < 0.0001 
 GO:0006090~pyruvate metabolic process 9 < 0.0001 
 GO:0006094~gluconeogenesis 7 < 0.0001 
 GO:0005996~monosaccharide metabolic process 18 < 0.0001 
 GO:0019319~hexose biosynthetic process 7 0.0001 
 GO:0034637~cellular carbohydrate biosynthetic process 9 0.0004 
 GO:0046364~monosaccharide biosynthetic process 7 0.0005 
 GO:0044275~cellular carbohydrate catabolic process 9 0.0006 
 GO:0006096~glycolysis 7 0.0006 
 GO:0046165~alcohol biosynthetic process 7 0.001 
 GO:0046164~alcohol catabolic process 8 0.002 
 GO:0006007~glucose catabolic process 7 0.002 
 GO:0016052~carbohydrate catabolic process 9 0.003 
 GO:0019320~hexose catabolic process 7 0.004 
 GO:0046365~monosaccharide catabolic process 7 0.005 
 GO:0016051~carbohydrate biosynthetic process 9 0.007 
 Cluster 3   
2.53 GO:0007010~cytoskeleton organization 25 0.0003 
 GO:0030029~actin filament-based process 16 0.002 
 GO:0030036~actin cytoskeleton organization 12 0.04 
 Cluster 4   
2.40 GO:0030048~actin filament-based movement 6 0.0002 
 GO:0033275~actin-myosin filament sliding 4 0.001 
 GO:0070252~actin-mediated cell contraction 4 0.001 
 GO:0030049~muscle filament sliding 4 0.001 
 GO:0030705~cytoskeleton-dependent intracellular transport 6 0.01 
 Cluster 5   
2.31 GO:0048514~blood vessel morphogenesis 14 0.003 
 GO:0001568~blood vessel development 15 0.004 
 GO:0001944~vasculature development 15 0.005 
 GO:0001525~angiogenesis 10 0.01 
 Cluster 6   
1.56 GO:0007517~muscle organ development 17 0.0001 
 GO:0060537~muscle tissue development 12 0.0004 
 GO:0014706~striated muscle tissue development 11 0.001 
 GO:0060538~skeletal muscle organ development 6 0.04 
 GO:0007519~skeletal muscle tissue development 6 0.04 
 GO:0031032~actomyosin structure organization 4 0.04 
 Cluster 7   
1.35 GO:0005977~glycogen metabolic process 5 0.01 
 GO:0044042~glucan metabolic process 5 0.01 
 GO:0006073~cellular glucan metabolic process 5 0.01 




Table 2. (continued) 
Cluster 





 Cluster 8   
1.31 GO:0032868~response to insulin stimulus 9 0.004 
 GO:0043434~response to peptide hormone stimulus 11 0.005 
 GO:0032869~cellular response to insulin stimulus 6 0.03 
1An enrichment score (ES) of > 1.3 is equivalent to a P-value of < 0.05. Fisher Exact P-value represents 






Table 3. Functional annotation cluster and corresponding Gene Ontology (GO) biological process terms for 
genes with higher expression (q < 0.10) in longissimus dorsi tissue of low transition average daily gain 
pigs1 
Cluster 





1.44 GO:0006511~ubiquitin-dependent protein catabolic process 12 0.01 
 GO:0030163~protein catabolic process 22 0.01 
 
GO:0051603~proteolysis involved in cellular protein catabolic 
process 
21 0.02 
 GO:0044257~cellular protein catabolic process 21 0.02 
 GO:0044265~cellular macromolecule catabolic process 24 0.02 
 
GO:0043632~modification-dependent macromolecule catabolic 
process 
20 0.02 
 GO:0019941~modification-dependent protein catabolic process 20 0.02 
 GO:0009057~macromolecule catabolic process 25 0.02 
1An enrichment score (ES) of > 1.3 is equivalent to a P-value of < 0.05. Fisher Exact P-value represents 





Table 4. Pathway Studio sub-network enrichment analysis to identify possible regulators of differentially 
expressed genes (q < 0.10) in longissimus dorsi muscle of low and high transition average daily gain (tADG) 
pigs. 









Higher expression in low tADG     
    NR3C1 Glucocorticoid receptor 11 2.07 0.03 
    PRL Prolactin 8 2.78 0.01 
    CREB1 Cyclic adenosine monophsphate 
responsive element binding 
protein 1 
7 2.38 0.03 
    JAK2 Janus kinase 2 5 3.74 0.02 
Lower expression in low tADG     
    GH1 Growth hormone 13 -1.54 0.03 
    TSH Thyroid stimulating hormone 11 -1.39 0.03 
    FOXO1 Forkhead box O1 10 -1.55 0.04 
    AR Androgen receptor 8 -1.52 0.01 
    FOXM1 Forkhead box M1 8 -1.52 0.01 
    MYB Myeloblastosis transcription factor 6 -1.77 0.001 
    PPARD Peroxisome proliferator-activated 
receptor delta 







Supplementary Table 1.  Primers used for RT qPCR analysis. 
Gene Name Forward primer Reverse primer Design RefSeq 
ACSL4 GCCCCTCTTATTTGCTGTGAA GGGTTTGGCTTGTCGTGAA NM_001038694.1 
AGL GGAGAAAGTGACAGAGCCAGAA ACTCAGGCCCACAATTTCCA FLDM-003439.1 
AMPD1 GTGTTTGAGGCCACCATCAAC CACGCTGTCGAAGCCAGTA NM_001123076.1 
APIP GTCTACGTCTGGGGAGAGAC TGATACGGCAACATCGAACAA XM_003122870.1 
AQP4 CTGGTCATGGTCTCCTGGTA TTGGAATCACAGCTGGCAAA NM_001110423.1 
BNIP3 CGCACACAGTGTTGGAGAAA TCCCTCCTCCTCTCCATGTAA XM_003359404.1 
BTG2 TTTTCAGCGGGGCTCTCC AGCCCTTGGATGGCTTTTCA NM_001097505.2 
CA3 AGTTCCAACTAGTCCTTGATGCA AACAGGCAGGATGGGTTGAA NM_001008688.1 
CCDC88C TGCACGACGTGGACTTCTA CCAACATGGCCTTGGTTTCA XM_001928733.1 
CDKN1B GACAGCCAGACGGGGTTA TCGGGGAACCGTCTGAAAC NM_214316.1 
CIRBP GAGTCAGGGTGGCAGCTA AACTGTCGTAGCTGTCTCTGTA XM_003122988.3 
CTGF AAGATCTCCAAGCCCGTCAA TGCATACCCCGCAGAACTTA U83916.1 
DDIT4L AGTTGCTAGACCGTAGCTTCC TTGGGTTCAGGGACAACGTAA XM_003129299.2 
EIF4EBP1 TGGAGTGTCGGAACTCACCT ATCACCCACAGGGCTGGT NM_001244225.1 
FBXO30 GGGGAAAAGGAAGTATCCAGA AGTGGTCAGCCATACTTAGGA XM_003121151.1 
FBXO32 GAAGGACATGCTGAACAGCAAA AGTACTTCCTTTGTGAACATAGATCCA NM_001044588.1 
FOXO1 CTCACGCTCTCGCAGATCTA AGCTGTTGCTGTCACCCTTA NM_214014.2 
GSTK1 CGGACCGTGGAGCTTTTCTA AGCTGCAGGTTGACATTCCA XM_003134573.1 
HSPA2 ACGACAAAGGTCGTCTAAGCA GGCCTCATCTTCCGACTTGTA XM_003356734.1 
HSPA9 ACAGGAACACCACCATTCCA CTCCACTTGAGTCTGTCCATCA XM_003123976.2 
IGF2 CAGCCCACAGCGATTCCAA GAGGCCAAGGCCAAGAAGAC NM_213883.2 
IVNS1ABP AAAAGCCACCACGTGAGAA TCCGAAGCAACGATTTTCCA NM_001161649.1 







Supplementary Table 1. (continued) 
Gene Name Forward primer Reverse primer Design RefSeq 
NDRG2 CCAGCTTGCAGACATGATCC CAGCTCCAACACCAATTCCAA NM_001078683.1 
PHB2 AGTGTGGTGGCCAAGTTCA GTCAGCTCCCTTCGGATCAA NM_001243556.1 
PSMC3 GGGTTGGTGGATGCTGAAAA AGGGTCTCCAGGATCAGGTA XM_003122809.1 
PSMD3 CTCCCAAATCGTACAACAAGGAC TCTGCCATCTCCTTGGCAAA XM_003131496.2 
PYGM TCCACTCCGAGATCCTCAAGAA GGGTGATGCCGTTGGTCTTA XM_003122588.2 
RBM3 TCGACCTGGAGGATATGGCTA TCCTCCTGAGTAGCGGTCATA NM_001243419.1 
RORC GGATCCACTACGGGGTTATCA AGGAGTAGGCCACGTTACAC XM_003355171.1 
SELENBP1 GCGGCTCCCAATGTCTTAC ACGTGTAAGCAGCTCCCATA XM_001929643.2 
SLC37A4 ATCCATGTACCTCTTCCGGGTA ACCAAACACAGCTCCCAACA NM_001199719.1 




Supplemental Table 2.  Descriptive statistics for RNA-seq read mapping. Paired ends were 
aligned to the Sus scrofa genome build 10.2 (Ensembl release 70) using the Genomic Short read 
Nucleotide Alignment Program (Version 2012-07-02). 
 Logissimus dorsi muscle  Adipose tissue 
  Mean ± SD Range   Mean ± SD Range 
Number of reads (in millions)      
    Total 15.7 ± 1.01 14.4 – 18.8  16.4 ± 1.46 13.6 – 19.7 
    No feature 1.2 ± 0.10 1.0 – 1.4  1.1 ± 0.16 0.8 – 1.4 
    Ambiguous 1.6 ± 0.13 1.3 – 1.9  1.7 ± 0.20 1.1 – 1.9 
    Uniquely aligned 12.9 ± 0.92 11.8 – 15.2  13.6 ± 1.21 11.3 – 16.5 
Aligned, % 92 ± 0.7% 91 – 94%  93 ± 0.7% 92 – 95% 




Supplementary Table 3. Real-time PCR results for validation of RNA-seq results for select genes. 
  RNAseq   RT-PCR 
Gene name Fold change P-value q-value   Fold change P-value FDR1 
Higher expression in 
low tADG 
   
 
     RORC 2.53 < 0.0001 0.004 
 
3.23 0.001 0.004 
  GSTK1 2.01 < 0.0001 0.01 
 
2.08 0.004 0.01 
  PSMC3 1.70 < 0.0001 0.02 
 
1.58 0.003 0.008 
  IVNS1ABP 2.00 0.0001 0.03 
 
2.30 0.002 0.006 
  BNIP3 2.07 0.0001 0.03 
 
2.40 0.002 0.006 
  CIRBP 2.02 0.0001 0.03 
 
1.66 0.003 0.008 
  FOXO1 2.38 0.0002 0.03 
 
3.99 0.01 0.02 
  SELENBP1 2.14 0.0003 0.03 
 
2.23 0.001 0.004 
  APIP 2.07 0.0004 0.04 
 
2.34 0.009 0.02 
  HSPA2 1.96 0.0004 0.04 
 
2.42 0.002 0.007 
  NDRG2 1.67 0.0003 0.04 
 
1.71 0.006 0.01 
  PSMD3 1.59 0.0004 0.04 
 
1.61 0.05 0.06 
  ACSL4 1.64 0.0008 0.05 
 
1.82 0.004 0.01 
  LIPE 2.29 0.001 0.05 
 
5.22 0.01 0.02 
  AQP4 2.42 0.001 0.05 
 
2.38 0.006 0.01 
  EIF4EBP1 1.72 0.001 0.06 
 
2.24 0.02 0.03 
  DDIT4L 2.25 0.002 0.06 
 
2.39 0.001 0.004 
  FBXO32 6.43 0.002 0.06 
 
13.29 0.02 0.03 
  PHB2 1.43 0.003 0.07 
 
1.43 0.01 0.02 
  MAX 1.81 0.003 0.07 
 
1.75 0.04 0.05 
  RBM3 2.37 0.004 0.08 
 
1.43 0.12 0.12 
  HSPA9 1.58 0.006 0.09 
 
1.31 0.02 0.03 
  CDKN1B 1.44 0.006 0.10 
 
1.38 0.07 0.08 
Lower expression in 
low tADG 
        CCDC88C -1.70 0.0001 0.03 
 
-2.18 0.0001 0.002 
  SLC37A4 -1.57 0.0001 0.03 
 
-2.35 0.0008 0.004 
  CA3 -1.73 0.0002 0.03 
 
-2.55 0.0001 0.002 
  CTGF -1.71 0.0002 0.03 
 
-2.70 0.04 0.05 
  IGF2 -1.35 0.0006 0.04 
 
-1.10 0.70 0.70 
  AGL -1.45 0.0006 0.04 
 
-1.80 0.0002 0.002 
  PYGM -1.25 0.004 0.08 
 
-1.37 0.02 0.03 
  AMPD1 -1.25 0.004 0.08 
 
-1.30 0.12 0.12 
  BTG2 -1.79 0.006 0.10   -1.76 0.04 0.05 






Supplementary Table 4.  Overrepresented GO biological process terms by genes with lower 
expression (q < 0.10) in logissimus dorsi tissue of low transition ADG pigs1  
GO Biological Process term Count P-value Benjamini FDR 
GO:0006936~muscle contraction 18 < 0.0001 0.0001 < 0.0001 
GO:0006006~glucose metabolic process 18 < 0.0001 0.0002 < 0.0001 
GO:0003012~muscle system process 18 < 0.0001 0.0002 < 0.0001 
GO:0019318~hexose metabolic process 18 < 0.0001 0.003 0.0001 
GO:0006941~striated muscle contraction 9 < 0.0001 0.004 0.0002 
GO:0006090~pyruvate metabolic process 9 < 0.0001 0.004 0.0002 
GO:0006094~gluconeogenesis 7 < 0.0001 0.01 0.0004 
GO:0005996~monosaccharide metabolic 
process 18 < 0.0001 0.01 0.0007 
GO:0019319~hexose biosynthetic process 7 0.0001 0.03 0.002 
GO:0007517~muscle organ development 17 0.0001 0.03 0.002 
GO:0030048~actin filament-based movement 6 0.0002 0.04 0.004 
GO:0007010~cytoskeleton organization 25 0.0003 0.05 0.006 
GO:0034637~cellular carbohydrate biosynthetic 
process 9 0.0004 0.05 0.006 
GO:0060537~muscle tissue development 12 0.0004 0.05 0.007 
GO:0046364~monosaccharide biosynthetic 
process 7 0.0005 0.05 0.008 
GO:0044275~cellular carbohydrate catabolic 
process 9 0.0006 0.06 0.01 
GO:0010564~regulation of cell cycle process 11 0.0006 0.06 0.01 
GO:0006096~glycolysis 7 0.0006 0.06 0.01 
GO:0014706~striated muscle tissue 
development 11 0.001 0.09 0.02 
GO:0046165~alcohol biosynthetic process 7 0.001 0.09 0.02 
GO:0070252~actin-mediated cell contraction 4 0.001 0.09 0.02 
GO:0033275~actin-myosin filament sliding 4 0.001 0.09 0.02 
GO:0030049~muscle filament sliding 4 0.001 0.09 0.02 
GO:0030029~actin filament-based process 16 0.002 0.14 0.03 
GO:0046164~alcohol catabolic process 8 0.002 0.15 0.03 
GO:0051329~interphase of mitotic cell cycle 10 0.002 0.15 0.04 
GO:0006007~glucose catabolic process 7 0.002 0.16 0.04 
GO:0007049~cell cycle 35 0.002 0.16 0.04 
GO:0051325~interphase 10 0.003 0.16 0.04 
GO:0048514~blood vessel morphogenesis 14 0.003 0.16 0.04 
GO:0033043~regulation of organelle 
organization 14 0.003 0.18 0.05 
GO:0016052~carbohydrate catabolic process 9 0.003 0.17 0.05 
GO:0001568~blood vessel development 15 0.004 0.20 0.06 
GO:0019320~hexose catabolic process 7 0.004 0.21 0.07 
GO:0032868~response to insulin stimulus 9 0.004 0.21 0.07 
GO:0001944~vasculature development 15 0.005 0.21 0.07 
GO:0043434~response to peptide hormone 
stimulus 11 0.005 0.21 0.08 
GO:0046365~monosaccharide catabolic process 7 0.005 0.23 0.09 
GO:0010638~positive regulation of organelle 
organization 8 0.005 0.23 0.09 
GO:0051130~positive regulation of cellular 
component organization 12 0.006 0.23 0.09 
GO:0016051~carbohydrate biosynthetic process 9 0.007 0.27 0.11 




GO Biological Process term Count P-value Benjamini FDR 
GO:0000278~mitotic cell cycle 20 0.008 0.30 0.13 
GO:0030336~negative regulation of cell 
migration 6 0.01 0.40 0.18 
GO:0060048~cardiac muscle contraction 4 0.01 0.40 0.19 
GO:0001502~cartilage condensation 4 0.01 0.40 0.19 
GO:0001525~angiogenesis 10 0.01 0.40 0.19 
GO:0006073~cellular glucan metabolic process 5 0.01 0.40 0.20 
GO:0005977~glycogen metabolic process 5 0.01 0.40 0.20 
GO:0044042~glucan metabolic process 5 0.01 0.40 0.20 
GO:0030705~cytoskeleton-dependent 
intracellular transport 6 0.01 0.40 0.20 
GO:0007169~transmembrane receptor protein 
tyrosine kinase signaling pathway 13 0.01 0.41 0.21 
GO:0040013~negative regulation of locomotion 6 0.01 0.42 0.22 
GO:0007346~regulation of mitotic cell cycle 10 0.02 0.44 0.24 
GO:0003015~heart process 4 0.02 0.46 0.26 
GO:0060047~heart contraction 4 0.02 0.46 0.26 
GO:0022402~cell cycle process 25 0.02 0.47 0.26 
GO:0006112~energy reserve metabolic process 5 0.02 0.50 0.29 
GO:0051271~negative regulation of cell motion 6 0.02 0.50 0.30 
GO:0006817~phosphate transport 3 0.02 0.50 0.30 
GO:0030198~extracellular matrix organization 8 0.02 0.53 0.33 
GO:0001501~skeletal system development 15 0.02 0.54 0.34 
GO:0045664~regulation of neuron differentiation 8 0.03 0.58 0.38 
GO:0031344~regulation of cell projection 
organization 7 0.03 0.60 0.40 
GO:0006260~DNA replication 11 0.03 0.60 0.41 
GO:0051960~regulation of nervous system 
development 10 0.03 0.60 0.41 
GO:0032869~cellular response to insulin 
stimulus 6 0.03 0.62 0.43 
GO:0022403~cell cycle phase 19 0.03 0.61 0.43 
GO:0010975~regulation of neuron projection 
development 6 0.03 0.63 0.45 
GO:0050767~regulation of neurogenesis 9 0.04 0.64 0.47 
GO:0048738~cardiac muscle tissue development 5 0.04 0.66 0.49 
GO:0050954~sensory perception of mechanical 
stimulus 6 0.04 0.66 0.49 
GO:0030036~actin cytoskeleton organization 12 0.04 0.68 0.51 
GO:0007519~skeletal muscle tissue development 6 0.04 0.68 0.52 
GO:0060538~skeletal muscle organ development 6 0.04 0.68 0.52 
GO:0031032~actomyosin structure organization 4 0.04 0.68 0.53 
GO:0051783~regulation of nuclear division 5 0.05 0.69 0.55 
GO:0007088~regulation of mitosis 5 0.05 0.69 0.55 
GO:0044264~cellular polysaccharide metabolic 
process 5 0.05 0.72 0.57 
1Count refers to the gene members that belong to an annotation term. Fisher Exact P-value, 
Benjamini, and false discovery rate (FDR) represents the degree of enrichment of the Gene 




Supplementary Table 5.  Overrepresented GO biological process terms by genes with higher 
expression (q < 0.10) in logissimus dorsi tissue of low transition ADG pigs1  
GO Biological Process term Count P-value Benjamini FDR 
GO:0006511~ubiquitin-dependent protein catabolic process 12 0.01 1.00 0.15 
GO:0031145~anaphase-promoting complex-dependent 
proteasomal ubiquitin-dependent protein catabolic process 6 0.01 1.00 0.17 
GO:0051436~negative regulation of ubiquitin-protein ligase 
activity during mitotic cell cycle 6 0.01 1.00 0.17 
GO:0051352~negative regulation of ligase activity 6 0.01 0.99 0.18 
GO:0051444~negative regulation of ubiquitin-protein ligase 
activity 6 0.01 0.99 0.18 
GO:0030163~protein catabolic process 22 0.01 0.98 0.18 
GO:0006446~regulation of translational initiation 5 0.01 0.96 0.19 
GO:0051437~positive regulation of ubiquitin-protein ligase 
activity during mitotic cell cycle 6 0.01 0.94 0.19 
GO:0032269~negative regulation of cellular protein 
metabolic process 10 0.01 0.92 0.20 
GO:0051443~positive regulation of ubiquitin-protein ligase 
activity 6 0.01 0.91 0.22 
GO:0051248~negative regulation of protein metabolic 
process 10 0.02 0.89 0.22 
GO:0051439~regulation of ubiquitin-protein ligase activity 
during mitotic cell cycle 6 0.02 0.88 0.23 
GO:0051603~proteolysis involved in cellular protein 
catabolic process 21 0.02 0.87 0.25 
GO:0044257~cellular protein catabolic process 21 0.02 0.86 0.25 
GO:0051351~positive regulation of ligase activity 6 0.02 0.84 0.26 
GO:0031397~negative regulation of protein ubiquitination 6 0.02 0.84 0.27 
GO:0010885~regulation of cholesterol storage 3 0.02 0.82 0.28 
GO:0044265~cellular macromolecule catabolic process 24 0.02 0.80 0.28 
GO:0043632~modification-dependent macromolecule 
catabolic process 20 0.02 0.79 0.28 
GO:0019941~modification-dependent protein catabolic 
process 20 0.02 0.79 0.28 
GO:0009057~macromolecule catabolic process 25 0.02 0.80 0.31 
GO:0051438~regulation of ubiquitin-protein ligase activity 6 0.02 0.80 0.32 
GO:0043434~response to peptide hormone stimulus 8 0.02 0.79 0.32 
GO:0016578~histone deubiquitination 3 0.02 0.78 0.33 
GO:0032268~regulation of cellular protein metabolic 
process 17 0.03 0.79 0.35 
GO:0051340~regulation of ligase activity 6 0.03 0.79 0.37 
GO:0031398~positive regulation of protein ubiquitination 6 0.03 0.81 0.40 
GO:0006869~lipid transport 7 0.03 0.83 0.43 
GO:0045947~negative regulation of translational initiation 3 0.04 0.87 0.48 
GO:0042254~ribosome biogenesis 7 0.04 0.86 0.49 
GO:0022613~ribonucleoprotein complex biogenesis 9 0.04 0.86 0.50 
GO:0042157~lipoprotein metabolic process 5 0.05 0.88 0.54 
1Count refers to the gene members that belong to an annotation term. Fisher Exact P-value, Benjamini, 




Supplementary Table 6.  Overrepresented KEGG Pathways by genes with lower or higher 
expression (q < 0.10) in logissimus dorsi tissue of low transition ADG pigs  
KEGG Pathway 
Number 
of Genes P-value Benjamini FDR 
Lower expression in low tADG 
        hsa00010:Glycolysis/Gluconeogenesis 9 < 0.0001 0.01 0.001 
    hsa04260:Cardiac muscle contraction 7 0.02 0.45 0.17 
    hsa04530:Tight junction 9 0.02 0.38 0.18 
    hsa04910:Insulin signaling pathway 10 0.02 0.36 0.20 
    hsa00620:Pyruvate metabolism 5 0.03 0.43 0.29 
    hsa00500:Starch and sucrose metabolism 4 0.04 0.48 0.37 
Higher expression in low tADG 
        hsa03050:Proteasome 6 0.001 0.13 0.01 





Supplementary Table 7. Differentially expressed RNA transcripts (q < 0.10) in longissimus dorsi muscle of 
pigs with low or high transition average day gain (tADG). 








low tADG P-value q-value 
ENSSSCG00000001652 GNMT 4.09  0.24  1.4E-06 0.004  
ENSSSCG00000006328 RXRG 0.47  2.13  1.3E-06 0.004  
ENSSSCG00000012911 CARNS1 0.53  1.90  1.6E-06 0.004  
ENSSSCG00000026427 RORC 2.53  0.39  1.3E-06 0.004  
ENSSSCG00000030284 TRNAU1AP 2.05  0.49  8.9E-07 0.004  
ENSSSCG00000011412 CACNA2D2 0.36  2.79  2.0E-06 0.004  
ENSSSCG00000005443 CTNNAL1 1.70  0.59  5.8E-06 0.01  
ENSSSCG00000016466 GSTK1 2.01  0.50  6.5E-06 0.01  
ENSSSCG00000017884 TEKT1 11.98  0.08  5.3E-06 0.01  
ENSSSCG00000016020 DUSP19 0.68  1.47  8.2E-06 0.01  
ENSSSCG00000020873 SYNGR1 1.82  0.55  1.1E-05 0.01  
ENSSSCG00000023408 SAMD4A 0.78  1.28  1.1E-05 0.01  
ENSSSCG00000024845 MTMR9 2.44  0.41  1.1E-05 0.01  
ENSSSCG00000009904 LC8 0.72  1.39  1.2E-05 0.01  
ENSSSCG00000015436 C7ORF74 4.31  0.23  1.4E-05 0.01  
ENSSSCG00000001881 MAN2C1 2.07  0.48  1.7E-05 0.01  
ENSSSCG00000012960 CST6 24.44  0.04  2.6E-05 0.02  
ENSSSCG00000009152 SGMS2 0.68  1.47  3.4E-05 0.02  
ENSSSCG00000015544 ZNF648 15.53  0.06  3.3E-05 0.02  
ENSSSCG00000017915 VMO1 3.21  0.31  3.3E-05 0.02  
ENSSSCG00000023616 CDC34 0.70  1.43  3.3E-05 0.02  
ENSSSCG00000023657 . 2.35  0.42  3.5E-05 0.02  
ENSSSCG00000023001 CCDC149 0.80  1.25  3.8E-05 0.02  
ENSSSCG00000009721 MYPN 0.76  1.32  4.3E-05 0.02  
ENSSSCG00000014011 RASGEF1C 0.57  1.75  4.4E-05 0.02  
ENSSSCG00000014128 CKMT2 0.71  1.40  4.5E-05 0.02  
ENSSSCG00000027473 . 4.88  0.21  4.5E-05 0.02  
ENSSSCG00000001916 C15ORF59 0.56  1.79  5.6E-05 0.02  
ENSSSCG00000011235 UBP1 0.83  1.20  5.6E-05 0.02  
ENSSSCG00000012345 PFKFB1 1.63  0.61  5.8E-05 0.02  
ENSSSCG00000013239 PSMC3 1.70  0.59  5.3E-05 0.02  
ENSSSCG00000005481 RGS3 0.66  1.52  6.1E-05 0.02  
ENSSSCG00000021638 NEU3 0.65  1.54  6.4E-05 0.02  
ENSSSCG00000004725 ZFP106 0.70  1.43  7.0E-05 0.02  
ENSSSCG00000030302 SEPW1 0.74  1.35  7.1E-05 0.02  
ENSSSCG00000021703 MYOZ3 0.73  1.38  7.4E-05 0.02  
ENSSSCG00000016287 CHRND 2.02  0.49  7.9E-05 0.02  
ENSSSCG00000021252 FAM211A 2.29  0.44  8.3E-05 0.03  
ENSSSCG00000008642 ASAP2 1.80  0.56  9.1E-05 0.03  
ENSSSCG00000026109 STAR 3.94  0.25  8.9E-05 0.03  
ENSSSCG00000000118 MICALL1 0.61  1.65  9.8E-05 0.03  
ENSSSCG00000002440 CCDC88C 0.59  1.70  1.3E-04 0.03  
ENSSSCG00000004814 LRRC28 0.75  1.34  1.3E-04 0.03  
ENSSSCG00000005604 PBX3 0.60  1.67  1.1E-04 0.03  
ENSSSCG00000009914 MLEC 0.66  1.51  1.2E-04 0.03  
ENSSSCG00000012149 RBBP7 1.57  0.64  1.2E-04 0.03  
ENSSSCG00000012653 ZDHHC9 2.80  0.36  1.3E-04 0.03  
ENSSSCG00000013377 USH1C 0.30  3.33  1.2E-04 0.03  




Supplementary Table 7 (continued) 








low tADG P-value q-value 
ENSSSCG00000015570 IVNS1ABP 2.00  0.50  1.3E-04 0.03  
ENSSSCG00000015924 SPC25 0.68  1.48  1.1E-04 0.03  
ENSSSCG00000017255 ABCA5 2.30  0.43  1.1E-04 0.03  
ENSSSCG00000023496 . 0.71  1.42  9.7E-05 0.03  
ENSSSCG00000023710 REEP1 0.67  1.48  1.0E-04 0.03  
ENSSSCG00000027667 EML1 0.65  1.54  1.3E-04 0.03  
ENSSSCG00000029331 PALLD 0.72  1.39  1.2E-04 0.03  
ENSSSCG00000029558 EXTL1 0.52  1.91  1.0E-04 0.03  
ENSSSCG00000001711 CLIC5 0.78  1.28  1.5E-04 0.03  
ENSSSCG00000002640 DEF8 1.81  0.55  1.5E-04 0.03  
ENSSSCG00000010359 LDB3 0.80  1.25  1.4E-04 0.03  
ENSSSCG00000013427 CIRBP 2.02  0.50  1.4E-04 0.03  
ENSSSCG00000024388 BNIP3 2.07  0.48  1.4E-04 0.03  
ENSSSCG00000026173 ABCA1 2.05  0.49  1.4E-04 0.03  
ENSSSCG00000030312 . 2.15  0.47  1.5E-04 0.03  
ENSSSCG00000027646 TIPARP 0.72  1.39  1.5E-04 0.03  
ENSSSCG00000012327 HSD17B10 1.71  0.59  1.6E-04 0.03  
ENSSSCG00000030406 C6ORF183 5.32  0.19  1.6E-04 0.03  
ENSSSCG00000009134 EGF 0.72  1.39  1.7E-04 0.03  
ENSSSCG00000006141 CA3 0.58  1.73  1.7E-04 0.03  
ENSSSCG00000000113 SLC16A8 2.58  0.39  1.8E-04 0.03  
ENSSSCG00000004192 CTGF 0.58  1.71  2.0E-04 0.03  
ENSSSCG00000009370 FOXO1 2.38  0.42  2.0E-04 0.03  
ENSSSCG00000010302 USP54 1.98  0.50  1.9E-04 0.03  
ENSSSCG00000015917 LIMA1 0.64  1.57  2.0E-04 0.03  
ENSSSCG00000030263 CHRNB1 1.88  0.53  2.0E-04 0.03  
ENSSSCG00000003837 PRKAA2 0.85  1.17  2.0E-04 0.03  
ENSSSCG00000001844 PLIN1 0.45  2.24  2.1E-04 0.03  
ENSSSCG00000011459 SELK 1.77  0.57  2.1E-04 0.03  
ENSSSCG00000025774 . 0.82  1.21  2.1E-04 0.03  
ENSSSCG00000001105 . 0.29  3.49  2.2E-04 0.03  
ENSSSCG00000002959 FAM98C 0.79  1.27  2.3E-04 0.03  
ENSSSCG00000008439 RHOQ 0.81  1.24  2.4E-04 0.03  
ENSSSCG00000000625 LRP6 0.78  1.29  2.7E-04 0.03  
ENSSSCG00000000727 CCND2 0.64  1.55  2.7E-04 0.03  
ENSSSCG00000006624 SELENBP1 2.14  0.47  2.6E-04 0.03  
ENSSSCG00000006848 SCAMC-1 0.83  1.21  2.8E-04 0.03  
ENSSSCG00000011195 GALNTL2 5.05  0.20  2.7E-04 0.03  
ENSSSCG00000013908 C19ORF60 1.76  0.57  2.7E-04 0.03  
ENSSSCG00000023869 TYMS 0.69  1.44  2.5E-04 0.03  
ENSSSCG00000024809 CLCN4 0.93  1.07  2.8E-04 0.03  
ENSSSCG00000026389 SYNJ2BP 0.83  1.21  2.5E-04 0.03  
ENSSSCG00000027013 . 2.23  0.45  2.5E-04 0.03  
ENSSSCG00000030999 MYH6 0.64  1.57  2.7E-04 0.03  
ENSSSCG00000002274 HSPA2 1.96  0.51  3.6E-04 0.04  
ENSSSCG00000002520 SLC25A29 1.64  0.61  3.2E-04 0.04  
ENSSSCG00000007346 ADIG 0.21  4.78  3.7E-04 0.04  
ENSSSCG00000007794 ZNF764 1.80  0.56  3.6E-04 0.04  
ENSSSCG00000008759 SEL1L3 0.74  1.35  3.5E-04 0.04  




Supplementary Table 7 (continued) 








low tADG P-value q-value 
ENSSSCG00000011676 ATP1B3 0.87  1.15  3.2E-04 0.04  
ENSSSCG00000011721 P2RY1 0.76  1.32  3.6E-04 0.04  
ENSSSCG00000013242 ACP2 1.84  0.54  3.4E-04 0.04  
ENSSSCG00000013299 APIP 2.07  0.48  3.6E-04 0.04  
ENSSSCG00000013622 TMEM205 1.73  0.58  3.4E-04 0.04  
ENSSSCG00000013743 LYL1 0.77  1.30  3.5E-04 0.04  
ENSSSCG00000013893 ARRDC2 2.44  0.41  3.2E-04 0.04  
ENSSSCG00000016104 TRAK2 0.88  1.14  3.3E-04 0.04  
ENSSSCG00000016641 LINC00998 0.88  1.13  3.7E-04 0.04  
ENSSSCG00000016835 SKP2 0.66  1.52  3.5E-04 0.04  
ENSSSCG00000017489 PSMD3 1.59  0.63  3.5E-04 0.04  
ENSSSCG00000020788 EML1 0.64  1.56  3.3E-04 0.04  
ENSSSCG00000021359 CDC42EP3 0.85  1.18  3.7E-04 0.04  
ENSSSCG00000022083 . 0.16  6.37  3.3E-04 0.04  
ENSSSCG00000022353 RAP1GDS1 0.78  1.29  3.0E-04 0.04  
ENSSSCG00000024107 . 2.58  0.39  3.0E-04 0.04  
ENSSSCG00000025782 C17ORF61 2.27  0.44  3.5E-04 0.04  
ENSSSCG00000026038 DDX28 1.65  0.61  3.7E-04 0.04  
ENSSSCG00000026457 . 0.53  1.89  3.2E-04 0.04  
ENSSSCG00000028035 ZC3H11A 0.82  1.21  3.0E-04 0.04  
ENSSSCG00000028752 ADSSL1 0.69  1.45  3.1E-04 0.04  
ENSSSCG00000029695 . 2.01  0.50  3.7E-04 0.04  
ENSSSCG00000030309 NDRG2 1.67  0.60  2.9E-04 0.04  
ENSSSCG00000002831 IRX3 2.52  0.40  3.8E-04 0.04  
ENSSSCG00000008230 ATOH8 1.80  0.56  3.8E-04 0.04  
ENSSSCG00000006390 CASQ1 0.73  1.36  4.0E-04 0.04  
ENSSSCG00000013927 ARMC6 0.95  1.05  4.0E-04 0.04  
ENSSSCG00000001134 . 0.53  1.90  4.0E-04 0.04  
ENSSSCG00000028454 C16ORF72 0.78  1.28  4.1E-04 0.04  
ENSSSCG00000005480 RGS3 0.66  1.52  4.2E-04 0.04  
ENSSSCG00000029846 . 0.76  1.32  4.2E-04 0.04  
ENSSSCG00000011831 APOD 1.97  0.51  4.4E-04 0.04  
ENSSSCG00000024001 PLXNA1 0.75  1.34  4.4E-04 0.04  
ENSSSCG00000027559 EGF 0.71  1.40  4.5E-04 0.04  
ENSSSCG00000013017 EHD1 0.79  1.27  4.5E-04 0.04  
ENSSSCG00000005778 HSBP1L1 0.61  1.63  4.7E-04 0.04  
ENSSSCG00000008806 YIPF7 0.88  1.14  4.6E-04 0.04  
ENSSSCG00000011516 EIF4E3 1.90  0.53  4.7E-04 0.04  
ENSSSCG00000014799 . 2.25  0.44  4.7E-04 0.04  
ENSSSCG00000022846 SLC4A3 1.91  0.52  4.7E-04 0.04  
ENSSSCG00000026804 . 0.75  1.33  4.7E-04 0.04  
ENSSSCG00000027935 FHOD3 0.73  1.36  4.7E-04 0.04  
ENSSSCG00000018052 NT5M 0.79  1.27  4.9E-04 0.04  
ENSSSCG00000029790 PCYOX1 0.84  1.20  4.9E-04 0.04  
ENSSSCG00000013241 LXR 1.69  0.59  5.1E-04 0.04  
ENSSSCG00000028156 C17ORF101 1.84  0.54  5.2E-04 0.04  
ENSSSCG00000001488 GCLC 0.89  1.13  5.4E-04 0.04  
ENSSSCG00000005364 TDRD7 0.84  1.19  5.3E-04 0.04  
ENSSSCG00000016426 ACTR3C 1.71  0.58  5.4E-04 0.04  




Supplementary Table 7 (continued) 








low tADG P-value q-value 
ENSSSCG00000024416 MYH13 0.64  1.57  5.4E-04 0.04  
ENSSSCG00000024428 CHRNA9 0.21  4.70  5.4E-04 0.04  
ENSSSCG00000010703 HTRA1 0.87  1.15  5.5E-04 0.04  
ENSSSCG00000022168 APBB2 0.87  1.15  5.5E-04 0.04  
ENSSSCG00000016626 CFTR 3.74  0.27  5.6E-04 0.04  
ENSSSCG00000004560 . 2.06  0.49  5.7E-04 0.04  
ENSSSCG00000012854 RASSF7 2.74  0.37  5.7E-04 0.04  
ENSSSCG00000015543 CACNA1E 4.43  0.23  5.7E-04 0.04  
ENSSSCG00000011224 GADL1 0.73  1.37  5.8E-04 0.04  
ENSSSCG00000015726 CNTNAP5 2.30  0.44  5.8E-04 0.04  
ENSSSCG00000004701 CATSPER2 1.81  0.55  5.9E-04 0.04  
ENSSSCG00000024883 IGF2 0.74  1.35  5.9E-04 0.04  
ENSSSCG00000002558 KIAA0284 1.95  0.51  6.0E-04 0.04  
ENSSSCG00000006054 ATP6V1C1 1.46  0.69  6.0E-04 0.04  
ENSSSCG00000013269 MAPK8IP1 1.80  0.56  6.0E-04 0.04  
ENSSSCG00000015747 MYOM2 0.78  1.28  6.1E-04 0.04  
ENSSSCG00000001063 MYLIP 2.13  0.47  6.4E-04 0.04  
ENSSSCG00000002016 THTPA 1.69  0.59  6.2E-04 0.04  
ENSSSCG00000006703 PRKAB2 0.77  1.31  6.2E-04 0.04  
ENSSSCG00000006783 DDX20 1.65  0.61  6.3E-04 0.04  
ENSSSCG00000006872 AGL 0.69  1.45  6.4E-04 0.04  
ENSSSCG00000013614 CNN1 0.75  1.33  6.3E-04 0.04  
ENSSSCG00000013667 COL5A3 0.86  1.16  6.4E-04 0.04  
ENSSSCG00000017215 SLC16A5 0.60  1.66  6.1E-04 0.04  
ENSSSCG00000023174 USP53 1.72  0.58  6.3E-04 0.04  
ENSSSCG00000023287 . 0.29  3.39  6.4E-04 0.04  
ENSSSCG00000015249 ADAMTS8 0.70  1.42  6.5E-04 0.04  
ENSSSCG00000006143 CA13 1.82  0.55  6.6E-04 0.04  
ENSSSCG00000006365 NIT1 0.88  1.13  6.7E-04 0.04  
ENSSSCG00000011827 LSG1 1.54  0.65  6.6E-04 0.04  
ENSSSCG00000020706 . 1.66  0.60  6.7E-04 0.04  
ENSSSCG00000003830 MYSM1 1.50  0.67  6.8E-04 0.04  
ENSSSCG00000017873 CAMKK1 0.78  1.28  6.8E-04 0.04  
ENSSSCG00000021964 PIK3R1 2.38  0.42  6.8E-04 0.04  
ENSSSCG00000015716 MARCO 0.39  2.54  6.9E-04 0.04  
ENSSSCG00000013335 LGR4 0.72  1.39  7.0E-04 0.04  
ENSSSCG00000018003 MYH1 0.73  1.38  7.0E-04 0.04  
ENSSSCG00000024045 . 2.04  0.49  7.0E-04 0.04  
ENSSSCG00000028054 ZNF526 1.57  0.64  7.2E-04 0.04  
ENSSSCG00000009544 COL4A1 0.85  1.18  7.3E-04 0.04  
ENSSSCG00000025966 EIF4H 1.47  0.68  7.4E-04 0.04  
ENSSSCG00000028372 FAM131A 0.75  1.34  7.3E-04 0.04  
ENSSSCG00000006774 PPM1J 0.69  1.44  7.5E-04 0.05  
ENSSSCG00000025997 . 1.53  0.65  7.6E-04 0.05  
ENSSSCG00000014798 ART5 2.35  0.42  7.7E-04 0.05  
ENSSSCG00000028982 AKR1C4 5.25  0.19  7.7E-04 0.05  
ENSSSCG00000000214 GPD1 0.87  1.15  8.0E-04 0.05  
ENSSSCG00000006704 . 2.62  0.38  7.9E-04 0.05  
ENSSSCG00000009123 CAMK2D 0.78  1.27  7.9E-04 0.05  
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low tADG P-value q-value 
ENSSSCG00000000779 KIF21A 0.75  1.33  8.4E-04 0.05  
ENSSSCG00000001823 UROC1 0.21  4.75  8.2E-04 0.05  
ENSSSCG00000005229 VLDLR 0.79  1.26  8.3E-04 0.05  
ENSSSCG00000005657 PKN3 1.70  0.59  8.3E-04 0.05  
ENSSSCG00000007528 PHACTR3 0.25  3.98  8.3E-04 0.05  
ENSSSCG00000012037 GCFC1 1.48  0.68  8.4E-04 0.05  
ENSSSCG00000012583 ACSL4 1.64  0.61  8.3E-04 0.05  
ENSSSCG00000012832 MXRA5 0.71  1.40  8.3E-04 0.05  
ENSSSCG00000014966 SESN3 0.62  1.63  8.1E-04 0.05  
ENSSSCG00000026551 LOXL2 0.78  1.29  8.4E-04 0.05  
ENSSSCG00000006732 TRIM45 0.94  1.06  8.6E-04 0.05  
ENSSSCG00000011382 USP4 1.46  0.69  8.7E-04 0.05  
ENSSSCG00000021149 RNF217 0.84  1.18  8.5E-04 0.05  
ENSSSCG00000027343 GABARAP 2.08  0.48  8.6E-04 0.05  
ENSSSCG00000028777 MYLK4 0.60  1.65  8.6E-04 0.05  
ENSSSCG00000015404 SEMA3C 0.93  1.08  8.7E-04 0.05  
ENSSSCG00000004769 CASC5 0.20  5.03  9.0E-04 0.05  
ENSSSCG00000022295 C9ORF16 0.81  1.23  9.1E-04 0.05  
ENSSSCG00000022060 RASSF9 3.25  0.31  9.2E-04 0.05  
ENSSSCG00000000488 MDM2 0.88  1.14  9.3E-04 0.05  
ENSSSCG00000008047 E4F1 1.51  0.66  9.3E-04 0.05  
ENSSSCG00000009775 CDK2AP1 0.88  1.13  9.5E-04 0.05  
ENSSSCG00000002763 PRMT7 1.49  0.67  9.9E-04 0.05  
ENSSSCG00000014305 SAR1B 1.57  0.64  9.8E-04 0.05  
ENSSSCG00000030274 PPEF1 1.74  0.57  9.8E-04 0.05  
ENSSSCG00000001686 KLIP-1 1.45  0.69  1.0E-03 0.05  
ENSSSCG00000003018 LIPE 2.29  0.44  1.0E-03 0.05  
ENSSSCG00000005893 ZNF34 1.59  0.63  1.0E-03 0.05  
ENSSSCG00000006892 DNTTIP2 1.53  0.66  1.0E-03 0.05  
ENSSSCG00000010073 CHCHD10 1.60  0.62  1.0E-03 0.05  
ENSSSCG00000010447 ACTA2 0.87  1.15  1.0E-03 0.05  
ENSSSCG00000011970 C3ORF26 0.80  1.25  1.0E-03 0.05  
ENSSSCG00000018007 MYH3 0.66  1.52  1.0E-03 0.05  
ENSSSCG00000020701 TTC9 2.06  0.49  1.0E-03 0.05  
ENSSSCG00000027443 MRAS 0.81  1.24  1.0E-03 0.05  
ENSSSCG00000006829 SYPL2 0.87  1.15  1.0E-03 0.05  
ENSSSCG00000001692 . 1.48  0.67  1.1E-03 0.05  
ENSSSCG00000007022 ANK1 0.75  1.33  1.1E-03 0.05  
ENSSSCG00000015756 XKR5 0.42  2.38  1.1E-03 0.05  
ENSSSCG00000030087 . 0.81  1.23  1.1E-03 0.05  
ENSSSCG00000007509 TMEPAI 0.72  1.39  1.1E-03 0.05  
ENSSSCG00000021339 . 0.49  2.03  1.1E-03 0.05  
ENSSSCG00000015144 GRAMD1B 1.84  0.54  1.1E-03 0.05  
ENSSSCG00000000724 FGF6 0.71  1.42  1.1E-03 0.05  
ENSSSCG00000003459 CELA2A 0.29  3.43  1.1E-03 0.05  
ENSSSCG00000003720 . 2.73  0.37  1.1E-03 0.05  
ENSSSCG00000009946 SART3 1.48  0.68  1.1E-03 0.05  
ENSSSCG00000010957 AGTPBP1 0.78  1.28  1.1E-03 0.05  
ENSSSCG00000013594 FBN3 0.56  1.78  1.1E-03 0.05  
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low tADG P-value q-value 
ENSSSCG00000015122 CD90 0.79  1.27  1.1E-03 0.05  
ENSSSCG00000018006 . 0.66  1.51  1.1E-03 0.05  
ENSSSCG00000025200 UBIAD1 1.59  0.63  1.1E-03 0.05  
ENSSSCG00000024342 AQP4 2.42  0.41  1.2E-03 0.05  
ENSSSCG00000016330 . 0.81  1.23  1.2E-03 0.05  
ENSSSCG00000025357 C2ORF43 0.81  1.23  1.2E-03 0.05  
ENSSSCG00000000975 PANX2 2.87  0.35  1.2E-03 0.05  
ENSSSCG00000006542 KCNN3 1.70  0.59  1.2E-03 0.05  
ENSSSCG00000007187 NSFL1C 1.47  0.68  1.2E-03 0.05  
ENSSSCG00000008553 PREB 0.87  1.16  1.2E-03 0.05  
ENSSSCG00000014851 SLCO2B1 0.83  1.21  1.2E-03 0.05  
ENSSSCG00000015720 BIN1 0.88  1.13  1.2E-03 0.05  
ENSSSCG00000021370 . 0.39  2.57  1.2E-03 0.05  
ENSSSCG00000028856 ABCF3 1.51  0.66  1.2E-03 0.05  
ENSSSCG00000001054 GFOD1 0.70  1.42  1.3E-03 0.05  
ENSSSCG00000001433 PPT2 0.86  1.16  1.3E-03 0.05  
ENSSSCG00000003722 CDH2 0.57  1.76  1.3E-03 0.05  
ENSSSCG00000004799 ZNF770 1.62  0.62  1.3E-03 0.05  
ENSSSCG00000005524 DAB2IP 0.85  1.17  1.3E-03 0.05  
ENSSSCG00000008966 PARM1 2.11  0.47  1.3E-03 0.05  
ENSSSCG00000009114 PRSS12 1.83  0.55  1.2E-03 0.05  
ENSSSCG00000009963 TPST2 0.88  1.13  1.2E-03 0.05  
ENSSSCG00000016364 GPC1 0.87  1.15  1.3E-03 0.05  
ENSSSCG00000016823 C1QTNF3 0.61  1.63  1.3E-03 0.05  
ENSSSCG00000017069 LARP1 0.84  1.19  1.3E-03 0.05  
ENSSSCG00000024696 CCNYL1 0.75  1.34  1.3E-03 0.05  
ENSSSCG00000005395 ALDOB 0.69  1.45  1.3E-03 0.05  
ENSSSCG00000006987 SLC7A2 0.78  1.28  1.3E-03 0.05  
ENSSSCG00000007504 RNPC1 0.80  1.25  1.3E-03 0.05  
ENSSSCG00000026298 . 0.76  1.32  1.3E-03 0.05  
ENSSSCG00000009338 FRY 0.80  1.25  1.3E-03 0.05  
ENSSSCG00000022946 . 0.87  1.15  1.3E-03 0.05  
ENSSSCG00000023435 DBI 0.93  1.08  1.3E-03 0.05  
ENSSSCG00000026354 PRPF18 1.55  0.65  1.3E-03 0.05  
ENSSSCG00000000896 NTN4 0.78  1.28  1.4E-03 0.05  
ENSSSCG00000016397 NEB 0.77  1.29  1.4E-03 0.05  
ENSSSCG00000004466 TTK 0.50  1.98  1.4E-03 0.06  
ENSSSCG00000022634 . 1.72  0.58  1.4E-03 0.06  
ENSSSCG00000024296 NKIRAS1 0.85  1.17  1.4E-03 0.06  
ENSSSCG00000025212 . 0.95  1.06  1.4E-03 0.06  
ENSSSCG00000029441 . 0.83  1.21  1.4E-03 0.06  
ENSSSCG00000012773 PNCK 0.52  1.91  1.4E-03 0.06  
ENSSSCG00000022301 EIF4EBP1 1.72  0.58  1.4E-03 0.06  
ENSSSCG00000030580 BUB1B 0.55  1.83  1.4E-03 0.06  
ENSSSCG00000005895 C8orf82 1.80  0.56  1.4E-03 0.06  
ENSSSCG00000001523 GRM4 0.58  1.73  1.5E-03 0.06  
ENSSSCG00000003359 TPRG1L 1.57  0.64  1.5E-03 0.06  
ENSSSCG00000003715 ZNF521 1.78  0.56  1.5E-03 0.06  
ENSSSCG00000006016 EIF3H 1.51  0.66  1.5E-03 0.06  
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low tADG P-value q-value 
ENSSSCG00000007939 ANKS3 1.60  0.63  1.5E-03 0.06  
ENSSSCG00000008493 CEBPZ 1.54  0.65  1.5E-03 0.06  
ENSSSCG00000008867 CTSO 0.85  1.18  1.5E-03 0.06  
ENSSSCG00000009671 PBK 0.68  1.46  1.5E-03 0.06  
ENSSSCG00000010192 RAB4A 0.91  1.10  1.5E-03 0.06  
ENSSSCG00000010351 FAM190B 0.93  1.08  1.5E-03 0.06  
ENSSSCG00000010814 ESRRG 0.74  1.36  1.5E-03 0.06  
ENSSSCG00000012669 ARHGAP36 3.20  0.31  1.5E-03 0.06  
ENSSSCG00000012813 BRCC3 1.50  0.67  1.5E-03 0.06  
ENSSSCG00000013049 RCOR2 0.67  1.50  1.5E-03 0.06  
ENSSSCG00000014285 SEPT8 0.90  1.11  1.5E-03 0.06  
ENSSSCG00000015862 LIMS2 0.85  1.17  1.5E-03 0.06  
ENSSSCG00000023049 . 2.10  0.48  1.5E-03 0.06  
ENSSSCG00000025208 RNF39 5.14  0.19  1.5E-03 0.06  
ENSSSCG00000025240 DDIT4L 2.25  0.44  1.5E-03 0.06  
ENSSSCG00000001930 PKM2 0.77  1.30  1.6E-03 0.06  
ENSSSCG00000011752 FNDC3B 0.94  1.06  1.6E-03 0.06  
ENSSSCG00000000743 FKBP4 1.55  0.65  1.6E-03 0.06  
ENSSSCG00000003486 ARHGEF10L 0.87  1.15  1.6E-03 0.06  
ENSSSCG00000004412 MICAL1 0.92  1.09  1.6E-03 0.06  
ENSSSCG00000011064 ACBD5 0.82  1.23  1.6E-03 0.06  
ENSSSCG00000016018 FRZB 0.77  1.30  1.6E-03 0.06  
ENSSSCG00000016574 KCP 0.66  1.52  1.6E-03 0.06  
ENSSSCG00000017608 . 0.67  1.50  1.6E-03 0.06  
ENSSSCG00000022371 . 0.59  1.70  1.6E-03 0.06  
ENSSSCG00000028065 USPL1 1.66  0.60  1.6E-03 0.06  
ENSSSCG00000028504 RFC2 1.55  0.64  1.6E-03 0.06  
ENSSSCG00000023109 GNL2 1.55  0.64  1.7E-03 0.06  
ENSSSCG00000022256 C10ORF10 2.21  0.45  1.7E-03 0.06  
ENSSSCG00000000950 E2F7 0.59  1.69  1.7E-03 0.06  
ENSSSCG00000002000 IPO4 1.51  0.66  1.7E-03 0.06  
ENSSSCG00000005981 FBXO32 6.43  0.16  1.7E-03 0.06  
ENSSSCG00000007017 . 0.69  1.44  1.7E-03 0.06  
ENSSSCG00000008002 NARFL 1.71  0.59  1.7E-03 0.06  
ENSSSCG00000010968 IL11RA 1.50  0.67  1.7E-03 0.06  
ENSSSCG00000014326 KIF20A 0.53  1.87  1.7E-03 0.06  
ENSSSCG00000030544 TMEM143 0.91  1.10  1.7E-03 0.06  
ENSSSCG00000029199 SCN4B 0.48  2.10  1.7E-03 0.06  
ENSSSCG00000025831 C5ORF13 0.73  1.37  1.7E-03 0.06  
ENSSSCG00000013513 PLIN5 2.27  0.44  1.8E-03 0.06  
ENSSSCG00000000645 . 2.05  0.49  1.8E-03 0.06  
ENSSSCG00000004729 GANC 1.65  0.60  1.8E-03 0.06  
ENSSSCG00000006229 ASPH 0.81  1.23  1.8E-03 0.06  
ENSSSCG00000008982 STBD1 0.78  1.29  1.8E-03 0.06  
ENSSSCG00000012439 PGK1 0.83  1.21  1.8E-03 0.06  
ENSSSCG00000012926 PC 0.79  1.26  1.8E-03 0.06  
ENSSSCG00000014190 FBXL17 0.77  1.30  1.8E-03 0.06  
ENSSSCG00000015424 PSMC2 1.52  0.66  1.8E-03 0.06  
ENSSSCG00000016082 BOLL 0.51  1.96  1.8E-03 0.06  
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low tADG P-value q-value 
ENSSSCG00000017109 ADAMTS16 0.68  1.47  1.8E-03 0.06  
ENSSSCG00000017213 HN1 0.90  1.11  1.8E-03 0.06  
ENSSSCG00000024500 C21ORF2 1.61  0.62  1.8E-03 0.06  
ENSSSCG00000027628 IL6R 2.37  0.42  1.8E-03 0.06  
ENSSSCG00000029311 MYPN 0.89  1.12  1.8E-03 0.06  
ENSSSCG00000029627 PWP2 1.57  0.64  1.8E-03 0.06  
ENSSSCG00000009378 CKAP2 0.66  1.51  1.9E-03 0.06  
ENSSSCG00000022584 PPP1R3F 0.78  1.28  1.9E-03 0.06  
ENSSSCG00000015611 . 1.63  0.61  1.9E-03 0.06  
ENSSSCG00000013742 NFIX 0.78  1.28  1.9E-03 0.06  
ENSSSCG00000012978 AP5B1 1.88  0.53  1.9E-03 0.06  
ENSSSCG00000001392 TCF19 0.72  1.39  1.9E-03 0.06  
ENSSSCG00000028235 . 0.11  8.83  1.9E-03 0.06  
ENSSSCG00000020999 LARP1B 0.80  1.25  1.9E-03 0.06  
ENSSSCG00000002279 GPX2 6.04  0.17  2.0E-03 0.06  
ENSSSCG00000003470 FAM131C 1.72  0.58  2.0E-03 0.06  
ENSSSCG00000010199 RET 0.78  1.28  2.0E-03 0.06  
ENSSSCG00000016863 OXCT1 0.81  1.24  2.0E-03 0.06  
ENSSSCG00000015918 B3GALT1 2.65  0.38  2.0E-03 0.06  
ENSSSCG00000015340 ASNS 1.02  0.98  2.0E-03 0.06  
ENSSSCG00000000166 C12ORF23 0.92  1.09  2.1E-03 0.06  
ENSSSCG00000010973 C9ORF23 1.50  0.66  2.1E-03 0.06  
ENSSSCG00000016535 CALD1 1.02  0.98  2.1E-03 0.06  
ENSSSCG00000005303 PIGO 1.54  0.65  2.1E-03 0.06  
ENSSSCG00000007774 CTF1 1.56  0.64  2.1E-03 0.06  
ENSSSCG00000028387 CNKSR1 1.05  0.96  2.1E-03 0.06  
ENSSSCG00000010825 . 0.78  1.29  2.1E-03 0.06  
ENSSSCG00000008294 . 0.77  1.30  2.1E-03 0.06  
ENSSSCG00000008561 CENPA 0.47  2.14  2.1E-03 0.06  
ENSSSCG00000012440 PGK2 0.82  1.21  2.1E-03 0.06  
ENSSSCG00000017376 MEOX1 0.75  1.33  2.1E-03 0.06  
ENSSSCG00000026089 . 2.25  0.44  2.1E-03 0.06  
ENSSSCG00000010947 FBP2 0.94  1.06  2.2E-03 0.07  
ENSSSCG00000017818 SERPINF1 0.91  1.10  2.2E-03 0.07  
ENSSSCG00000007433 PCIF1 1.48  0.68  2.2E-03 0.07  
ENSSSCG00000022922 . 0.73  1.38  2.2E-03 0.07  
ENSSSCG00000023142 GAMT 0.78  1.28  2.2E-03 0.07  
ENSSSCG00000029352 CCNL1 1.51  0.66  2.2E-03 0.07  
ENSSSCG00000030024 SEC24D 0.86  1.17  2.2E-03 0.07  
ENSSSCG00000009684 MSRA 0.82  1.23  2.2E-03 0.07  
ENSSSCG00000001487 KLHL31 0.72  1.40  2.2E-03 0.07  
ENSSSCG00000004233 SMPDL3A 3.30  0.30  2.2E-03 0.07  
ENSSSCG00000005455 SVEP1 0.87  1.15  2.2E-03 0.07  
ENSSSCG00000007585 BETA-ACTIN 1.03  0.97  2.2E-03 0.07  
ENSSSCG00000029617 . 1.60  0.63  2.2E-03 0.07  
ENSSSCG00000001091 KIAA0319 0.35  2.83  2.3E-03 0.07  
ENSSSCG00000001738 . 0.66  1.52  2.3E-03 0.07  
ENSSSCG00000004928 CILP 0.82  1.22  2.3E-03 0.07  
ENSSSCG00000011928 CCDC80 0.85  1.18  2.3E-03 0.07  
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low tADG P-value q-value 
ENSSSCG00000014539 ZFP62 1.53  0.66  2.3E-03 0.07  
ENSSSCG00000015135 SORL1 0.70  1.42  2.3E-03 0.07  
ENSSSCG00000002001 REC8 1.57  0.64  2.4E-03 0.07  
ENSSSCG00000014914 . 0.16  6.26  2.4E-03 0.07  
ENSSSCG00000006666 SV2A 5.83  0.17  2.4E-03 0.07  
ENSSSCG00000004570 TPM1 0.82  1.21  2.4E-03 0.07  
ENSSSCG00000022446 SEL1L3 0.78  1.29  2.4E-03 0.07  
ENSSSCG00000005627 AK1 0.88  1.14  2.4E-03 0.07  
ENSSSCG00000029430 . 0.82  1.22  2.5E-03 0.07  
ENSSSCG00000002873 GPI 0.75  1.33  2.5E-03 0.07  
ENSSSCG00000003340 GLTPD1 2.07  0.48  2.5E-03 0.07  
ENSSSCG00000003673 CEP192 2.25  0.45  2.6E-03 0.07  
ENSSSCG00000007304 . 3.22  0.31  2.6E-03 0.07  
ENSSSCG00000007592 EIF2AK1 1.54  0.65  2.6E-03 0.07  
ENSSSCG00000007932 ROGDI 1.70  0.59  2.5E-03 0.07  
ENSSSCG00000007942 HO2 2.06  0.48  2.6E-03 0.07  
ENSSSCG00000008563 . 7.32  0.14  2.6E-03 0.07  
ENSSSCG00000010224 EGR2 0.76  1.31  2.6E-03 0.07  
ENSSSCG00000010680 FAM45A 1.42  0.70  2.5E-03 0.07  
ENSSSCG00000011035 . 0.85  1.17  2.5E-03 0.07  
ENSSSCG00000011212 RARB 0.78  1.29  2.6E-03 0.07  
ENSSSCG00000011535 ARL8B 1.38  0.73  2.6E-03 0.07  
ENSSSCG00000012290 WDR45 1.63  0.61  2.6E-03 0.07  
ENSSSCG00000012823 DKC1 1.52  0.66  2.5E-03 0.07  
ENSSSCG00000014113 HOMER1 0.76  1.31  2.6E-03 0.07  
ENSSSCG00000014168 ELL2 1.87  0.54  2.6E-03 0.07  
ENSSSCG00000015462 TPK1 0.78  1.28  2.5E-03 0.07  
ENSSSCG00000015779 CDKN2AIP 1.47  0.68  2.6E-03 0.07  
ENSSSCG00000016998 NPM1 1.47  0.68  2.5E-03 0.07  
ENSSSCG00000020783 SLC41A1 0.85  1.18  2.5E-03 0.07  
ENSSSCG00000021573 KCNJ5 0.67  1.50  2.6E-03 0.07  
ENSSSCG00000021626 TMBIM1 1.61  0.62  2.6E-03 0.07  
ENSSSCG00000021739 HSD17B12 0.92  1.09  2.5E-03 0.07  
ENSSSCG00000022967 . 0.60  1.67  2.5E-03 0.07  
ENSSSCG00000025272 HEMK1 1.69  0.59  2.6E-03 0.07  
ENSSSCG00000026257 STMN1 0.87  1.14  2.6E-03 0.07  
ENSSSCG00000026784 LMNB2 0.98  1.02  2.6E-03 0.07  
ENSSSCG00000026968 SLC20A2 0.91  1.10  2.6E-03 0.07  
ENSSSCG00000027091 OAZ3 0.07  13.68  2.6E-03 0.07  
ENSSSCG00000028791 . 0.43  2.35  2.6E-03 0.07  
ENSSSCG00000022401 AGTRAP 1.72  0.58  2.7E-03 0.07  
ENSSSCG00000003257 CACNG6 0.83  1.20  2.7E-03 0.07  
ENSSSCG00000011553 TTLL3 1.80  0.55  2.7E-03 0.07  
ENSSSCG00000015227 SRPR 0.93  1.08  2.7E-03 0.07  
ENSSSCG00000015402 CACNA2D1 0.84  1.19  2.7E-03 0.07  
ENSSSCG00000017191 SRP68 1.38  0.72  2.7E-03 0.07  
ENSSSCG00000024655 PHB2 1.43  0.70  2.7E-03 0.07  
ENSSSCG00000027474 . 2.53  0.40  2.7E-03 0.07  
ENSSSCG00000028100 XPO1 1.81  0.55  2.7E-03 0.07  
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low tADG P-value q-value 
ENSSSCG00000025136 . 0.83  1.21  2.7E-03 0.07  
ENSSSCG00000008572 FAM59B 1.92  0.52  2.7E-03 0.07  
ENSSSCG00000003357 ACTRT2 0.27  3.65  2.8E-03 0.07  
ENSSSCG00000014062 C5ORF25 1.65  0.61  2.8E-03 0.07  
ENSSSCG00000014217 FEM1C 0.83  1.20  2.7E-03 0.07  
ENSSSCG00000021588 DAPK2 1.72  0.58  2.8E-03 0.07  
ENSSSCG00000023975 C15ORF52 0.85  1.17  2.8E-03 0.07  
ENSSSCG00000017731 PSMD11 1.46  0.68  2.8E-03 0.07  
ENSSSCG00000006735 PTGFRN 0.86  1.16  2.8E-03 0.07  
ENSSSCG00000007530 PPP1R3D 0.64  1.56  2.8E-03 0.07  
ENSSSCG00000010831 DUSP10 0.83  1.21  2.8E-03 0.07  
ENSSSCG00000016344 . 1.82  0.55  2.8E-03 0.07  
ENSSSCG00000017593 UTP18 1.63  0.61  2.8E-03 0.07  
ENSSSCG00000021606 . 0.85  1.18  2.8E-03 0.07  
ENSSSCG00000026492 . 0.45  2.24  2.8E-03 0.07  
ENSSSCG00000026753 OSBPL11 1.98  0.51  2.8E-03 0.07  
ENSSSCG00000030730 IGLV-4 0.43  2.33  2.8E-03 0.07  
ENSSSCG00000008079 FAM120A 0.96  1.04  2.9E-03 0.07  
ENSSSCG00000000273 PRR13 0.96  1.05  2.9E-03 0.07  
ENSSSCG00000008580 PTRHD1 0.82  1.21  2.9E-03 0.07  
ENSSSCG00000011557 CIDE-C 0.51  1.97  2.9E-03 0.07  
ENSSSCG00000002282 MAX 1.81  0.55  2.9E-03 0.07  
ENSSSCG00000010190 ACTA1 0.79  1.27  2.9E-03 0.07  
ENSSSCG00000027441 . 1.87  0.54  2.9E-03 0.07  
ENSSSCG00000003699 GREB1L 2.10  0.48  2.9E-03 0.07  
ENSSSCG00000021724 KIF19 2.52  0.40  2.9E-03 0.07  
ENSSSCG00000013755 CCDC130 1.54  0.65  3.0E-03 0.07  
ENSSSCG00000016516 ATP6V0A4 0.45  2.23  3.0E-03 0.07  
ENSSSCG00000023149 HIST1H2AC 0.59  1.69  3.0E-03 0.07  
ENSSSCG00000013113 TMEM132A 0.82  1.22  3.0E-03 0.07  
ENSSSCG00000016720 PGAM2 0.84  1.20  3.0E-03 0.07  
ENSSSCG00000008629 ROCK2 0.85  1.18  3.0E-03 0.07  
ENSSSCG00000018005 MYH1 0.71  1.42  3.0E-03 0.07  
ENSSSCG00000023591 GPR111 0.37  2.70  3.0E-03 0.07  
ENSSSCG00000026116 FHOD1 0.85  1.18  3.0E-03 0.07  
ENSSSCG00000003514 . 0.81  1.23  3.1E-03 0.07  
ENSSSCG00000010688 MCMBP 1.47  0.68  3.1E-03 0.07  
ENSSSCG00000012378 PDZD11 1.64  0.61  3.1E-03 0.07  
ENSSSCG00000014876 MYO7A 0.66  1.52  3.1E-03 0.07  
ENSSSCG00000016125 INO80D 1.55  0.65  3.1E-03 0.07  
ENSSSCG00000020879 FBXW7 0.97  1.04  3.1E-03 0.07  
ENSSSCG00000021632 VAPA 0.83  1.21  3.1E-03 0.07  
ENSSSCG00000015581 CENPF 0.61  1.63  3.1E-03 0.07  
ENSSSCG00000026055 . 1.61  0.62  3.1E-03 0.07  
ENSSSCG00000001752 CHRNA3 0.39  2.54  3.2E-03 0.07  
ENSSSCG00000001071 . 0.78  1.28  3.2E-03 0.07  
ENSSSCG00000011973 COL8A1 0.64  1.56  3.2E-03 0.07  
ENSSSCG00000027204 . 0.73  1.37  3.2E-03 0.07  
ENSSSCG00000011371 NDUFAF3 1.69  0.59  3.2E-03 0.07  




Supplementary Table 7      








low tADG P-value q-value 
ENSSSCG00000013366 LDHA 0.80  1.25  3.2E-03 0.07  
ENSSSCG00000022373 JMJD6 1.47  0.68  3.2E-03 0.07  
ENSSSCG00000003140 FGF21 0.62  1.60  3.3E-03 0.07  
ENSSSCG00000011998 VGLL3 0.74  1.34  3.3E-03 0.07  
ENSSSCG00000016113 BMPR2 0.93  1.08  3.3E-03 0.07  
ENSSSCG00000016722 UBE2D4 0.87  1.16  3.3E-03 0.07  
ENSSSCG00000012291 GPKOW 1.68  0.60  3.3E-03 0.08  
ENSSSCG00000010029 DRG1 1.52  0.66  3.3E-03 0.08  
ENSSSCG00000001494 BAG2 0.81  1.23  3.4E-03 0.08  
ENSSSCG00000007481 ZFP64 0.78  1.27  3.4E-03 0.08  
ENSSSCG00000007799 HUMMLC2B 0.89  1.12  3.4E-03 0.08  
ENSSSCG00000023608 . 0.34  2.96  3.4E-03 0.08  
ENSSSCG00000017186 RNF157 0.83  1.20  3.4E-03 0.08  
ENSSSCG00000029991 SNIP1 1.51  0.66  3.4E-03 0.08  
ENSSSCG00000001079 E2F3 0.80  1.25  3.4E-03 0.08  
ENSSSCG00000014865 PRKRIR 1.61  0.62  3.5E-03 0.08  
ENSSSCG00000017379 ETV4 1.60  0.63  3.5E-03 0.08  
ENSSSCG00000017523 PNPO 0.80  1.26  3.5E-03 0.08  
ENSSSCG00000008590 MFSD2B 0.74  1.35  3.5E-03 0.08  
ENSSSCG00000004497 PSTPIP2 0.84  1.20  3.5E-03 0.08  
ENSSSCG00000006832 PSRC1 0.68  1.46  3.6E-03 0.08  
ENSSSCG00000006995 ASAH1 0.99  1.01  3.6E-03 0.08  
ENSSSCG00000009125 ANK2 0.84  1.19  3.6E-03 0.08  
ENSSSCG00000009947 CMLKR1 0.83  1.20  3.6E-03 0.08  
ENSSSCG00000015545 GLUL 1.83  0.55  3.6E-03 0.08  
ENSSSCG00000021641 PDGFB 0.91  1.10  3.6E-03 0.08  
ENSSSCG00000024817 RASSF2 0.78  1.28  3.6E-03 0.08  
ENSSSCG00000006891 GCLM 0.82  1.23  3.6E-03 0.08  
ENSSSCG00000023124 ADD1 1.77  0.57  3.6E-03 0.08  
ENSSSCG00000000377 . 1.44  0.70  3.6E-03 0.08  
ENSSSCG00000002819 ARL2BP 0.85  1.18  3.8E-03 0.08  
ENSSSCG00000003566 NUDC 1.43  0.70  3.8E-03 0.08  
ENSSSCG00000004121 FBXO30 1.77  0.56  3.8E-03 0.08  
ENSSSCG00000004307 AKIRIN2 0.92  1.09  3.8E-03 0.08  
ENSSSCG00000005982 WDYHV1 1.47  0.68  3.7E-03 0.08  
ENSSSCG00000008041 PKD1 0.93  1.07  3.8E-03 0.08  
ENSSSCG00000010083 PPIL2 1.56  0.64  3.7E-03 0.08  
ENSSSCG00000010312 PLAU 0.81  1.23  3.7E-03 0.08  
ENSSSCG00000011622 KBTBD12 0.92  1.09  3.8E-03 0.08  
ENSSSCG00000012264 ZNF674 1.64  0.61  3.7E-03 0.08  
ENSSSCG00000012300 FOXP3 0.56  1.79  3.7E-03 0.08  
ENSSSCG00000013583 CAMSAP3 4.67  0.21  3.8E-03 0.08  
ENSSSCG00000013605 ACTL9 0.67  1.50  3.7E-03 0.08  
ENSSSCG00000014598 PPFIBP2 1.68  0.59  3.7E-03 0.08  
ENSSSCG00000015604 NEK2 0.53  1.88  3.8E-03 0.08  
ENSSSCG00000015961 CDCA7 0.74  1.36  3.8E-03 0.08  
ENSSSCG00000016157 MYL1 0.86  1.17  3.8E-03 0.08  
ENSSSCG00000016685 WIPF3 1.58  0.63  3.7E-03 0.08  
ENSSSCG00000016923 . 0.79  1.27  3.7E-03 0.08  
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low tADG P-value q-value 
ENSSSCG00000021917 HIPK4 0.85  1.18  3.7E-03 0.08  
ENSSSCG00000023280 SULT2B1 0.56  1.78  3.8E-03 0.08  
ENSSSCG00000025460 SPSB2 0.90  1.11  3.8E-03 0.08  
ENSSSCG00000025973 SLC25A30 0.85  1.18  3.8E-03 0.08  
ENSSSCG00000026495 SAMD11 0.67  1.49  3.8E-03 0.08  
ENSSSCG00000026809 TFDP2 0.84  1.19  3.8E-03 0.08  
ENSSSCG00000027516 CIR1 1.59  0.63  3.8E-03 0.08  
ENSSSCG00000001992 RABGGTA 0.82  1.22  3.9E-03 0.08  
ENSSSCG00000006033 EIF3E 1.58  0.63  3.9E-03 0.08  
ENSSSCG00000011304 ZNF445 1.42  0.71  3.8E-03 0.08  
ENSSSCG00000024651 HEYL 0.85  1.17  3.9E-03 0.08  
ENSSSCG00000002430 EFCAB11 2.05  0.49  3.9E-03 0.08  
ENSSSCG00000005012 ARF6 1.05  0.95  3.9E-03 0.08  
ENSSSCG00000006277 KIAA0146 1.79  0.56  3.9E-03 0.08  
ENSSSCG00000006865 RTCA 0.87  1.15  3.9E-03 0.08  
ENSSSCG00000008522 XDH 9.97  0.10  3.9E-03 0.08  
ENSSSCG00000012631 LONRF3 1.65  0.61  3.9E-03 0.08  
ENSSSCG00000013008 CDCA5 0.78  1.27  3.9E-03 0.08  
ENSSSCG00000013904 . 0.77  1.29  3.9E-03 0.08  
ENSSSCG00000021591 . 2.37  0.42  3.9E-03 0.08  
ENSSSCG00000023784 SEMA3C 0.94  1.06  3.9E-03 0.08  
ENSSSCG00000008974 SDAD1 1.54  0.65  4.0E-03 0.08  
ENSSSCG00000023733 NPG1 17.46  0.06  4.0E-03 0.08  
ENSSSCG00000004806 . 0.67  1.48  4.0E-03 0.08  
ENSSSCG00000012026 ADAMTS1 0.81  1.24  4.0E-03 0.08  
ENSSSCG00000015023 . 0.65  1.55  4.0E-03 0.08  
ENSSSCG00000015840 WRN 1.73  0.58  4.1E-03 0.08  
ENSSSCG00000022342 . 0.86  1.16  4.1E-03 0.08  
ENSSSCG00000008434 TTC7A 0.78  1.28  4.1E-03 0.08  
ENSSSCG00000013875 USE1 1.44  0.69  4.1E-03 0.08  
ENSSSCG00000016983 STC2 0.74  1.34  4.1E-03 0.08  
ENSSSCG00000026074 . 0.69  1.45  4.1E-03 0.08  
ENSSSCG00000015255 IGSF9B 0.61  1.65  4.1E-03 0.08  
ENSSSCG00000001571 MTCH1 1.47  0.68  4.2E-03 0.08  
ENSSSCG00000004094 PPP1R14C 0.69  1.45  4.2E-03 0.08  
ENSSSCG00000008515 MEMO1 0.87  1.15  4.2E-03 0.08  
ENSSSCG00000010272 ADAMTS14 0.64  1.57  4.2E-03 0.08  
ENSSSCG00000022018 . 0.86  1.16  4.2E-03 0.08  
ENSSSCG00000025335 ZNF323 1.79  0.56  4.2E-03 0.08  
ENSSSCG00000026637 U6 0.22  4.50  4.2E-03 0.08  
ENSSSCG00000000690 MLF2 1.00  1.00  4.3E-03 0.08  
ENSSSCG00000004012 THBS2 0.49  2.03  4.3E-03 0.08  
ENSSSCG00000004500 C18ORF25 0.90  1.10  4.3E-03 0.08  
ENSSSCG00000006737 IGSF3 0.77  1.30  4.2E-03 0.08  
ENSSSCG00000009211 PIGY 1.62  0.62  4.2E-03 0.08  
ENSSSCG00000013022 PYGM 0.80  1.25  4.2E-03 0.08  
ENSSSCG00000014947 EEF1A1 0.85  1.18  4.3E-03 0.08  
ENSSSCG00000021265 ACR 8.54  0.12  4.2E-03 0.08  
ENSSSCG00000024064 RNF6 1.48  0.68  4.3E-03 0.08  
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low tADG P-value q-value 
ENSSSCG00000030002 . 1.45  0.69  4.2E-03 0.08  
ENSSSCG00000006754 AMPD1 0.80  1.25  4.3E-03 0.08  
ENSSSCG00000026686 PDZD9 0.46  2.18  4.3E-03 0.08  
ENSSSCG00000009324 SLC7A1 0.89  1.12  4.3E-03 0.08  
ENSSSCG00000022162 RAB11FIP5 2.64  0.38  4.4E-03 0.08  
ENSSSCG00000024112 . 0.64  1.55  4.4E-03 0.08  
ENSSSCG00000002861 NUDT19 0.95  1.06  4.5E-03 0.08  
ENSSSCG00000003662 NT5C1A 0.68  1.48  4.4E-03 0.08  
ENSSSCG00000004098 . 0.66  1.52  4.4E-03 0.08  
ENSSSCG00000006564 RAB13 0.93  1.08  4.5E-03 0.08  
ENSSSCG00000008508 FAM98A 0.95  1.05  4.4E-03 0.08  
ENSSSCG00000012607 FAM70A 3.46  0.29  4.5E-03 0.08  
ENSSSCG00000021092 FAM53C 0.83  1.21  4.5E-03 0.08  
ENSSSCG00000025329 DDX49 1.62  0.62  4.5E-03 0.08  
ENSSSCG00000026456 . 0.88  1.14  4.4E-03 0.08  
ENSSSCG00000001550 C6ORF81 4.70  0.21  4.5E-03 0.08  
ENSSSCG00000003595 SERINC2 0.92  1.09  4.5E-03 0.08  
ENSSSCG00000023728 TBCEL 0.84  1.20  4.5E-03 0.08  
ENSSSCG00000015548 RGSL1 2.63  0.38  4.6E-03 0.08  
ENSSSCG00000021997 ALS2CL 1.57  0.64  4.6E-03 0.08  
ENSSSCG00000023097 ZNF408 1.55  0.64  4.6E-03 0.08  
ENSSSCG00000006187 MSC 0.81  1.24  4.6E-03 0.08  
ENSSSCG00000011649 PPP2R3A 0.94  1.06  4.6E-03 0.08  
ENSSSCG00000008991 FREM3 0.86  1.17  4.6E-03 0.09  
ENSSSCG00000010025 LIMK2 1.65  0.60  4.6E-03 0.09  
ENSSSCG00000012595 LRCH2 1.53  0.65  4.6E-03 0.09  
ENSSSCG00000016186 . 1.55  0.65  4.6E-03 0.09  
ENSSSCG00000016658 ANLN 0.69  1.44  4.6E-03 0.09  
ENSSSCG00000020910 STYXL1 0.80  1.25  4.6E-03 0.09  
ENSSSCG00000009346 N4BP2L2 1.50  0.67  4.7E-03 0.09  
ENSSSCG00000007351 FAM83D 0.63  1.58  4.7E-03 0.09  
ENSSSCG00000024023 HNMT 0.76  1.31  4.7E-03 0.09  
ENSSSCG00000027530 TAF12 1.53  0.65  4.7E-03 0.09  
ENSSSCG00000001384 VARS2 1.38  0.72  4.7E-03 0.09  
ENSSSCG00000006324 ALDH9A1 1.05  0.95  4.7E-03 0.09  
ENSSSCG00000022191 . 1.54  0.65  4.7E-03 0.09  
ENSSSCG00000024633 JAKMIP3 2.64  0.38  4.7E-03 0.09  
ENSSSCG00000002429 FOXN3 0.85  1.17  4.7E-03 0.09  
ENSSSCG00000009548 ANKRD10 0.87  1.15  4.7E-03 0.09  
ENSSSCG00000000141 EIF3D 1.39  0.72  4.7E-03 0.09  
ENSSSCG00000005704 EXOSC2 1.62  0.62  4.8E-03 0.09  
ENSSSCG00000007551 GPR146 1.71  0.58  4.8E-03 0.09  
ENSSSCG00000016178 IGFBP5 0.57  1.77  4.8E-03 0.09  
ENSSSCG00000000691 COPS7A 0.95  1.05  4.8E-03 0.09  
ENSSSCG00000025619 . 2.82  0.35  4.8E-03 0.09  
ENSSSCG00000009220 DMP1 2.11  0.47  4.9E-03 0.09  
ENSSSCG00000009441 SUGT1 1.39  0.72  4.8E-03 0.09  
ENSSSCG00000017472 IGFBP4 1.05  0.96  4.9E-03 0.09  
ENSSSCG00000022362 PPP3R1 0.86  1.16  4.8E-03 0.09  
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low tADG P-value q-value 
ENSSSCG00000005005 RPL36A 1.71  0.58  4.9E-03 0.09  
ENSSSCG00000023333 FCN2 0.78  1.28  4.9E-03 0.09  
ENSSSCG00000003998 ZNF274 1.65  0.61  4.9E-03 0.09  
ENSSSCG00000025941 . 0.88  1.14  4.9E-03 0.09  
ENSSSCG00000025940 . 1.37  0.73  4.9E-03 0.09  
ENSSSCG00000017083 SPARC 0.94  1.07  5.0E-03 0.09  
ENSSSCG00000003435 MIIP 1.53  0.65  5.0E-03 0.09  
ENSSSCG00000011655 . 0.59  1.69  5.0E-03 0.09  
ENSSSCG00000002389 VASH1 0.77  1.29  5.0E-03 0.09  
ENSSSCG00000030911 CH242-353D8.1 0.84  1.19  5.0E-03 0.09  
ENSSSCG00000011589 IFT122 1.90  0.53  5.1E-03 0.09  
ENSSSCG00000002806 MMP15 0.76  1.31  5.2E-03 0.09  
ENSSSCG00000005998 DEPTOR 0.76  1.32  5.1E-03 0.09  
ENSSSCG00000006345 OLFML2B 0.81  1.23  5.1E-03 0.09  
ENSSSCG00000008153 NHE-2 0.74  1.36  5.2E-03 0.09  
ENSSSCG00000008273 WBP1 1.67  0.60  5.2E-03 0.09  
ENSSSCG00000011215 OXSM 1.80  0.56  5.1E-03 0.09  
ENSSSCG00000013248 LRP4 1.86  0.54  5.1E-03 0.09  
ENSSSCG00000013457 DOT1L 0.90  1.11  5.2E-03 0.09  
ENSSSCG00000015405 CD36 1.51  0.66  5.1E-03 0.09  
ENSSSCG00000016323 COPS8 1.44  0.70  5.1E-03 0.09  
ENSSSCG00000022147 CHURC1 1.49  0.67  5.1E-03 0.09  
ENSSSCG00000023735 . 2.72  0.37  5.2E-03 0.09  
ENSSSCG00000026668 HIST1H2BG 0.30  3.32  5.2E-03 0.09  
ENSSSCG00000028228 XPO1 1.57  0.64  5.2E-03 0.09  
ENSSSCG00000009040 SMAD1 0.86  1.16  5.2E-03 0.09  
ENSSSCG00000003872 EPS15 0.94  1.07  5.2E-03 0.09  
ENSSSCG00000025146 . 0.86  1.16  5.2E-03 0.09  
ENSSSCG00000029027 . 0.83  1.20  5.3E-03 0.09  
ENSSSCG00000012001 ROBO1 0.81  1.23  5.3E-03 0.09  
ENSSSCG00000014559 PSMD13 1.43  0.70  5.3E-03 0.09  
ENSSSCG00000008097 TTL 0.82  1.22  5.3E-03 0.09  
ENSSSCG00000012745 HMGB3 0.84  1.19  5.3E-03 0.09  
ENSSSCG00000008378 FAM161A 1.41  0.71  5.3E-03 0.09  
ENSSSCG00000002663 GINS2 0.64  1.55  5.3E-03 0.09  
ENSSSCG00000007618 ZNF500 1.58  0.63  5.3E-03 0.09  
ENSSSCG00000025020 PCSK9 0.56  1.78  5.4E-03 0.09  
ENSSSCG00000027428 ENHO 0.85  1.17  5.4E-03 0.09  
ENSSSCG00000028635 GTF2IRD2 1.59  0.63  5.4E-03 0.09  
ENSSSCG00000028740 CTDSPL 1.59  0.63  5.4E-03 0.09  
ENSSSCG00000030404 PAPD5 0.90  1.11  5.4E-03 0.09  
ENSSSCG00000006261 TCEA1 1.50  0.67  5.4E-03 0.09  
ENSSSCG00000005378 ANKS6 1.63  0.62  5.5E-03 0.09  
ENSSSCG00000009042 OTUD4 0.88  1.13  5.5E-03 0.09  
ENSSSCG00000010313 VCL 0.93  1.07  5.5E-03 0.09  
ENSSSCG00000014248 LMNB1 0.81  1.23  5.5E-03 0.09  
ENSSSCG00000022601 ZNF10 1.45  0.69  5.5E-03 0.09  
ENSSSCG00000025473 PIGM 1.86  0.54  5.5E-03 0.09  
ENSSSCG00000027594 USP16 1.43  0.70  5.5E-03 0.09  
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low tADG P-value q-value 
ENSSSCG00000016095 CLK1 1.56  0.64  5.6E-03 0.09  
ENSSSCG00000003463 AGMAT 3.04  0.33  5.6E-03 0.09  
ENSSSCG00000003154 GYS1 0.86  1.16  5.6E-03 0.09  
ENSSSCG00000005381 . 0.73  1.36  5.6E-03 0.09  
ENSSSCG00000016717 MPP6 1.63  0.61  5.6E-03 0.09  
ENSSSCG00000024018 SLC16A3 0.79  1.26  5.6E-03 0.09  
ENSSSCG00000029219 SH3BGR 0.86  1.16  5.6E-03 0.09  
ENSSSCG00000007082 OTOR 0.58  1.74  5.6E-03 0.09  
ENSSSCG00000024577 . 0.87  1.15  5.7E-03 0.09  
ENSSSCG00000006135 CPNE3 1.01  0.99  5.7E-03 0.09  
ENSSSCG00000011885 FBXO40 0.79  1.26  5.7E-03 0.09  
ENSSSCG00000009076 PLK4 0.78  1.28  5.8E-03 0.09  
ENSSSCG00000013849 TPM4 1.03  0.97  5.8E-03 0.09  
ENSSSCG00000025470 TSSK4 0.81  1.24  5.8E-03 0.09  
ENSSSCG00000006035 ANGPT1 0.65  1.54  5.8E-03 0.09  
ENSSSCG00000006059 NCALD 0.95  1.05  5.8E-03 0.09  
ENSSSCG00000007798 TBC1D10B 0.79  1.27  5.9E-03 0.09  
ENSSSCG00000008089 CKAP2L 0.65  1.54  5.8E-03 0.09  
ENSSSCG00000008765 PCDH7 0.88  1.13  5.9E-03 0.09  
ENSSSCG00000009545 COL4A2 0.93  1.07  5.9E-03 0.09  
ENSSSCG00000014338 HSPA9 1.58  0.63  5.8E-03 0.09  
ENSSSCG00000015460 . 2.08  0.48  5.8E-03 0.09  
ENSSSCG00000017953 FXR2 0.94  1.06  5.8E-03 0.09  
ENSSSCG00000021988 TUSC3 0.86  1.17  5.9E-03 0.09  
ENSSSCG00000005890 ZNF7 1.53  0.65  5.9E-03 0.09  
ENSSSCG00000016925 PLK2 0.76  1.31  5.9E-03 0.09  
ENSSSCG00000027778 GLO1 0.93  1.07  6.0E-03 0.10  
ENSSSCG00000005380 COL15A1 0.80  1.24  6.1E-03 0.10  
ENSSSCG00000007027 SLC20A2 0.96  1.04  6.1E-03 0.10  
ENSSSCG00000012054 DOPEY2 1.75  0.57  6.1E-03 0.10  
ENSSSCG00000028322 BTG2 0.56  1.79  6.1E-03 0.10  
ENSSSCG00000024103 ADPRHL1 0.94  1.06  6.1E-03 0.10  
ENSSSCG00000028169 . 0.95  1.05  6.1E-03 0.10  
ENSSSCG00000026351 SCA7 0.78  1.29  6.1E-03 0.10  
ENSSSCG00000027527 SLC1A4 0.76  1.31  6.1E-03 0.10  
ENSSSCG00000020775 OBSCN 0.82  1.22  6.2E-03 0.10  
ENSSSCG00000028475 KPNA1 0.96  1.04  6.2E-03 0.10  
ENSSSCG00000006549 IL6R 2.78  0.36  6.2E-03 0.10  
ENSSSCG00000029576 ZNF239 1.49  0.67  6.2E-03 0.10  
ENSSSCG00000012703 RBMX 1.50  0.66  6.3E-03 0.10  
ENSSSCG00000029035 ZNF558 1.49  0.67  6.3E-03 0.10  
ENSSSCG00000003645 UTP11L 1.56  0.64  6.3E-03 0.10  
ENSSSCG00000008893 REST 0.85  1.18  6.3E-03 0.10  
ENSSSCG00000013716 . 1.69  0.59  6.3E-03 0.10  
ENSSSCG00000015116 MCAM 0.95  1.05  6.3E-03 0.10  
ENSSSCG00000005679 ASB6 1.45  0.69  6.3E-03 0.10  
ENSSSCG00000026331 ADCK4 1.92  0.52  6.4E-03 0.10  
ENSSSCG00000009640 ENTPD4 0.83  1.20  6.4E-03 0.10  
ENSSSCG00000027140 CDKN1B 1.44  0.69  6.4E-03 0.10  




Supplementary Table 7 (continued) 








low tADG P-value q-value 
ENSSSCG00000001500 COL21A1 0.84  1.19  6.4E-03 0.10  
ENSSSCG00000001701 HSPCB 1.42  0.70  6.4E-03 0.10  
ENSSSCG00000014831 PAAF1 1.62  0.62  6.4E-03 0.10  
ENSSSCG00000025355 ZNF146 1.75  0.57  6.4E-03 0.10  
ENSSSCG00000012411 PHKA1 0.77  1.31  6.5E-03 0.10  
ENSSSCG00000004415 . 1.79  0.56  6.5E-03 0.10  
ENSSSCG00000009194 HPGDS 0.30  3.37  6.5E-03 0.10  
ENSSSCG00000020865 MBP 1.65  0.60  6.5E-03 0.10  
ENSSSCG00000002621 TRAM2 1.57  0.64  6.6E-03 0.10  
ENSSSCG00000014859 SERPINH1 0.98  1.02  6.6E-03 0.10  
ENSSSCG00000017499 STARD3 1.43  0.70  6.6E-03 0.10  
ENSSSCG00000027257 PSMB1 1.48  0.67  6.6E-03 0.10  
ENSSSCG00000026526 CATSPER4 2.23  0.45  6.6E-03 0.10  
ENSSSCG00000004390 SESN1 1.50  0.67  6.6E-03 0.10  
ENSSSCG00000005083 DHRS7 1.60  0.62  6.6E-03 0.10  
ENSSSCG00000015842 PPP2CB 0.98  1.02  6.7E-03 0.10  
ENSSSCG00000015873 ACVR1C 0.18  5.50  6.6E-03 0.10  
ENSSSCG00000024329 C12ORF43 1.58  0.63  6.6E-03 0.10  






CHAPTER 6. GENERAL DISCUSSION 
To manipulate is “to use or change in a skillful way or for a particular purpose” 
(Merriam-Webster, 2015). As it pertains to growth in the pig, manipulation involves 
altering growth to improve body weight gain, feed efficiency, or nutrient utilization, and, 
ultimately, overall profitability for pork production systems. To regulate is “to set or 
adjust the amount, degree, or rate of” (Merriam-Webster, 2015). In animals, regulation of 
growth is under hormonal control and can be heavily influenced by genetic, 
environmental, management and nutritional factors. In this dissertation, we investigated 
both the manipulation (Chapters 2 and 3) and the regulation (Chapter 4) of post-weaning 
growth in pigs. 
When studying the regulation of growth in Chapter 4, we found increased 
expression of glycolytic genes in faster growing pigs accompanied by increased 
expression of myosin heavy chain (MHC) isoforms that are associated with fast 
glycolytic and fast oxidative/glycolytic fibers (types IIA, IIB, and IIX), without a 
significant change in expression of the MHC type I isoform, which is associated with 
slow oxidative muscle fibers. Ractopamine is able to manipulate growth through skeletal 
muscle hypertrophy and up-regulation of skeletal muscle-specific contractile proteins 
(Adeola et al., 1992; Grant et al., 1993). Feeding β-adrenergic receptor agonists increases 
the frequency and size of type II fibers, especially type IIB fibers, the fastest contracting, 
most glycolytic muscle fiber type (Beermann et al., 1987; Depreux et al., 2002). 
Gunawan et al. (2007) showed that RAC increased expression of the MHC isomer type 
IIB, but not MHC type I. This indicates that faster growth is associated with transition to 




if this is a true cause and effect relationship or simply an association between the whole 
animal and its underlying physiology. In any event, RAC achieves improved growth not 
by correcting metabolic differences in slower growing pigs, but through direct effects on 
protein synthesis. This is clearly revealed by the fact that faster growing pigs respond 
with a greater increase in rate of growth than slower growing pigs, although both benefit 
from the use of RAC in the diet (Patience et al., 2009). 
Feeding RAC may be a way to overcome down regulation in growth and reduce 
the negative impact that pigs with poor post-weaning growth rates have on production 
system throughput. Patience et al. (2009) showed that RAC dramatically reduced the 
number of tail-end pigs, from 7.5% to 0.8%, which demonstrates the importance of RAC 
as a tool to improve the value of slow growing pigs, especially in systems that heavily 
penalize the marketing of lightweight pigs. 
It is well understood that growth of animals and their response to dietary or other 
management interventions can be specific to conditions on the farm. For example, the 
health status and sanitation of farms can have an impact on the effectiveness of antibiotic 
growth promoters (AGPs). Numerous studies have demonstrated improved growth and 
nutrient utilization responses in pigs fed AGPs (Hays, 1979; Jordan et al., 1960; Roth and 
Kirchgessner, 1993); however, others have reported little to no response in high-health 
pigs reared in “clean” environments (Van Lunen, 2003; Weber and Kerr, 2008). In 
Chapters 2 and 3, we found very little impact of tylosin phosphate (TP) on nutrient 
digestibility or utilization for growth. Pigs employed in our studies had a high health 
status and were housed in individual pens, which were cleaned frequently to facilitate 




likely resulted in a low incidence of pathogen exposure and low immune system 
stimulation. Since the primary modes of action of AGPs involve reduction in immune 
stimulation caused by pathogenic bacteria and subclinical infections (Gaskins et al., 2002; 
Visek, 1978), the environments in which these experiments were conducted likely 
minimized the opportunity for TP to impact growth and nutrient utilization. Future 
research involving the manipulation of growth utilizing antimicrobial agents should be 
conducted under more immune challenging environments similar to those experienced in 
commercial practice or using controlled disease challenge models. This will be difficult 
because nutrient balance and similarly intensive research needs to be conducted on 
animals housed individually. Therefore, it may be necessary to artificially induce immune 
system stimulation or to intentionally expose animals to pathogens, a practice that is not 
possible in most research facilities. 
Pigs reared in conventional commercial facilities achieve approximately 70% of 
their genetic potential for growth (Holck et al., 1998). Immunological stress is likely the 
primary cause of this shortfall in growth performance. Immune system activation results 
in the production of proinflammatory cytokines, which reduce feed intake and growth 
performance by antagonizing anabolic growth signaling and repartitioning nutrients and 
energy away from skeletal muscle and adipose tissue growth in order to support the 
immune system (Gabler and Spurlock, 2008; Spurlock, 1997). 
In Chapter 4, we identified changes in transcript abundance in the longissimus 
dorsi muscle that indicated a possible shift in poor growing pigs to decreased protein 
synthesis, increased protein degradation, and reduced glucose metabolism. Although no 




pigs have been established (Huang et al., 2012; Huang and Harding, 2014; Jones et al., 
2014), it is possible that the some of the alterations in gene expression in skeletal muscle 
reported in Chapter 4 were due to immune stimulation. 
Crossland et al. (2008) demonstrated that Akt/forkhead box O (FOXO) signaling 
plays a role in simultaneous up-regulation in muscle protein degradation and impairment 
of carbohydrate metabolism during immune stimulation using a rodent model of 
lipopolysaccharide (LPS)-induced endotoxaemia. In non-catabolic states (e.g. the muscle 
of a fast growing pig), stimulation with growth factors, such as insulin-like growth factor-
1, and hormones, such as insulin, leads to the activation of the Akt/phosphatidylinositol-3 
kinase signaling cascade. Activation of this pathway inactivates protein degradation via 
phosphorylation of FOXO proteins and activates protein synthesis via the mammalian 
target of rapamycin. When anabolic signaling is low and when cytokine levels are 
elevated, FOXO phosphorylation is low and FOXO proteins translocate to the nucleus to 
up-regulate the transcription of genes involved in protein degradation and the negative 
regulation of carbohydrate metabolism (Crossland et al., 2008). In Chapter 4, we reported 
higher expression of FOXO1 and atrogin 1, a key E3 ubiquitin ligase, and reduced 
expression of several key genes involved in carbohydrate metabolism (e.g. pyruvate 
kinase, glucose-6-phosphate isomerase, and glycogen phosphorylase) in poor growing 
pigs. More research is needed to confirm these responses in poor growing pigs at the 
levels of protein expression and protein activity. 
Many of these pathways are shared among several catabolic events; therefore it is 
challenging in this type of experiment to quantify how much of the differences between 




indirect effects of immune stimulation versus feed intake alone. It would be beneficial for 
future research in this area to use direct comparisons between poor transitioning pigs, 
pair-fed pigs, and normal contemporaries to separate the effect of feed intake. In the 
future, it would also be very beneficial to measure gene expression in the liver, which 
mediates many of the responses to immune system activation; our study considered 
muscle and adipose tissue only. 
Feeding of dried distillers grains with solubles (DDGS) is another factor which 
may impact growth in a situationally dependent manner. Several studies have 
demonstrated that DDGS inclusion may reduce pig growth performance during the 
grower-finisher period (Hinson et al., 2007; Linneen et al., 2008; Whitney et al., 2006); 
however, there are many examples in the literature where feeding DDGS did not reduce 
ADG (Cook et al., 2005; DeDecker et al., 2005; Widmer et al., 2008) even at levels up to 
60% of the diet (Weber et al., 2015). In Chapter 3, we observed reduced growth 
performance and feed intake in pigs feed a high fiber diet containing 30% DDGS. We 
speculate that the reduction in feed intake was likely due to a restriction in the amount of 
time pigs were allowed access to their feed. Corn DDGS is much lower in bulk density 
than corn and soybean meal at 483 kg/m3 vs. 718 and 673 kg/m3, respectively 
(Rosentrater, 2006), which may cause a reduction in the amount of feed that a pig 
consumes per meal or per unit time. This may be especially important to note when high 
fiber ingredients are fed in commercial production situations where the feed intake 
capacity of the pigs may be limited by health or environmental factors (e.g. health 




As expected, amino acid, nitrogen, and energy digestibility were lower in diets 
which contained DDGS (Chapters 2 and 3). The DDGS diets contained more dietary fiber, 
and much of the fiber in DDGS is insoluble (Gutierrez et al., 2014). Insoluble fiber is 
poorly digested by the pig in both the upper and lower gut and negatively contributes to 
the apparent total tract digestibility of energy in diets which contain DDGS. The lower 
digestibility of nutrients and energy within DDGS compared to corn and soybean meal is 
well documented (NRC, 2012) and diets were formulated to account for these differences. 
However, traditional digestibility measurements may overestimate the feeding value of 
DDGS. Diets used in these experiments were formulated to contain equal concentrations 
of metabolizable energy (ME); however, the ME system may overestimate the actual net 
energy contributions of feedstuffs that are high in dietary fiber and protein, such as 
DDGS (Noblet, 2007; NRC, 2012). 
Also, during the DDGS drying process, lysine is sometimes destroyed or 
converted to compounds that cannot be utilized by the pig due to Maillard reactions 
(Pahm et al., 2009). Maillard reaction end-products may be either excreted in feces or 
absorbed and excreted in urine (Faist and Erbersdobler, 2001). Higher concentrations of 
dietary fiber may also reduce the utilization of AA by increasing specific endogenous 
losses (Lenis et al., 1996) which contribute to higher fecal N losses. Thus, the SID 
concentration reported for corn DDGS and determined using classical approaches may 
overstate their nutritive value, leading to over-estimation of dietary available amino acid 
content (Stein et al., 2007). This may contribute to the reduced growth performance 
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